{
  "metadata": {
    "generated_at": "2025-10-04T16:41:21.570155",
    "total_interventions": 575,
    "unique_interventions": 539,
    "unique_conditions": 279,
    "unique_papers": 288,
    "canonical_entities": 191,
    "positive_correlations": 387,
    "negative_correlations": 74,
    "intervention_categories": {
      "medication": 211,
      "therapy": 82,
      "supplement": 50,
      "exercise": 39,
      "surgery": 37,
      "lifestyle": 31,
      "diet": 29,
      "biologics": 26,
      "emerging": 23,
      "procedure": 21,
      "device": 12,
      "test": 12
    },
    "condition_categories": {
      "musculoskeletal": 57,
      "oncological": 55,
      "digestive": 54,
      "rheumatological": 53,
      "cardiac": 48,
      "psychiatric": 43,
      "renal": 42,
      "endocrine": 42,
      "infectious": 41,
      "neurological": 32,
      "pulmonary": 31,
      "dermatological": 30,
      "other": 13,
      "immunological": 10,
      "hematological": 10,
      "toxicological": 5,
      "nutritional": 5
    }
  },
  "top_performers": {
    "interventions": [
      {
        "name": "alkaloid",
        "intervention_category": "supplement",
        "count": 10,
        "avg_strength": null,
        "paper_count": 1
      },
      {
        "name": "Percutaneous Mechanical Aspiration (PMA)",
        "intervention_category": "procedure",
        "count": 5,
        "avg_strength": null,
        "paper_count": 2
      },
      {
        "name": "Potassium-competitive acid blockers (PCABs)",
        "intervention_category": "medication",
        "count": 5,
        "avg_strength": null,
        "paper_count": 1
      },
      {
        "name": "aerobic exercise",
        "intervention_category": "exercise",
        "count": 5,
        "avg_strength": null,
        "paper_count": 5
      },
      {
        "name": "elobixibat",
        "intervention_category": "medication",
        "count": 5,
        "avg_strength": null,
        "paper_count": 1
      },
      {
        "name": "EEG",
        "intervention_category": "test",
        "count": 4,
        "avg_strength": null,
        "paper_count": 1
      },
      {
        "name": "all-trans retinoic acid (ATRA)",
        "intervention_category": "medication",
        "count": 4,
        "avg_strength": null,
        "paper_count": 1
      },
      {
        "name": "corticosteroids",
        "intervention_category": "medication",
        "count": 4,
        "avg_strength": null,
        "paper_count": 2
      },
      {
        "name": "cycling",
        "intervention_category": "exercise",
        "count": 4,
        "avg_strength": null,
        "paper_count": 2
      },
      {
        "name": "music therapy",
        "intervention_category": "therapy",
        "count": 4,
        "avg_strength": null,
        "paper_count": 2
      }
    ],
    "conditions": [
      {
        "name": "knee osteoarthritis",
        "condition_category": "musculoskeletal",
        "count": 18,
        "intervention_count": 18,
        "paper_count": 9
      },
      {
        "name": "rheumatoid arthritis",
        "condition_category": "rheumatological",
        "count": 15,
        "intervention_count": 15,
        "paper_count": 4
      },
      {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "condition_category": "endocrine",
        "count": 14,
        "intervention_count": 14,
        "paper_count": 1
      },
      {
        "name": "Helicobacter pylori infection",
        "condition_category": "digestive",
        "count": 12,
        "intervention_count": 12,
        "paper_count": 5
      },
      {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "condition_category": "oncological",
        "count": 11,
        "intervention_count": 11,
        "paper_count": 1
      },
      {
        "name": "sepsis",
        "condition_category": "infectious",
        "count": 9,
        "intervention_count": 9,
        "paper_count": 3
      },
      {
        "name": "inflammatory bowel disease (IBD)",
        "condition_category": "digestive",
        "count": 8,
        "intervention_count": 8,
        "paper_count": 4
      },
      {
        "name": "kidney stones",
        "condition_category": "renal",
        "count": 8,
        "intervention_count": 8,
        "paper_count": 2
      },
      {
        "name": "prostate cancer",
        "condition_category": "oncological",
        "count": 8,
        "intervention_count": 8,
        "paper_count": 2
      },
      {
        "name": "Large vessel vasculitis",
        "condition_category": "rheumatological",
        "count": 6,
        "intervention_count": 6,
        "paper_count": 1
      }
    ]
  },
  "interventions": [
    {
      "id": 1168,
      "intervention": {
        "name": "Digital health (DH)",
        "canonical_name": "Digital health (DH)",
        "category": "emerging",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "Arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "Systematic review of randomized controlled trials",
        "sample_size": 2449,
        "duration": null,
        "population": "Rheumatoid arthritis (n=5), gout (n=2), juvenile idiopathic arthritis (n=1)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of Digital Health Intervention in Enhancing Medication Adherence Among Arthritis Patients: A Systematic Review of Randomized Controlled Trials.",
        "journal": "Nepal journal of epidemiology",
        "publication_date": "2024",
        "pubmed_id": "40919069",
        "doi": "10.3126/nje.v14i4.77347"
      },
      "supporting_quote": "It is concluded that 62.5% of the RCTs showed significant contributions of digital health tools in arthritis management, mainly by enhancing medication adherence and thus improving patients' QoL.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:06:34"
    },
    {
      "id": 1166,
      "intervention": {
        "name": "virtual reality technology (VRT)",
        "canonical_name": null,
        "category": "device",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "rehabilitation after anterior cruciate ligament reconstruction",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 387,
        "duration": null,
        "population": "patients who had undergone ACLR",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of virtual reality technology in rehabilitation after anterior cruciate ligament reconstruction: A systematic review and meta-analysis.",
        "journal": "PloS one",
        "publication_date": "2025",
        "pubmed_id": "40029868",
        "doi": "10.1371/journal.pone.0314766"
      },
      "supporting_quote": "VRT significantly enhanced knee function, walking ability, gait function, and knee muscle strength post-ACLR.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:05:09"
    },
    {
      "id": 1167,
      "intervention": {
        "name": "traditional therapy",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "rehabilitation after anterior cruciate ligament reconstruction",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 387,
        "duration": null,
        "population": "patients who had undergone ACLR",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of virtual reality technology in rehabilitation after anterior cruciate ligament reconstruction: A systematic review and meta-analysis.",
        "journal": "PloS one",
        "publication_date": "2025",
        "pubmed_id": "40029868",
        "doi": "10.1371/journal.pone.0314766"
      },
      "supporting_quote": "VRT is a more effective treatment than traditional therapy in post-ACLR rehabilitation.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:05:09"
    },
    {
      "id": 1164,
      "intervention": {
        "name": "repetitive transcranial magnetic stimulation (rTMS)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "schizophrenia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 100,
        "duration": "24 months",
        "population": "patients with schizophrenia",
        "adverse_effects": "no serious adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "Clinical efficacy and safety of repetitive transcranial magnetic stimulation (RTMS) in combination with antipsychotic medications in patients with schizophrenia.",
        "journal": "Pakistan journal of pharmaceutical sciences",
        "publication_date": "2025",
        "pubmed_id": "40996171",
        "doi": "10.36721/PJPS.2025.38.5.REG.13925.1"
      },
      "supporting_quote": "rTMS combined with antipsychotic drugs has good efficacy and safety in the treatment of schizophrenia",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:04:14"
    },
    {
      "id": 1165,
      "intervention": {
        "name": "antipsychotic medications",
        "canonical_name": "antipsychotic medications",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "schizophrenia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.8,
        "extraction_confidence": 1.0,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 100,
        "duration": "24 months",
        "population": "patients with schizophrenia",
        "adverse_effects": "no serious adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "Clinical efficacy and safety of repetitive transcranial magnetic stimulation (RTMS) in combination with antipsychotic medications in patients with schizophrenia.",
        "journal": "Pakistan journal of pharmaceutical sciences",
        "publication_date": "2025",
        "pubmed_id": "40996171",
        "doi": "10.36721/PJPS.2025.38.5.REG.13925.1"
      },
      "supporting_quote": "Antipsychotic drugs are commonly used treatments, but they have many side effects",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:04:14"
    },
    {
      "id": 1163,
      "intervention": {
        "name": "mesenchymal stem cell (MSC) injections",
        "canonical_name": null,
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 467,
        "duration": "up to 12 months",
        "population": "adults with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Contextual effects of mesenchymal stem cell injections for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials.",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "41041444",
        "doi": "10.3389/fmed.2025.1636181"
      },
      "supporting_quote": "Randomized controlled trials enrolling adults with KOA that compared MSC injections with inert placebo were included.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:03:24"
    },
    {
      "id": 1162,
      "intervention": {
        "name": "Hericium erinaceus (HE)",
        "canonical_name": "catechin",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "neural stimulation",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "stomach discomfort, headache, allergic reactions",
        "cost_category": null
      },
      "paper": {
        "title": "Benefits, side effects, and uses of",
        "journal": "Frontiers in nutrition",
        "publication_date": "2025",
        "pubmed_id": "40959699",
        "doi": "10.3389/fnut.2025.1641246"
      },
      "supporting_quote": "HE is effective in neuroprotection, enhancing cognitive function, preventing and alleviating cancer, promoting gut health, and improving symptoms of anxiety and depression",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:02:54"
    },
    {
      "id": 1161,
      "intervention": {
        "name": "vitamin D supplementation",
        "canonical_name": "vitamin D supplementation",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "diabetic kidney disease (DKD)",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Role of vitamin D in the development and progression of diabetic kidney disease: an overview of meta-analyses.",
        "journal": "Therapeutic advances in endocrinology and metabolism",
        "publication_date": "2025",
        "pubmed_id": "40297636",
        "doi": "10.1177/20420188251319476"
      },
      "supporting_quote": "The review suggested that vitamin D supplementation could help in reducing proteinuria among DKD patients.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:02:24"
    },
    {
      "id": 1160,
      "intervention": {
        "name": "Clinical pharmacist integration",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "secondary stroke prevention",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "global population with stroke or TIA",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Integrating clinical pharmacists in care management for secondary stroke prevention clinical trials: a scoping review.",
        "journal": "Frontiers in neurology",
        "publication_date": "2025",
        "pubmed_id": "41041674",
        "doi": "10.3389/fneur.2025.1666409"
      },
      "supporting_quote": "Published RCTs examining CP impact within secondary stroke prevention teams suggest that interventions inclusive of CPs delivering medication education, reconciliation, and titration may improve vascular risk factor control, medication adherence, and patient-oriented outcomes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:01:59"
    },
    {
      "id": 1159,
      "intervention": {
        "name": "Comprehensive Behavioral (ComB) model",
        "canonical_name": "cognitive behavioral therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "trichotillomania",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "What do therapists with prior experience treating trichotillomania do differently?",
        "journal": "Bulletin of the Menninger Clinic",
        "publication_date": "2025",
        "pubmed_id": "40990973",
        "doi": "10.1521/bumc.2025.89.3.194"
      },
      "supporting_quote": "therapists with previous experience treating trichotillomania (TTM) achieved better outcomes than did TTM-novice therapists in a randomized controlled trial of the Comprehensive Behavioral (ComB) model",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:00:59"
    },
    {
      "id": 1158,
      "intervention": {
        "name": "immune checkpoint inhibitors (ICIs)",
        "canonical_name": "immune checkpoint inhibitors (ICIs)",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "advanced non-small cell lung cancer",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "multicenter retrospective analysis",
        "sample_size": 1175,
        "duration": null,
        "population": "NSCLC patients with hypertension and without hypertension",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Application of immunotherapy in advanced non-small cell lung cancer with hypertension: a multicenter retrospective analysis.",
        "journal": "Frontiers in oncology",
        "publication_date": "2025",
        "pubmed_id": "41018088",
        "doi": "10.3389/fonc.2025.1621363"
      },
      "supporting_quote": "Immune checkpoint inhibitors (ICIs) have become the standard treatment for advanced non-small cell lung cancer (NSCLC).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:00:32"
    },
    {
      "id": 1157,
      "intervention": {
        "name": "Yoga",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{\"practices\": [\"suryanamaskara\", \"bhujangasana\", \"matsyasana\", \"sarvangasana\", \"halasana\", \"ujjayi pranayama\", \"anulomvilom/nadishodhana\", \"bhastrika pranayama\", \"bhramari pranayama\", \"kapalbhati\", \"jalandhara bandha\"]}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "Thyroid Diseases",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Can Yoga Help to Manage the Symptoms of Thyroid Diseases?",
        "journal": "International journal of yoga",
        "publication_date": "2025",
        "pubmed_id": "40365364",
        "doi": "10.4103/ijoy.ijoy_147_24"
      },
      "supporting_quote": "Studies revealed a trend toward balance in thyroid hormone, reduction in psychological symptoms such as stress, anxiety, and depression, and improvement in the quality of life of thyroid patients through Yoga.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 11:00:05"
    },
    {
      "id": 1156,
      "intervention": {
        "name": "preoperative exercise training",
        "canonical_name": "chemotherapy",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "operable non-small cell lung cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 1022,
        "duration": null,
        "population": "patients scheduled for lung resection",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Postoperative outcomes of preoperative exercise training in patients with operable non-small cell lung cancer: a systematic review and meta-analysis.",
        "journal": "Frontiers in oncology",
        "publication_date": "2025",
        "pubmed_id": "41018094",
        "doi": "10.3389/fonc.2025.1563478"
      },
      "supporting_quote": "preoperative exercise training was effective for lung cancer patients scheduled for lung resection, potentially reducing postoperative complications and hospital stay duration",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:59:26"
    },
    {
      "id": 1155,
      "intervention": {
        "name": "non-invasive vagus nerve stimulation (nVNS)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "drug-resistant epilepsy",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 120,
        "duration": "12 weeks",
        "population": null,
        "adverse_effects": "headaches and neck discomfort",
        "cost_category": null
      },
      "paper": {
        "title": "Investigating the efficacy of non-invasive vagus nerve stimulation in treating drug-resistant epilepsy.",
        "journal": "Bioinformation",
        "publication_date": "2025",
        "pubmed_id": "40978640",
        "doi": "10.6026/973206300211551"
      },
      "supporting_quote": "Over 12 weeks, the intervention group showed a 45% reduction in seizures and a 30% improvement in quality of life",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:58:56"
    },
    {
      "id": 1153,
      "intervention": {
        "name": "arthroscopic reduction without fixation (ARnF)",
        "canonical_name": "open reduction internal fixation (ORIF)",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Broberg & Morrey Type II radial head fractures with a mechanical rotation block",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "case-control study",
        "sample_size": 11,
        "duration": "up to 1 year postoperatively",
        "population": "patients with Broberg & Morrey Type II radial head fractures and a mechanical rotation block",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Arthroscopic reduction with non-fixation for Broberg & Morrey type II radial head fracture with mechanical rotation block: a propensity score-matched case-control study.",
        "journal": "Frontiers in surgery",
        "publication_date": "2025",
        "pubmed_id": "41040671",
        "doi": "10.3389/fsurg.2025.1680368"
      },
      "supporting_quote": "ARnF achieved outcomes comparable to ARIF while avoiding implant costs and implant-related risks",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:57:52"
    },
    {
      "id": 1154,
      "intervention": {
        "name": "arthroscopic reduction with internal fixation (ARIF) using cannulated screws",
        "canonical_name": "open reduction internal fixation (ORIF)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Broberg & Morrey Type II radial head fractures with a mechanical rotation block",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "case-control study",
        "sample_size": null,
        "duration": "up to 1 year postoperatively",
        "population": "patients with Broberg & Morrey Type II radial head fractures and a mechanical rotation block",
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Arthroscopic reduction with non-fixation for Broberg & Morrey type II radial head fracture with mechanical rotation block: a propensity score-matched case-control study.",
        "journal": "Frontiers in surgery",
        "publication_date": "2025",
        "pubmed_id": "41040671",
        "doi": "10.3389/fsurg.2025.1680368"
      },
      "supporting_quote": "ARnF achieved outcomes comparable to ARIF while avoiding implant costs and implant-related risks",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:57:52"
    },
    {
      "id": 1151,
      "intervention": {
        "name": "PD-1/PD-L1 inhibitors combined with chemotherapy",
        "canonical_name": "immune checkpoint inhibitors (ICIs)",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "stage IIIb-IV non-small-cell lung cancer (NSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.95,
        "extraction_confidence": 0.98,
        "study_confidence": 0.97
      },
      "study": {
        "type": "phase 3 randomized controlled trials",
        "sample_size": 9335,
        "duration": null,
        "population": "patients with stage IIIb-IV NSCLC",
        "adverse_effects": "increased incidence of total/grade 3-5 treatment emergent AEs, immune-related AEs (irAEs), blood toxicity related AEs (anemia, neutrophil count decreased)",
        "cost_category": null
      },
      "paper": {
        "title": "The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials.",
        "journal": "Frontiers in oncology",
        "publication_date": "2025",
        "pubmed_id": "41018097",
        "doi": "10.3389/fonc.2025.1590017"
      },
      "supporting_quote": "Our updated analysis confirmed at PC therapy significantly improves OS (hazard ratio [HR]: 0.73 [0.69, 0.77], P < 0.00001), PFS (HR: 0.56 [0.52, 0.60], P < 0.00001), duration of response (DOR, HR: 0.50 [0.45, 0.54], P < 0.00001) and objective response rate (ORR)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:56:55"
    },
    {
      "id": 1152,
      "intervention": {
        "name": "chemotherapy",
        "canonical_name": "chemotherapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "stage IIIb-IV non-small-cell lung cancer (NSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.15,
        "extraction_confidence": 0.92,
        "study_confidence": 0.87
      },
      "study": {
        "type": "phase 3 randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with stage IIIb-IV NSCLC",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials.",
        "journal": "Frontiers in oncology",
        "publication_date": "2025",
        "pubmed_id": "41018097",
        "doi": "10.3389/fonc.2025.1590017"
      },
      "supporting_quote": "Our updated analysis confirmed at PC therapy significantly improves OS (hazard ratio [HR]: 0.73 [0.69, 0.77], P < 0.00001), PFS (HR: 0.56 [0.52, 0.60], P < 0.00001), duration of response (DOR, HR: 0.50 [0.45, 0.54], P < 0.00001) and objective response rate (ORR)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:56:55"
    },
    {
      "id": 1150,
      "intervention": {
        "name": "rituximab therapy",
        "canonical_name": null,
        "category": "biologics",
        "details": "{\"dosage\": \"1,000 mg \\u00d7 2 or 375 mg/m\\u00b2 \\u00d7 3-4\", \"frequency\": \"individualized or standard\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "idiopathic membranous nephropathy (IMN)",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "prospective cohort study",
        "sample_size": 140,
        "duration": "1 year",
        "population": "patients from the east coastal region of China",
        "adverse_effects": "6.4% vs 12.9%",
        "cost_category": "high"
      },
      "paper": {
        "title": "B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal Region of China.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41041325",
        "doi": "10.3389/fimmu.2025.1633532"
      },
      "supporting_quote": "B cell- and anti-PLA2R antibody-targeted rituximab therapy may be a cost-effective and safe alternative for patients with IMN.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:55:26"
    },
    {
      "id": 1148,
      "intervention": {
        "name": "Acupuncture",
        "canonical_name": "traditional Asian nutraceuticals",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "polycystic ovary syndrome (PCOS)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 1000,
        "duration": null,
        "population": "Chinese infertile women with PCOS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Impact of mean arterial pressure on reproductive endocrine characteristics in infertile patients with polycystic ovary syndrome: a secondary analysis of a randomized clinical trial.",
        "journal": "Frontiers in endocrinology",
        "publication_date": "2025",
        "pubmed_id": "41040863",
        "doi": "10.3389/fendo.2025.1594813"
      },
      "supporting_quote": "A total of 1,000 PCOS subjects were enrolled in the clinical trial project of Acupuncture and Clomiphene in the treatment of PCOS infertility patients (PCOSAct)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:54:47"
    },
    {
      "id": 1149,
      "intervention": {
        "name": "Clomiphene",
        "canonical_name": "traditional Asian nutraceuticals",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "polycystic ovary syndrome (PCOS)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 1000,
        "duration": null,
        "population": "Chinese infertile women with PCOS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Impact of mean arterial pressure on reproductive endocrine characteristics in infertile patients with polycystic ovary syndrome: a secondary analysis of a randomized clinical trial.",
        "journal": "Frontiers in endocrinology",
        "publication_date": "2025",
        "pubmed_id": "41040863",
        "doi": "10.3389/fendo.2025.1594813"
      },
      "supporting_quote": "A total of 1,000 PCOS subjects were enrolled in the clinical trial project of Acupuncture and Clomiphene in the treatment of PCOS infertility patients (PCOSAct)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:54:47"
    },
    {
      "id": 1146,
      "intervention": {
        "name": "probiotic supplementation",
        "canonical_name": null,
        "category": "supplement",
        "details": "{\"duration\": \"4 weeks following eradication therapy\", \"frequency\": null, \"dosage\": null}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": 305,
        "duration": "January 2023 to December 2023",
        "population": "adult patients with confirmed H. pylori infection treated at Kunshan Hospital of Traditional Chinese Medicine and Jinxi People's Hospital of Kunshan",
        "adverse_effects": "no serious adverse events were reported in either group",
        "cost_category": null
      },
      "paper": {
        "title": "The role of probiotic supplementation in reducing",
        "journal": "Frontiers in pharmacology",
        "publication_date": "2025",
        "pubmed_id": "40727106",
        "doi": "10.3389/fphar.2025.1621090"
      },
      "supporting_quote": "Probiotic supplementation is associated with a reduced risk of H. pylori recurrence after classic quadruple therapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:53:52"
    },
    {
      "id": 1147,
      "intervention": {
        "name": "standard quadruple therapy",
        "canonical_name": null,
        "category": "medication",
        "details": "{\"duration\": \"14 days\", \"frequency\": null, \"dosage\": null}",
        "delivery_method": null
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.95,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": 305,
        "duration": "January 2023 to December 2023",
        "population": "adult patients with confirmed H. pylori infection treated at Kunshan Hospital of Traditional Chinese Medicine and Jinxi People's Hospital of Kunshan",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The role of probiotic supplementation in reducing",
        "journal": "Frontiers in pharmacology",
        "publication_date": "2025",
        "pubmed_id": "40727106",
        "doi": "10.3389/fphar.2025.1621090"
      },
      "supporting_quote": "All patients received standard quadruple therapy for 14 days",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:53:52"
    },
    {
      "id": 1145,
      "intervention": {
        "name": "electro-acupuncture",
        "canonical_name": null,
        "category": "therapy",
        "details": "{\"duration\": \"6 weeks (12 sessions)\", \"frequency\": \"twice a week\"}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "irritable bowel syndrome with constipation (IBS-C)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 1.0
      },
      "study": {
        "type": "randomized, double-blinded, sham-controlled trial",
        "sample_size": 30,
        "duration": "14 weeks total (2-week screening + 6-week treatment + 6-week follow-up)",
        "population": "IBS-C patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Electro-acupuncture for irritable bowel syndrome with constipation: study protocol of a pilot, randomized, double-blinded, sham-controlled trial.",
        "journal": "Frontiers in neurology",
        "publication_date": "2025",
        "pubmed_id": "41018183",
        "doi": "10.3389/fneur.2025.1632822"
      },
      "supporting_quote": "This a multicentre, randomized, double-blinded, sham-controlled trial. A total of 60 IBS-C patients are randomized to receive either electro-acupuncture (n = 30) or sham acupuncture (n = 30).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:52:45"
    },
    {
      "id": 1144,
      "intervention": {
        "name": "celecoxib",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Knee osteoarthritis (KOA)",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "animal study (rabbit model)",
        "sample_size": 40,
        "duration": null,
        "population": "New Zealand rabbits",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Acupotomy Modulation of NLRP3/Caspase-1/GSDMD Pathway on Chondrocyte Pyroptosis in Knee Osteoarthritis.",
        "journal": "Journal of pain research",
        "publication_date": "2025",
        "pubmed_id": "41019426",
        "doi": "10.2147/JPR.S537826"
      },
      "supporting_quote": "Outcomes were assessed using behavioral scoring, micro-CT imaging, histological staining, serum inflammatory markers (ELISA), and the expression of NLRP3 inflammasome-associated proteins (qPCR and Western blot).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:52:07"
    },
    {
      "id": 1140,
      "intervention": {
        "name": "triple therapy",
        "canonical_name": "levofloxacin triple therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "cross-sectional study",
        "sample_size": 709,
        "duration": null,
        "population": "adults with Helicobacter pylori infection in Bahrain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Helicobacter pylori in Bahrain: A Comprehensive Study of Patient Characteristics, Treatment Approaches, and Cure Rates.",
        "journal": "Cureus",
        "publication_date": "2025-02",
        "pubmed_id": "40130098",
        "doi": "10.7759/cureus.79341"
      },
      "supporting_quote": "triple therapy (n=384, 72.3%) being the most used regimen",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:49:47"
    },
    {
      "id": 1141,
      "intervention": {
        "name": "concomitant therapy",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "cross-sectional study",
        "sample_size": 709,
        "duration": null,
        "population": "adults with Helicobacter pylori infection in Bahrain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Helicobacter pylori in Bahrain: A Comprehensive Study of Patient Characteristics, Treatment Approaches, and Cure Rates.",
        "journal": "Cureus",
        "publication_date": "2025-02",
        "pubmed_id": "40130098",
        "doi": "10.7759/cureus.79341"
      },
      "supporting_quote": "concomitant regimen (n=72, 13.6%)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:49:47"
    },
    {
      "id": 1142,
      "intervention": {
        "name": "bismuth-based quadruple therapy",
        "canonical_name": "bismuth-based quadruple therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "cross-sectional study",
        "sample_size": 709,
        "duration": null,
        "population": "adults with Helicobacter pylori infection in Bahrain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Helicobacter pylori in Bahrain: A Comprehensive Study of Patient Characteristics, Treatment Approaches, and Cure Rates.",
        "journal": "Cureus",
        "publication_date": "2025-02",
        "pubmed_id": "40130098",
        "doi": "10.7759/cureus.79341"
      },
      "supporting_quote": "Bismuth-based quadruple therapy (P<0.001)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:49:47"
    },
    {
      "id": 1143,
      "intervention": {
        "name": "levofloxacin triple therapy",
        "canonical_name": "levofloxacin triple therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "cross-sectional study",
        "sample_size": 709,
        "duration": null,
        "population": "adults with Helicobacter pylori infection in Bahrain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Helicobacter pylori in Bahrain: A Comprehensive Study of Patient Characteristics, Treatment Approaches, and Cure Rates.",
        "journal": "Cureus",
        "publication_date": "2025-02",
        "pubmed_id": "40130098",
        "doi": "10.7759/cureus.79341"
      },
      "supporting_quote": "levofloxacin triple therapy (P=0.020)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:49:47"
    },
    {
      "id": 1136,
      "intervention": {
        "name": "cyclosporine",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "new-onset diabetes after transplantation (NODAT)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "renal transplant recipients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "[Risk factors for new-onset diabetes after transplantation in kidney transplant recipients: own data and meta-analysis].",
        "journal": "Terapevticheskii arkhiv",
        "publication_date": "2025-02-21",
        "pubmed_id": "40237731",
        "doi": "10.26442/00403660.2025.01.203029"
      },
      "supporting_quote": "Patients with NODAT were more likely to be treated with cyclosporine",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:48:07"
    },
    {
      "id": 1137,
      "intervention": {
        "name": "i-mTOR",
        "canonical_name": null,
        "category": "emerging",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "new-onset diabetes after transplantation (NODAT)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "renal transplant recipients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "[Risk factors for new-onset diabetes after transplantation in kidney transplant recipients: own data and meta-analysis].",
        "journal": "Terapevticheskii arkhiv",
        "publication_date": "2025-02-21",
        "pubmed_id": "40237731",
        "doi": "10.26442/00403660.2025.01.203029"
      },
      "supporting_quote": "Patients with NODAT were more likely to be treated with i-mTOR",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:48:07"
    },
    {
      "id": 1138,
      "intervention": {
        "name": "steroids",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "new-onset diabetes after transplantation (NODAT)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "renal transplant recipients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "[Risk factors for new-onset diabetes after transplantation in kidney transplant recipients: own data and meta-analysis].",
        "journal": "Terapevticheskii arkhiv",
        "publication_date": "2025-02-21",
        "pubmed_id": "40237731",
        "doi": "10.26442/00403660.2025.01.203029"
      },
      "supporting_quote": "Patients with NODAT were more likely to be treated with steroids",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:48:07"
    },
    {
      "id": 1139,
      "intervention": {
        "name": "SGLT2 inhibitor",
        "canonical_name": "tolvaptan",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "new-onset diabetes after transplantation (NODAT)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "renal transplant recipients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "[Risk factors for new-onset diabetes after transplantation in kidney transplant recipients: own data and meta-analysis].",
        "journal": "Terapevticheskii arkhiv",
        "publication_date": "2025-02-21",
        "pubmed_id": "40237731",
        "doi": "10.26442/00403660.2025.01.203029"
      },
      "supporting_quote": "Therefore, randomized studies are needed to evaluate SGLT2 inhibitor in RTRs",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:48:07"
    },
    {
      "id": 1133,
      "intervention": {
        "name": "ACL preservation procedures",
        "canonical_name": "ACL preservation procedures",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Anterior cruciate ligament injury",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "meta-analysis",
        "sample_size": 1101,
        "duration": null,
        "population": "patients with proximal ACL ruptures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "[Early Surgical Treatment Options for Anterior Cruciate Ligament Injury].",
        "journal": "Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca",
        "publication_date": "2025-03",
        "pubmed_id": "40145588",
        "doi": "10.55095/achot2024/055"
      },
      "supporting_quote": "The most comprehensive information was provided by a large meta-analysis conducted by Van der List et al. in 2019, which compared 1101 patients from 13 studies who had undergone an ACL preservation surgery.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:46:43"
    },
    {
      "id": 1134,
      "intervention": {
        "name": "ACL repair with InternalBrace (Arthrex© implant system) ligament augmentation",
        "canonical_name": "ACL preservation procedures",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Anterior cruciate ligament injury",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "retrospective study",
        "sample_size": null,
        "duration": null,
        "population": "patients with proximal ACL ruptures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "[Early Surgical Treatment Options for Anterior Cruciate Ligament Injury].",
        "journal": "Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca",
        "publication_date": "2025-03",
        "pubmed_id": "40145588",
        "doi": "10.55095/achot2024/055"
      },
      "supporting_quote": "Wilson et al. carried out a retrospective study of patients who underwent ACL repair with InternalBrace (Arthrex© implant system) ligament augmentation.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:46:43"
    },
    {
      "id": 1135,
      "intervention": {
        "name": "ACL reconstruction surgery using a graft",
        "canonical_name": "ACL preservation procedures",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Anterior cruciate ligament injury",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "comparison study",
        "sample_size": null,
        "duration": null,
        "population": "patients with proximal ACL ruptures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "[Early Surgical Treatment Options for Anterior Cruciate Ligament Injury].",
        "journal": "Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca",
        "publication_date": "2025-03",
        "pubmed_id": "40145588",
        "doi": "10.55095/achot2024/055"
      },
      "supporting_quote": "These values are consistent with similar outcomes reported in patients undergoing ACL reconstruction surgery using a graft.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:46:43"
    },
    {
      "id": 1131,
      "intervention": {
        "name": "Time-restricted eating (TRE)",
        "canonical_name": "Healthy Eating Advice (HE)",
        "category": "diet",
        "details": "{\"duration\": \"12 months\", \"eating_window\": \"8 hours/day\"}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "Autosomal dominant polycystic kidney disease (ADPKD)",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 29,
        "duration": "12 months",
        "population": "Adults with ADPKD, mean age 48 ± 9 years, BMI 31.1±5 kg/m²",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Time-restricted eating and autosomal dominant polycystic kidney disease: a pilot, randomized clinical trial.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-04",
        "pubmed_id": "40207097",
        "doi": "10.1093/ckj/sfaf069"
      },
      "supporting_quote": "A 12-month, randomized, controlled, behavioral dietary intervention compared TRE with a control group given healthy eating advice without TRE (HE)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:45:25"
    },
    {
      "id": 1132,
      "intervention": {
        "name": "Healthy Eating Advice (HE)",
        "canonical_name": "Healthy Eating Advice (HE)",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Autosomal dominant polycystic kidney disease (ADPKD)",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 29,
        "duration": "12 months",
        "population": "Adults with ADPKD, mean age 48 ± 9 years, BMI 31.1±5 kg/m²",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Time-restricted eating and autosomal dominant polycystic kidney disease: a pilot, randomized clinical trial.",
        "journal": "Clinical kidney journal",
        "publication_date": "2025-04",
        "pubmed_id": "40207097",
        "doi": "10.1093/ckj/sfaf069"
      },
      "supporting_quote": "A 12-month, randomized, controlled, behavioral dietary intervention compared TRE with a control group given healthy eating advice without TRE (HE)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:45:25"
    },
    {
      "id": 1130,
      "intervention": {
        "name": "tolvaptan",
        "canonical_name": "tolvaptan",
        "category": "medication",
        "details": "{\"duration\": \"\\u22652 years\", \"dosage\": null, \"frequency\": null}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "autosomal dominant polycystic kidney disease (ADPKD)",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "chart review and historical control comparison",
        "sample_size": 149,
        "duration": "up to 4 years of follow-up",
        "population": "adults with ADPKD in nephrology practice",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in US Clinical Practice With Comparison to Historical Control Data.",
        "journal": "Kidney medicine",
        "publication_date": "2025-05",
        "pubmed_id": "40242785",
        "doi": "10.1016/j.xkme.2025.100988"
      },
      "supporting_quote": "The annual rate of eGFR decline was slower in tolvaptan-treated patients versus historical controls",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:44:21"
    },
    {
      "id": 1128,
      "intervention": {
        "name": "conservative treatment",
        "canonical_name": null,
        "category": null,
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "acute Anterior cruciate ligament injury",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial (pilot)",
        "sample_size": null,
        "duration": null,
        "population": "patients with acute ACL injury",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The feasibility of conducting a randomized controlled trial that compares immediate versus optional delayed surgical repair for treatment of acute Anterior cruciate ligament injury-results of the IODA pilot trial.",
        "journal": "Pilot and feasibility studies",
        "publication_date": "2025-05-08",
        "pubmed_id": "40340976",
        "doi": "10.1186/s40814-025-01652-2"
      },
      "supporting_quote": "Patients were randomized to either conservative treatment (e.g., rehabilitation with optional delayed surgery in case of persistent instability)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:43:46"
    },
    {
      "id": 1129,
      "intervention": {
        "name": "immediate surgical repair",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "acute Anterior cruciate ligament injury",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial (pilot)",
        "sample_size": null,
        "duration": null,
        "population": "patients with acute ACL injury",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The feasibility of conducting a randomized controlled trial that compares immediate versus optional delayed surgical repair for treatment of acute Anterior cruciate ligament injury-results of the IODA pilot trial.",
        "journal": "Pilot and feasibility studies",
        "publication_date": "2025-05-08",
        "pubmed_id": "40340976",
        "doi": "10.1186/s40814-025-01652-2"
      },
      "supporting_quote": "or immediate surgery (< 12 weeks post-injury)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:43:46"
    },
    {
      "id": 1127,
      "intervention": {
        "name": "self-care training using the teach-back method",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{\"duration\": \"two sessions, each lasting 45 to 60 minutes\", \"frequency\": \"not specified\"}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "hypothyroidism",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled clinical trial",
        "sample_size": 62,
        "duration": "not specified",
        "population": "patients with hypothyroidism visiting Vali-e-Asr Hospital, affiliated with Birjand University of Medical Sciences",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The impact of self-care training using the teach-back method with telephone follow-up on adherence to treatment in patients with hypothyroidism: a randomized controlled clinical trial.",
        "journal": "BMC health services research",
        "publication_date": "2025-06-02",
        "pubmed_id": "40457369",
        "doi": "10.1186/s12913-025-12962-9"
      },
      "supporting_quote": "The present study aimed to determine the impact of self-care training using the teach-back method combined with telephone follow-up on adherence to treatment in patients with hypothyroidism.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:42:56"
    },
    {
      "id": 1125,
      "intervention": {
        "name": "aortic valve replacement (AVR)",
        "canonical_name": "transcatheter aortic valve replacement (TAVR)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "asymptomatic severe aortic stenosis",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Navigating the silence: reconsidering treatment paradigms in asymptomatic severe aortic stenosis.",
        "journal": "Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese",
        "publication_date": "2025-06-16",
        "pubmed_id": "40532874",
        "doi": "10.1016/j.hjc.2025.06.004"
      },
      "supporting_quote": "current clinical practice guidelines recommend aortic valve replacement (AVR) therapy in asymptomatic severe aortic stenosis",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:42:20"
    },
    {
      "id": 1126,
      "intervention": {
        "name": "transcatheter aortic valve replacement (TAVR)",
        "canonical_name": "transcatheter aortic valve replacement (TAVR)",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "asymptomatic severe aortic stenosis",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Navigating the silence: reconsidering treatment paradigms in asymptomatic severe aortic stenosis.",
        "journal": "Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese",
        "publication_date": "2025-06-16",
        "pubmed_id": "40532874",
        "doi": "10.1016/j.hjc.2025.06.004"
      },
      "supporting_quote": "Evolving and recently published randomized controlled trials-namely EARLY-TAVR, EVoLVeD, and TAVR-UNLOAD-randomizing asymptomatic patients to early intervention or a watchful waiting strategy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:42:20"
    },
    {
      "id": 1124,
      "intervention": {
        "name": "heart valve clinic (HVC)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "valvular heart disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "prospective cohort studies",
        "sample_size": 1082,
        "duration": null,
        "population": "patients with valvular heart disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Benefits of heart valve clinics for patients: a systematic review.",
        "journal": "BMJ open",
        "publication_date": "2025-06-18",
        "pubmed_id": "40533205",
        "doi": "10.1136/bmjopen-2024-096538"
      },
      "supporting_quote": "HVCs facilitate stratified and precise management of the whole-life cycle of patients with VHD, enhancing early detection and referral, and leading to reduced mortality and major cardiac events compared with SOC.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:41:32"
    },
    {
      "id": 1122,
      "intervention": {
        "name": "open reduction internal fixation (ORIF)",
        "canonical_name": "open reduction internal fixation (ORIF)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "trimalleolar ankle fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "retrospective analysis",
        "sample_size": 602,
        "duration": null,
        "population": "adult patients (≥18 years) with trimalleolar ankle fractures",
        "adverse_effects": "lower complication and readmission rates compared to TTCA",
        "cost_category": null
      },
      "paper": {
        "title": "Tibiotalocalcaneal Arthrodesis vs Open Reduction Internal Fixation for Trimalleolar Ankle Fractures in High-Risk Patients: A National Database Analysis.",
        "journal": "Foot & ankle orthopaedics",
        "publication_date": "2025-07",
        "pubmed_id": "41040423",
        "doi": "10.1177/24730114251375027"
      },
      "supporting_quote": "ORIF was associated with significantly lower complication and readmission rates compared with TTCA for trimalleolar ankle fractures.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:41:02"
    },
    {
      "id": 1123,
      "intervention": {
        "name": "tibiotalocalcaneal arthrodesis (TTCA)",
        "canonical_name": "open reduction internal fixation (ORIF)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "trimalleolar ankle fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "retrospective analysis",
        "sample_size": 602,
        "duration": null,
        "population": "adult patients (≥18 years) with trimalleolar ankle fractures",
        "adverse_effects": "higher complication and readmission rates compared to ORIF",
        "cost_category": null
      },
      "paper": {
        "title": "Tibiotalocalcaneal Arthrodesis vs Open Reduction Internal Fixation for Trimalleolar Ankle Fractures in High-Risk Patients: A National Database Analysis.",
        "journal": "Foot & ankle orthopaedics",
        "publication_date": "2025-07",
        "pubmed_id": "41040423",
        "doi": "10.1177/24730114251375027"
      },
      "supporting_quote": "TTCA was associated with higher overall complication rates compared to ORIF.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:41:02"
    },
    {
      "id": 1119,
      "intervention": {
        "name": "oral isotretinoin",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 675,
        "duration": null,
        "population": "predominantly from Asia and the Middle East",
        "adverse_effects": "acne flare-ups, pruritus, cheilitis, xerosis",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of Combined Oral Isotretinoin and Desloratadine or Levocetirizine vs. Isotretinoin Monotherapy in Treating Acne Vulgaris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.",
        "journal": "Biomedicines",
        "publication_date": "2025-07-30",
        "pubmed_id": "40868102",
        "doi": "10.3390/biomedicines13081847"
      },
      "supporting_quote": "Oral isotretinoin remains the most effective treatment",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:40:02"
    },
    {
      "id": 1120,
      "intervention": {
        "name": "desloratadine",
        "canonical_name": "desloratadine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 675,
        "duration": null,
        "population": "predominantly from Asia and the Middle East",
        "adverse_effects": "reduced acne flare-ups, pruritus, cheilitis compared to levocetirizine group",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of Combined Oral Isotretinoin and Desloratadine or Levocetirizine vs. Isotretinoin Monotherapy in Treating Acne Vulgaris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.",
        "journal": "Biomedicines",
        "publication_date": "2025-07-30",
        "pubmed_id": "40868102",
        "doi": "10.3390/biomedicines13081847"
      },
      "supporting_quote": "Combination therapy with isotretinoin and desloratadine showed a significantly greater reduction in GAGS score",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:40:02"
    },
    {
      "id": 1121,
      "intervention": {
        "name": "levocetirizine",
        "canonical_name": "desloratadine",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 675,
        "duration": null,
        "population": "predominantly from Asia and the Middle East",
        "adverse_effects": "no significant reduction in mucocutaneous adverse events compared to desloratadine group",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of Combined Oral Isotretinoin and Desloratadine or Levocetirizine vs. Isotretinoin Monotherapy in Treating Acne Vulgaris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.",
        "journal": "Biomedicines",
        "publication_date": "2025-07-30",
        "pubmed_id": "40868102",
        "doi": "10.3390/biomedicines13081847"
      },
      "supporting_quote": "Overall, desloratadine improved tolerability and reduced mucocutaneous adverse events more than levocetirizine",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:40:02"
    },
    {
      "id": 1117,
      "intervention": {
        "name": "Mono-Segment Fixation (MSF)",
        "canonical_name": null,
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Thoracolumbar Spine Fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 13,
        "duration": "one year",
        "population": "adult patients with thoracolumbar spine fractures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Mono-Segment Fixation Versus Short-Segment Fixation in Adult Patients With Thoracolumbar Spine Fractures: A Randomized Controlled Trial.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41001316",
        "doi": "10.7759/cureus.90939"
      },
      "supporting_quote": "Mono-segmental fixation (MSF), a recently introduced concept, advocates instrumenting only the fractured vertebra and one adjacent vertebra either above or below.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:38:43"
    },
    {
      "id": 1118,
      "intervention": {
        "name": "Short-Segment Fixation (SSF)",
        "canonical_name": null,
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Thoracolumbar Spine Fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 13,
        "duration": "one year",
        "population": "adult patients with thoracolumbar spine fractures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Mono-Segment Fixation Versus Short-Segment Fixation in Adult Patients With Thoracolumbar Spine Fractures: A Randomized Controlled Trial.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41001316",
        "doi": "10.7759/cureus.90939"
      },
      "supporting_quote": "Short-segment fixation (SSF), involving one vertebra above and below the fracture",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:38:43"
    },
    {
      "id": 1116,
      "intervention": {
        "name": "pegloticase",
        "canonical_name": null,
        "category": "biologics",
        "details": "{\"dosage\": null, \"duration\": \"52 weeks\", \"frequency\": null, \"intensity\": null}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "uncontrolled gout",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.7,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 145,
        "duration": "52 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial Analysis.",
        "journal": "ACR open rheumatology",
        "publication_date": "2025-08",
        "pubmed_id": "40810458",
        "doi": "10.1002/acr2.70080"
      },
      "supporting_quote": "Using the study full and simplified definitions, nearly half to three-quarters of patients who remained on pegloticase for 52 weeks achieved gout remission.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:37:48"
    },
    {
      "id": 1112,
      "intervention": {
        "name": "tamsulosin",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 1.0
      },
      "study": {
        "type": "randomized controlled trial (meta-analysis)",
        "sample_size": null,
        "duration": null,
        "population": "patients undergoing extracorporeal shock wave lithotripsy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.",
        "journal": "Minerva urology and nephrology",
        "publication_date": "2025-08",
        "pubmed_id": "40891477",
        "doi": "10.23736/S2724-6051.25.06296-2"
      },
      "supporting_quote": "tamsulosin, compared to placebo, demonstrated improved stone clearance post-SWL",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:37:14"
    },
    {
      "id": 1113,
      "intervention": {
        "name": "vitamin D and calcium supplementation",
        "canonical_name": "vitamin D and calcium supplementation",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 1.0
      },
      "study": {
        "type": "randomized controlled trial (meta-analysis)",
        "sample_size": null,
        "duration": null,
        "population": "patients at high risk of kidney stones",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.",
        "journal": "Minerva urology and nephrology",
        "publication_date": "2025-08",
        "pubmed_id": "40891477",
        "doi": "10.23736/S2724-6051.25.06296-2"
      },
      "supporting_quote": "vitamin D and calcium supplementation were ineffective for primary prevention",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:37:14"
    },
    {
      "id": 1114,
      "intervention": {
        "name": "thiazides",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "recurrent kidney calculi",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 1.0
      },
      "study": {
        "type": "randomized controlled trial (meta-analysis)",
        "sample_size": 571,
        "duration": null,
        "population": "patients affected by recurrent kidney calculi",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.",
        "journal": "Minerva urology and nephrology",
        "publication_date": "2025-08",
        "pubmed_id": "40891477",
        "doi": "10.23736/S2724-6051.25.06296-2"
      },
      "supporting_quote": "use of thiazides, compared to placebo, was associated with a statistically significant decrease in renal stones",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:37:14"
    },
    {
      "id": 1115,
      "intervention": {
        "name": "potassium citrate",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "nephrolithiasis recurrence",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 1.0
      },
      "study": {
        "type": "randomized controlled trial (meta-analysis)",
        "sample_size": null,
        "duration": null,
        "population": "patients at risk of nephrolithiasis recurrence",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.",
        "journal": "Minerva urology and nephrology",
        "publication_date": "2025-08",
        "pubmed_id": "40891477",
        "doi": "10.23736/S2724-6051.25.06296-2"
      },
      "supporting_quote": "use of potassium citrate was able to prevent the risk of nephrolithiasis recurrence",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:37:14"
    },
    {
      "id": 1110,
      "intervention": {
        "name": "intense pulsed light combined with 3% tranexamic acid",
        "canonical_name": "intense pulsed light combined with 3% tranexamic acid",
        "category": "device",
        "details": "{\"dosage\": \"external use of 3% tranexamic acid\"}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "facial erythema associated with acne and rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 28,
        "duration": null,
        "population": "patients with facial erythema associated with acne and rosacea",
        "adverse_effects": "no obvious adverse reactions reported",
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Intense Pulsed Light Combined With 3% Tranexamic Acid for Facial Erythema Associated With Acne Vulgaris and Rosacea.",
        "journal": "Lasers in surgery and medicine",
        "publication_date": "2025-08",
        "pubmed_id": "40518702",
        "doi": "10.1002/lsm.70029"
      },
      "supporting_quote": "Intense pulsed light combined with 3% tranexamic acid can effectively improve the degree of acne and rosacea erythema without serious adverse effects.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:35:36"
    },
    {
      "id": 1111,
      "intervention": {
        "name": "intense pulsed light only",
        "canonical_name": "intense pulsed light combined with 3% tranexamic acid",
        "category": "device",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "facial erythema associated with acne and rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 28,
        "duration": null,
        "population": "patients with facial erythema associated with acne and rosacea",
        "adverse_effects": "no obvious adverse reactions reported",
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Intense Pulsed Light Combined With 3% Tranexamic Acid for Facial Erythema Associated With Acne Vulgaris and Rosacea.",
        "journal": "Lasers in surgery and medicine",
        "publication_date": "2025-08",
        "pubmed_id": "40518702",
        "doi": "10.1002/lsm.70029"
      },
      "supporting_quote": "The control group was treated with intense pulsed light only.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:35:36"
    },
    {
      "id": 1107,
      "intervention": {
        "name": "proton pump inhibitors (PPIs)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "gastroesophageal reflux disease (GERD) and chronic respiratory symptoms",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Association Between Gastroesophageal Reflux Disease and Chronic Respiratory Symptoms: A Systematic Review of Recent Clinical Evidence and Therapeutic Implications.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41041114",
        "doi": "10.7759/cureus.91372"
      },
      "supporting_quote": "acid-suppressive therapies - particularly proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) - leading to symptomatic improvement in several patient populations",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:34:37"
    },
    {
      "id": 1108,
      "intervention": {
        "name": "potassium-competitive acid blockers (P-CABs)",
        "canonical_name": "potassium-competitive acid blockers (P-CABs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "gastroesophageal reflux disease (GERD) and chronic respiratory symptoms",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Association Between Gastroesophageal Reflux Disease and Chronic Respiratory Symptoms: A Systematic Review of Recent Clinical Evidence and Therapeutic Implications.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41041114",
        "doi": "10.7759/cureus.91372"
      },
      "supporting_quote": "acid-suppressive therapies - particularly proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) - leading to symptomatic improvement in several patient populations",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:34:37"
    },
    {
      "id": 1109,
      "intervention": {
        "name": "diaphragmatic breathing",
        "canonical_name": "traditional Asian nutraceuticals",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "gastroesophageal reflux disease-induced chronic cough",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Association Between Gastroesophageal Reflux Disease and Chronic Respiratory Symptoms: A Systematic Review of Recent Clinical Evidence and Therapeutic Implications.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41041114",
        "doi": "10.7759/cureus.91372"
      },
      "supporting_quote": "Non-pharmacological interventions such as diaphragmatic breathing also showed clinical benefit in GERD-induced chronic cough",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:34:37"
    },
    {
      "id": 1105,
      "intervention": {
        "name": "Firsekibart",
        "canonical_name": null,
        "category": "emerging",
        "details": "{\"dosage\": \"200 mg\", \"frequency\": \"single dose\", \"category\": \"anti-interleukin-1\\u03b2 monoclonal antibody\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "acute gout flares",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized phase 3 trial",
        "sample_size": 311,
        "duration": "12 weeks",
        "population": "patients with frequent acute gout flares unsuitable for standard therapy",
        "adverse_effects": "71.2% of Firsekibart-treated patients experienced treatment-emergent adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial.",
        "journal": "Innovation (Cambridge (Mass.))",
        "publication_date": "2025-08-04",
        "pubmed_id": "40814346",
        "doi": "10.1016/j.xinn.2025.101015"
      },
      "supporting_quote": "Firsekibart is effective and well tolerated for acute gout flares in patients unsuitable for standard therapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:32:03"
    },
    {
      "id": 1106,
      "intervention": {
        "name": "compound betamethasone (CB)",
        "canonical_name": "compound betamethasone (CB)",
        "category": "medication",
        "details": "{\"dosage\": \"7 mg\", \"frequency\": \"single dose\", \"category\": \"steroid\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "acute gout flares",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.85,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized phase 3 trial",
        "sample_size": 311,
        "duration": "12 weeks",
        "population": "patients with frequent acute gout flares unsuitable for standard therapy",
        "adverse_effects": "69.9% of CB-treated patients experienced treatment-emergent adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial.",
        "journal": "Innovation (Cambridge (Mass.))",
        "publication_date": "2025-08-04",
        "pubmed_id": "40814346",
        "doi": "10.1016/j.xinn.2025.101015"
      },
      "supporting_quote": "The full analysis set included 311 patients (Firsekibart: N = 156; CB: N = 155)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:32:03"
    },
    {
      "id": 1103,
      "intervention": {
        "name": "iscalimab (CFZ533)",
        "canonical_name": null,
        "category": "biologics",
        "details": "{\"dosage\": \"10 mg/kg\", \"duration\": \"24 weeks\", \"frequency\": \"intravenous administration\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "proliferative lupus nephritis",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 39,
        "duration": "24 weeks",
        "population": "patients with systemic lupus erythematosus and active proliferative lupus nephritis",
        "adverse_effects": "mild to moderate adverse events, severe infections in immunosuppressed patients",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study.",
        "journal": "RMD open",
        "publication_date": "2025-08-14",
        "pubmed_id": "40813108",
        "doi": "10.1136/rmdopen-2025-005557"
      },
      "supporting_quote": "Iscalimab showed a significant improvement in proteinuria (UPCR) in patients with active LN",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:30:52"
    },
    {
      "id": 1104,
      "intervention": {
        "name": "standard-of-care therapy",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "proliferative lupus nephritis",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study.",
        "journal": "RMD open",
        "publication_date": "2025-08-14",
        "pubmed_id": "40813108",
        "doi": "10.1136/rmdopen-2025-005557"
      },
      "supporting_quote": "Patients were randomly assigned to receive either intravenous iscalimab (10 mg/kg) or placebo for 24 weeks on top of SoC for LN",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:30:52"
    },
    {
      "id": 1102,
      "intervention": {
        "name": "LuCUS-guided strategy",
        "canonical_name": null,
        "category": "test",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "dyspnoea",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "prospective, interventional, multicentre, stepped-wedge randomised controlled trial",
        "sample_size": 504,
        "duration": "2 years",
        "population": "elderly ED patients aged >65 years presenting with acute dyspnoea and signs of severity (respiratory rate ≥22 or SpO2 <92% on room air)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Lung and cardiac ultrasound for respiratory distress in the elderly: study protocol of the LUC REED stepped-wedge cluster randomised trial.",
        "journal": "BMJ open",
        "publication_date": "2025-08-16",
        "pubmed_id": "40819865",
        "doi": "10.1136/bmjopen-2025-104715"
      },
      "supporting_quote": "The primary objective of the LUC REED trial is to evaluate the impact of a LuCUS-guided strategy versus standard care on reducing inappropriate treatment of dyspnoea in elderly ED patients.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:29:52"
    },
    {
      "id": 1100,
      "intervention": {
        "name": "rivaroxaban",
        "canonical_name": "antiplatelet therapy",
        "category": "medication",
        "details": "{\"dosage\": \"20/15 mg\", \"duration\": \"1 month\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "symptomatic severe aortic stenosis post-TAVR",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 454,
        "duration": "12 months",
        "population": "patients without indications for long-term anticoagulation or dual antiplatelet therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Rationale and design of SCOPE trial: a prospective, multicentre, open-label, randomised controlled trial to evaluate the overall efficacy and safety of a",
        "journal": "BMJ open",
        "publication_date": "2025-08-16",
        "pubmed_id": "40819859",
        "doi": "10.1136/bmjopen-2024-098551"
      },
      "supporting_quote": "Participants will be randomly assigned to receive either anticoagulation with rivaroxaban (20/15 mg)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:29:15"
    },
    {
      "id": 1101,
      "intervention": {
        "name": "antiplatelet therapy",
        "canonical_name": "antiplatelet therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "symptomatic severe aortic stenosis post-TAVR",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 454,
        "duration": "12 months",
        "population": "patients without indications for long-term anticoagulation or dual antiplatelet therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Rationale and design of SCOPE trial: a prospective, multicentre, open-label, randomised controlled trial to evaluate the overall efficacy and safety of a",
        "journal": "BMJ open",
        "publication_date": "2025-08-16",
        "pubmed_id": "40819859",
        "doi": "10.1136/bmjopen-2024-098551"
      },
      "supporting_quote": "or conventional antiplatelet therapy (aspirin or clopidogrel)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:29:15"
    },
    {
      "id": 1098,
      "intervention": {
        "name": "Meridian-Sinew Release Therapy (MSRT)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "gouty arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 376,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Meridian-Sinew Release Therapy as an adjunctive treatment for gouty arthritis: a systematic review and meta-analysis.",
        "journal": "Journal of orthopaedic surgery and research",
        "publication_date": "2025-08-18",
        "pubmed_id": "40826358",
        "doi": "10.1186/s13018-025-06123-1"
      },
      "supporting_quote": "MSRT, as an adjunct therapy, may offer clinical benefits in managing gouty arthritis by reducing urate deposition, relieving inflammation, and improving joint function with good safety.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:28:17"
    },
    {
      "id": 1099,
      "intervention": {
        "name": "conventional Western medicine (WM)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "gouty arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 376,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Meridian-Sinew Release Therapy as an adjunctive treatment for gouty arthritis: a systematic review and meta-analysis.",
        "journal": "Journal of orthopaedic surgery and research",
        "publication_date": "2025-08-18",
        "pubmed_id": "40826358",
        "doi": "10.1186/s13018-025-06123-1"
      },
      "supporting_quote": "The study compared MSRTW to Western medicine treatment (WM) alone.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:28:17"
    },
    {
      "id": 1094,
      "intervention": {
        "name": "catheter-directed thrombolysis",
        "canonical_name": "Percutaneous Mechanical Aspiration (PMA)",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "deep venous thrombosis (DVT)",
        "canonical_name": null,
        "category": null,
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "selected patients with iliofemoral DVT",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interventional Procedures in Deep Venous Thrombosis Treatment: A Review of Techniques, Outcomes, and Patient Selection.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-08-18",
        "pubmed_id": "40870521",
        "doi": "10.3390/medicina61081476"
      },
      "supporting_quote": "Randomized trials (CaVenT, ATTRACT, CAVA) showed that catheter-directed and pharmacomechanical approaches improved venous patency and reduced moderate-to-severe PTS in selected patients with iliofemoral DVT",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:27:27"
    },
    {
      "id": 1095,
      "intervention": {
        "name": "mechanical thrombectomy",
        "canonical_name": "Percutaneous Mechanical Aspiration (PMA)",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "deep venous thrombosis (DVT)",
        "canonical_name": null,
        "category": null,
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "selected patients with iliofemoral DVT",
        "adverse_effects": "device-specific complication profiles",
        "cost_category": null
      },
      "paper": {
        "title": "Interventional Procedures in Deep Venous Thrombosis Treatment: A Review of Techniques, Outcomes, and Patient Selection.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-08-18",
        "pubmed_id": "40870521",
        "doi": "10.3390/medicina61081476"
      },
      "supporting_quote": "Mechanical thrombectomy devices (e.g., AngioJet, ClotTriever, FlowTriever) achieved high thrombus clearance and shorter procedural times",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:27:27"
    },
    {
      "id": 1096,
      "intervention": {
        "name": "pharmacomechanical thrombectomy",
        "canonical_name": "Percutaneous Mechanical Aspiration (PMA)",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "deep venous thrombosis (DVT)",
        "canonical_name": null,
        "category": null,
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "selected patients with iliofemoral DVT",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interventional Procedures in Deep Venous Thrombosis Treatment: A Review of Techniques, Outcomes, and Patient Selection.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-08-18",
        "pubmed_id": "40870521",
        "doi": "10.3390/medicina61081476"
      },
      "supporting_quote": "Randomized trials (CaVenT, ATTRACT, CAVA) showed that catheter-directed and pharmacomechanical approaches improved venous patency and reduced moderate-to-severe PTS in selected patients with iliofemoral DVT",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:27:27"
    },
    {
      "id": 1097,
      "intervention": {
        "name": "venous stenting",
        "canonical_name": "Percutaneous Mechanical Aspiration (PMA)",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "deep venous thrombosis (DVT)",
        "canonical_name": null,
        "category": null,
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interventional Procedures in Deep Venous Thrombosis Treatment: A Review of Techniques, Outcomes, and Patient Selection.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-08-18",
        "pubmed_id": "40870521",
        "doi": "10.3390/medicina61081476"
      },
      "supporting_quote": "Observational data demonstrated venous stenting patency rates of 74-89% at 12 months",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:27:27"
    },
    {
      "id": 1093,
      "intervention": {
        "name": "mycophenolate mofetil (MMF)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "IgA nephropathy",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.85,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trials and observational studies",
        "sample_size": null,
        "duration": null,
        "population": "patients with recent disease onset and active proliferative lesions such as endocapillary hypercellularity and crescent formation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Intraglomerular Inflammation as a Guide for Mycophenolate Mofetil-Based Treatment in IgA Nephropathy.",
        "journal": "Diagnostics (Basel, Switzerland)",
        "publication_date": "2025-08-20",
        "pubmed_id": "40870953",
        "doi": "10.3390/diagnostics15162101"
      },
      "supporting_quote": "Trials conducted in Chinese cohorts demonstrated significant benefits of MMF, including proteinuria reduction, delayed progression to ESKD, and improved long-term renal outcomes",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:25:48"
    },
    {
      "id": 1091,
      "intervention": {
        "name": "reverse total shoulder arthroplasty",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": "surgical"
      },
      "condition": {
        "name": "rotator cuff tear arthropathy",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 102,
        "duration": "12 months",
        "population": "patients eligible for reverse total shoulder arthroplasty",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prosthesis versus exercise for rotator cuff tear arthropathy - protocol of a randomised controlled trial.",
        "journal": "Danish medical journal",
        "publication_date": "2025-08-22",
        "pubmed_id": "40927835",
        "doi": "10.61409/A09240645"
      },
      "supporting_quote": "In this Nordic multicentre, randomised, controlled clinical trial, 102 patients with rotator cuff tear arthropathy who are eligible for reverse total shoulder arthroplasty will be allocated (1:1) to either reverse total shoulder arthroplasty followed by usual care",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:24:52"
    },
    {
      "id": 1092,
      "intervention": {
        "name": "exercise intervention",
        "canonical_name": "exercise intervention",
        "category": "exercise",
        "details": "{\"duration\": \"12 weeks\", \"frequency\": \"one weekly physiotherapist-supervised session and two home-based exercises\"}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "rotator cuff tear arthropathy",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 102,
        "duration": "12 months",
        "population": "patients eligible for reverse total shoulder arthroplasty",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prosthesis versus exercise for rotator cuff tear arthropathy - protocol of a randomised controlled trial.",
        "journal": "Danish medical journal",
        "publication_date": "2025-08-22",
        "pubmed_id": "40927835",
        "doi": "10.61409/A09240645"
      },
      "supporting_quote": "The exercise intervention comprises 12 weeks of exercise with one weekly physiotherapist-supervised session and two home-based exercises",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:24:52"
    },
    {
      "id": 1090,
      "intervention": {
        "name": "mesenchymal stem cell therapy",
        "canonical_name": "bioinductive collagen patch (REGENETEN)",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "lupus nephritis",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Advances in mesenchymal stem cell therapy for lupus nephritis.",
        "journal": "World journal of stem cells",
        "publication_date": "2025-08-26",
        "pubmed_id": "40951714",
        "doi": "10.4252/wjsc.v17.i8.104930"
      },
      "supporting_quote": "Recently, the therapeutic role of mesenchymal stem cells (MSCs) in LN has received extensive attention worldwide.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:23:53"
    },
    {
      "id": 1089,
      "intervention": {
        "name": "statin use",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Impact of Statin Use on Sepsis Mortality: A Systematic Review and Meta-Analysis.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-08-30",
        "pubmed_id": "41010954",
        "doi": "10.3390/medicina61091563"
      },
      "supporting_quote": "Statin use among septic patients is associated with a reduction in mortality, suggesting that statins may offer a beneficial therapeutic effect in the clinical setting.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:20:18"
    },
    {
      "id": 1083,
      "intervention": {
        "name": "sodium bicarbonate",
        "canonical_name": "ammonium chloride",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": "For urinary alkalinization, the most effective pharmaceutical was sodium bicarbonate",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:19:49"
    },
    {
      "id": 1084,
      "intervention": {
        "name": "Citro-Soda®",
        "canonical_name": null,
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": "For urinary alkalinization, the most effective OTC formulation was Citro-Soda®",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:19:49"
    },
    {
      "id": 1085,
      "intervention": {
        "name": "lacto-ovo-vegetarian diet",
        "canonical_name": null,
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": "For urinary alkalinization, the most effective dietary change was lacto-ovo-vegetarian diet",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:19:49"
    },
    {
      "id": 1086,
      "intervention": {
        "name": "ammonium chloride",
        "canonical_name": "ammonium chloride",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": "For urinary acidification, the most effective intervention was ammonium chloride",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:19:49"
    },
    {
      "id": 1087,
      "intervention": {
        "name": "methionine",
        "canonical_name": "high protein diet",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": "For urinary acidification, the most effective intervention was methionine",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:19:49"
    },
    {
      "id": 1088,
      "intervention": {
        "name": "high protein diet",
        "canonical_name": "high protein diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulators of urinary pH in the context of urinary stone disease: a literature review.",
        "journal": "Translational andrology and urology",
        "publication_date": "2025-08-30",
        "pubmed_id": "40949433",
        "doi": "10.21037/tau-2025-275"
      },
      "supporting_quote": "For urinary acidification, the most effective dietary change was high protein diet",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:19:49"
    },
    {
      "id": 1081,
      "intervention": {
        "name": "Rifampin-based regimen (4 months daily)",
        "canonical_name": "Rifampin-based regimen (4 months daily)",
        "category": "medication",
        "details": "{\"dosage\": \"10 mg/kg\", \"duration\": \"4 months\", \"frequency\": \"daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Tuberculosis infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 454,
        "duration": "phase 2b randomized trial",
        "population": "participants aged ≥10 years",
        "adverse_effects": null,
        "cost_category": "medium"
      },
      "paper": {
        "title": "Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial.",
        "journal": "Open forum infectious diseases",
        "publication_date": "2025-09",
        "pubmed_id": "40980570",
        "doi": "10.1093/ofid/ofaf563"
      },
      "supporting_quote": "Overall, 454 participants received 4R10 and 461 participants received 2R20.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:17:56"
    },
    {
      "id": 1082,
      "intervention": {
        "name": "Rifampin-based regimen (2 months daily)",
        "canonical_name": "Extracorporeal shock wave lithotripsy (ESWL)",
        "category": "medication",
        "details": "{\"dosage\": \"20 mg/kg\", \"duration\": \"2 months\", \"frequency\": \"daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Tuberculosis infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 461,
        "duration": "phase 2b randomized trial",
        "population": "participants aged ≥10 years",
        "adverse_effects": null,
        "cost_category": "medium"
      },
      "paper": {
        "title": "Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial.",
        "journal": "Open forum infectious diseases",
        "publication_date": "2025-09",
        "pubmed_id": "40980570",
        "doi": "10.1093/ofid/ofaf563"
      },
      "supporting_quote": "Overall, 454 participants received 4R10 and 461 participants received 2R20.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:17:56"
    },
    {
      "id": 1080,
      "intervention": {
        "name": "visual art therapy",
        "canonical_name": null,
        "category": "therapy",
        "details": "{\"duration\": \"from a single 15-30 minute session to 5-12 week programs\", \"frequency\": null, \"intensity\": null}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "anxiety disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 1.0
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": 1686,
        "duration": "varies across studies (October 2017-June 2025)",
        "population": "adults aged 18-65 years",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "THE IMPACT OF VISUAL ART THERAPY ON ANXIETY: A SYSTEMATIC REVIEW.",
        "journal": "Psychiatria Danubina",
        "publication_date": "2025-09",
        "pubmed_id": "40982872",
        "doi": null
      },
      "supporting_quote": "All 14 trials found significantly greater anxiety reduction in art therapy groups compared to controls",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:16:20"
    },
    {
      "id": 1079,
      "intervention": {
        "name": "antiviral drugs",
        "canonical_name": "tenofovir disoproxil fumarate (TDF)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "colitis",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.7,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "prospective cohort study",
        "sample_size": null,
        "duration": null,
        "population": "children with colitis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cytomegalovirus Detection by PCR on Fresh and Formalin-Fixed Colon Tissue Biopsies of Children with Colitis: A Prospective Cohort Study.",
        "journal": "Iranian journal of medical sciences",
        "publication_date": "2025-09",
        "pubmed_id": "40977955",
        "doi": "10.30476/ijms.2025.103842.3741"
      },
      "supporting_quote": "FT-PCR-positive inflammatory bowel disease (IBD) cases treated with antiviral drugs showed a poorer outcome than the non-treated cases",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:15:46"
    },
    {
      "id": 1078,
      "intervention": {
        "name": "donanemab",
        "canonical_name": "Vonoprazan",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "preclinical Alzheimer's disease (AD)",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "double-blind, placebo-controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "Participants 55-80 years of age with CDR scale-Global score (CDR-GS) of 0 or 0.5",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3.",
        "journal": "Alzheimer's & dementia : the journal of the Alzheimer's Association",
        "publication_date": "2025-09",
        "pubmed_id": "40955720",
        "doi": "10.1002/alz.70662"
      },
      "supporting_quote": "TRAILBLAZER-ALZ 3 is investigating donanemab in preclinical Alzheimer's disease (AD)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:15:18"
    },
    {
      "id": 1076,
      "intervention": {
        "name": "tubeless PCNL",
        "canonical_name": "MG puncture needle",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "large kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "reduced incidence of intra- and postoperative complications",
        "cost_category": null
      },
      "paper": {
        "title": "[Methods for Improving the Safety of Tubeless Percutaneous Nephrolithotripsy: Current State of the Problem].",
        "journal": "Urologiia (Moscow, Russia : 1999)",
        "publication_date": "2025-09",
        "pubmed_id": "40937804",
        "doi": null
      },
      "supporting_quote": "The use of additional imaging technologies and atraumatic instruments for percutaneous access may reduce the complication rate after tubeless and totally tubeless PCNL.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:14:47"
    },
    {
      "id": 1077,
      "intervention": {
        "name": "MG puncture needle",
        "canonical_name": "MG puncture needle",
        "category": "device",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "large kidney stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "[Methods for Improving the Safety of Tubeless Percutaneous Nephrolithotripsy: Current State of the Problem].",
        "journal": "Urologiia (Moscow, Russia : 1999)",
        "publication_date": "2025-09",
        "pubmed_id": "40937804",
        "doi": null
      },
      "supporting_quote": "These conditions can be achieved not only by the surgeons experience, but also through the use of new atraumatic instruments for puncturing the collecting system and creating percutaneous access, such as the MG puncture needle",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:14:47"
    },
    {
      "id": 1075,
      "intervention": {
        "name": "oral anticoagulation (OAC)",
        "canonical_name": "oral anticoagulation (OAC)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "nonvalvular atrial fibrillation (NVAF) for stroke prevention",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "bleeding risks",
        "cost_category": null
      },
      "paper": {
        "title": "SCAI/HRS Technical Review on Transcatheter Left Atrial Appendage Occlusion.",
        "journal": "Journal of the Society for Cardiovascular Angiography & Interventions",
        "publication_date": "2025-09",
        "pubmed_id": "41040450",
        "doi": "10.1016/j.jscai.2025.103784"
      },
      "supporting_quote": "While oral anticoagulation (OAC) is the standard therapy for stroke prevention, many patients cannot tolerate long-term OAC due to bleeding risks.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:13:55"
    },
    {
      "id": 1072,
      "intervention": {
        "name": "optimal medical therapy (OMT)",
        "canonical_name": "optimal medical therapy (OMT)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "ischemic left ventricular systolic dysfunction",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic Dysfunction.",
        "journal": "Journal of the Society for Cardiovascular Angiography & Interventions",
        "publication_date": "2025-09",
        "pubmed_id": "41040436",
        "doi": "10.1016/j.jscai.2025.103820"
      },
      "supporting_quote": "Coronary artery bypass grafting (CABG) improves survival compared with optimal medical therapy (OMT) alone in patients with ischemic left ventricular systolic dysfunction",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:12:58"
    },
    {
      "id": 1073,
      "intervention": {
        "name": "percutaneous coronary intervention (PCI)",
        "canonical_name": null,
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "ischemic left ventricular systolic dysfunction",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic Dysfunction.",
        "journal": "Journal of the Society for Cardiovascular Angiography & Interventions",
        "publication_date": "2025-09",
        "pubmed_id": "41040436",
        "doi": "10.1016/j.jscai.2025.103820"
      },
      "supporting_quote": "However, the randomized controlled trials (RCT) evaluating these 2 revascularization modalities may differ in terms of baseline surgical risk.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:12:58"
    },
    {
      "id": 1074,
      "intervention": {
        "name": "coronary artery bypass grafting (CABG)",
        "canonical_name": "coronary artery bypass grafting (CABG)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "ischemic left ventricular systolic dysfunction",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic Dysfunction.",
        "journal": "Journal of the Society for Cardiovascular Angiography & Interventions",
        "publication_date": "2025-09",
        "pubmed_id": "41040436",
        "doi": "10.1016/j.jscai.2025.103820"
      },
      "supporting_quote": "Coronary artery bypass grafting (CABG) improves survival compared with optimal medical therapy (OMT) alone in patients with ischemic left ventricular systolic dysfunction",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:12:58"
    },
    {
      "id": 1071,
      "intervention": {
        "name": "Tranexamic acid (TXA)",
        "canonical_name": null,
        "category": "medication",
        "details": "{\"dosage\": \"1,000 mg\", \"frequency\": \"single intravenous administration\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "postoperative pain after arthroscopic rotator cuff repair",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "prospective, double-blind, randomized, controlled trial",
        "sample_size": 165,
        "duration": null,
        "population": "patients scheduled to have arthroscopic rotator cuff repair with one surgeon at one institution",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Use of Tranexamic Acid Reduces Opioid Consumption After Arthroscopic Rotator Cuff Repair.",
        "journal": "Journal of shoulder and elbow surgery",
        "publication_date": "2025-09-02",
        "pubmed_id": "40907869",
        "doi": "10.1016/j.jse.2025.07.023"
      },
      "supporting_quote": "TXA use independently reduced opioid consumption significantly for the first 3 days after ARCR by 18 MME",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:11:16"
    },
    {
      "id": 1069,
      "intervention": {
        "name": "moxibustion with aconite cake",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "anxiety and depression",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 45,
        "duration": "3 months",
        "population": "newly diagnosed human immunodeficiency virus patients",
        "adverse_effects": "no significant adverse reactions occurred",
        "cost_category": null
      },
      "paper": {
        "title": "Observation on the efficacy of moxibustion with fuzi cake combined with auricular point pressing in treating anxiety and depression in newly diagnosed people living with HIV: A randomized controlled trial.",
        "journal": "Medicine",
        "publication_date": "2025-09-05",
        "pubmed_id": "40922288",
        "doi": "10.1097/MD.0000000000044437"
      },
      "supporting_quote": "Moxibustion with aconite cake combined with earlobe acupressure can effectively alleviate anxiety and depression in newly diagnosed human immunodeficiency virus patients",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:10:36"
    },
    {
      "id": 1070,
      "intervention": {
        "name": "earlobe acupressure",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "anxiety and depression",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 45,
        "duration": "3 months",
        "population": "newly diagnosed human immunodeficiency virus patients",
        "adverse_effects": "no significant adverse reactions occurred",
        "cost_category": null
      },
      "paper": {
        "title": "Observation on the efficacy of moxibustion with fuzi cake combined with auricular point pressing in treating anxiety and depression in newly diagnosed people living with HIV: A randomized controlled trial.",
        "journal": "Medicine",
        "publication_date": "2025-09-05",
        "pubmed_id": "40922288",
        "doi": "10.1097/MD.0000000000044437"
      },
      "supporting_quote": "Moxibustion with aconite cake combined with earlobe acupressure can effectively alleviate anxiety and depression in newly diagnosed human immunodeficiency virus patients",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:10:36"
    },
    {
      "id": 1068,
      "intervention": {
        "name": "bioinductive collagen patch (REGENETEN)",
        "canonical_name": "bioinductive collagen patch (REGENETEN)",
        "category": "device",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "rotator cuff retear",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "observational, prospective multicenter study",
        "sample_size": 21,
        "duration": "24 months",
        "population": "patients with rotator cuff retear after prior arthroscopic rotator cuff repair",
        "adverse_effects": "no intraoperative or immediate postoperative complications occurred",
        "cost_category": null
      },
      "paper": {
        "title": "Biological augmentation in revision surgery: effect of a bioinductive collagen patch in patients with rotator cuff retear and a previous arthroscopic rotator cuff repair.",
        "journal": "Journal of shoulder and elbow surgery",
        "publication_date": "2025-09-10",
        "pubmed_id": "40939824",
        "doi": "10.1016/j.jse.2025.07.031"
      },
      "supporting_quote": "Biologic augmentation with a bioinductive collagen patch provides clinical and functional improvement in patients undergoing revision rotator cuff tear repair, with over 70% of the revision repairs remaining intact at 1-year follow-up.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:09:35"
    },
    {
      "id": 1065,
      "intervention": {
        "name": "GLP-1 receptor agonists (GLP-1 RAs)",
        "canonical_name": "GLP-1 receptor agonists (GLP-1 RAs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "major depressive disorder (MDD)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-10",
        "pubmed_id": "41010364",
        "doi": "10.3390/life15091422"
      },
      "supporting_quote": "Early clinical trials in patients with metabolic disorders suggest improvements in depressive symptoms, quality of life, and cognitive function",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:09:00"
    },
    {
      "id": 1066,
      "intervention": {
        "name": "GLP-1 receptor agonists (GLP-1 RAs)",
        "canonical_name": "GLP-1 receptor agonists (GLP-1 RAs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "bipolar disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-10",
        "pubmed_id": "41010364",
        "doi": "10.3390/life15091422"
      },
      "supporting_quote": "Early clinical trials in patients with metabolic disorders suggest improvements in depressive symptoms, quality of life, and cognitive function",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:09:00"
    },
    {
      "id": 1067,
      "intervention": {
        "name": "GLP-1 receptor agonists (GLP-1 RAs)",
        "canonical_name": "GLP-1 receptor agonists (GLP-1 RAs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "metabolic dysfunction",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-10",
        "pubmed_id": "41010364",
        "doi": "10.3390/life15091422"
      },
      "supporting_quote": "Early clinical trials in patients with metabolic disorders suggest improvements in depressive symptoms, quality of life, and cognitive function",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:09:00"
    },
    {
      "id": 1058,
      "intervention": {
        "name": "monoclonal antibodies against Tumor Necrosis Factor-alpha (TNF-α)",
        "canonical_name": "monoclonal antibodies against Tumor Necrosis Factor-alpha (TNF-α)",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": null,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessing Monoclonal and Polyclonal Antibodies in Sepsis and Septic Shock: A Systematic Review of Efficacy and Safety.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-11",
        "pubmed_id": "41009426",
        "doi": "10.3390/ijms26188859"
      },
      "supporting_quote": "Monoclonal antibodies against single cytokines e.g., Tumor Necrosis Factor-alpha (TNF-α) and endotoxin, did not significantly reduce 28-day mortality in unselected cohorts",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:07:49"
    },
    {
      "id": 1059,
      "intervention": {
        "name": "monoclonal antibodies against endotoxin",
        "canonical_name": null,
        "category": "biologics",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": null,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessing Monoclonal and Polyclonal Antibodies in Sepsis and Septic Shock: A Systematic Review of Efficacy and Safety.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-11",
        "pubmed_id": "41009426",
        "doi": "10.3390/ijms26188859"
      },
      "supporting_quote": "Monoclonal antibodies against single cytokines e.g., Tumor Necrosis Factor-alpha (TNF-α) and endotoxin, did not significantly reduce 28-day mortality in unselected cohorts",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:07:49"
    },
    {
      "id": 1060,
      "intervention": {
        "name": "monoclonal antibodies against Interleukin-6 (IL-6)",
        "canonical_name": "complement component 5a inhibitors (anti-C5a)",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": null,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessing Monoclonal and Polyclonal Antibodies in Sepsis and Septic Shock: A Systematic Review of Efficacy and Safety.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-11",
        "pubmed_id": "41009426",
        "doi": "10.3390/ijms26188859"
      },
      "supporting_quote": "subgroup analyses of patients with elevated Interleukin-6 (IL-6) or early septic shock showed trends toward benefit",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:07:49"
    },
    {
      "id": 1061,
      "intervention": {
        "name": "Intravenous Immunoglobulin (IVIG)",
        "canonical_name": null,
        "category": "biologics",
        "details": "{}",
        "delivery_method": "intravenous"
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": null,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessing Monoclonal and Polyclonal Antibodies in Sepsis and Septic Shock: A Systematic Review of Efficacy and Safety.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-11",
        "pubmed_id": "41009426",
        "doi": "10.3390/ijms26188859"
      },
      "supporting_quote": "Intravenous Immunoglobulin (IVIG) enriched for Immunoglobulin M (IgM) demonstrated the most consistent mortality reduction when administered early in hyperinflammatory phases",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:07:49"
    },
    {
      "id": 1062,
      "intervention": {
        "name": "checkpoint inhibitors targeting Programmed Cell Death Protein 1/Programmed Death-Ligand 1 inhibitors (anti-PD-1/PD-L1)",
        "canonical_name": "botulinum neurotoxin of type A (BoNT-A)",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": null,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessing Monoclonal and Polyclonal Antibodies in Sepsis and Septic Shock: A Systematic Review of Efficacy and Safety.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-11",
        "pubmed_id": "41009426",
        "doi": "10.3390/ijms26188859"
      },
      "supporting_quote": "Emerging precision strategies-including checkpoint inhibitors targeting Programmed Cell Death Protein 1/Programmed Death-Ligand 1 inhibitors (anti-PD-1/PD-L1), complement component 5a inhibitors (anti-C5a), and anti-adrenomedullin-were safe and improved organ-support-free days and Sequential Organ Failure Assessment (SOFA) scores",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:07:49"
    },
    {
      "id": 1063,
      "intervention": {
        "name": "complement component 5a inhibitors (anti-C5a)",
        "canonical_name": "complement component 5a inhibitors (anti-C5a)",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": null,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessing Monoclonal and Polyclonal Antibodies in Sepsis and Septic Shock: A Systematic Review of Efficacy and Safety.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-11",
        "pubmed_id": "41009426",
        "doi": "10.3390/ijms26188859"
      },
      "supporting_quote": "Emerging precision strategies-including checkpoint inhibitors targeting Programmed Cell Death Protein 1/Programmed Death-Ligand 1 inhibitors (anti-PD-1/PD-L1), complement component 5a inhibitors (anti-C5a), and anti-adrenomedullin-were safe and improved organ-support-free days and Sequential Organ Failure Assessment (SOFA) scores",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:07:49"
    },
    {
      "id": 1064,
      "intervention": {
        "name": "anti-adrenomedullin",
        "canonical_name": "zinc therapy",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": null,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessing Monoclonal and Polyclonal Antibodies in Sepsis and Septic Shock: A Systematic Review of Efficacy and Safety.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-11",
        "pubmed_id": "41009426",
        "doi": "10.3390/ijms26188859"
      },
      "supporting_quote": "Emerging precision strategies-including checkpoint inhibitors targeting Programmed Cell Death Protein 1/Programmed Death-Ligand 1 inhibitors (anti-PD-1/PD-L1), complement component 5a inhibitors (anti-C5a), and anti-adrenomedullin-were safe and improved organ-support-free days and Sequential Organ Failure Assessment (SOFA) scores",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:07:49"
    },
    {
      "id": 1057,
      "intervention": {
        "name": "exercise and nutritional intervention",
        "canonical_name": "aerobic exercise",
        "category": "lifestyle",
        "details": "{\"duration\": \"12 weeks\", \"frequency\": \"guided by physical therapist and dietitian\"}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "frailty in patients with cirrhosis listed for liver transplantation",
        "canonical_name": null,
        "category": "immunological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.85,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 66,
        "duration": "12 weeks",
        "population": "patients with increased Liver Frailty Index (LFI) (≥3.2)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Simultaneous physical and nutritional intervention reduces frailty in patients with cirrhosis listed for liver transplantation: a randomized controlled trial.",
        "journal": "Annals of hepatology",
        "publication_date": "2025-09-11",
        "pubmed_id": "40945851",
        "doi": "10.1016/j.aohep.2025.102114"
      },
      "supporting_quote": "There was a significant improvement in LFI at the end of the study in the intervention group",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:04:14"
    },
    {
      "id": 1056,
      "intervention": {
        "name": "combination of traditional Chinese and Western medicine",
        "canonical_name": "combination of traditional Chinese and Western medicine",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "refractory epilepsy (RE)",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "meta-analysis of randomized controlled trials",
        "sample_size": 1521,
        "duration": null,
        "population": "RE patients",
        "adverse_effects": "no statistically significant difference in the incidence of adverse effects between treatment and control groups",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety in treating refractory epilepsy with a combination of traditional Chinese and Western medicine: A meta-analysis of randomized controlled trials.",
        "journal": "Medicine",
        "publication_date": "2025-09-12",
        "pubmed_id": "40958268",
        "doi": "10.1097/MD.0000000000044484"
      },
      "supporting_quote": "The combination of traditional Chinese and Western medicine may be an effective treatment option for RE, but further studies are needed to be assessed",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:03:36"
    },
    {
      "id": 1054,
      "intervention": {
        "name": "nivolumab monotherapy",
        "canonical_name": "nivolumab monotherapy",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "advanced melanoma",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": 714,
        "duration": "48 months",
        "population": "patients with advanced melanoma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047.",
        "journal": "Journal for immunotherapy of cancer",
        "publication_date": "2025-09-12",
        "pubmed_id": "40940136",
        "doi": "10.1136/jitc-2025-012747"
      },
      "supporting_quote": "This analysis compared TFS for nivolumab plus relatlimab and nivolumab monotherapy in patients with advanced melanoma.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:03:05"
    },
    {
      "id": 1055,
      "intervention": {
        "name": "nivolumab plus relatlimab",
        "canonical_name": "nivolumab monotherapy",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "advanced melanoma",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": 714,
        "duration": "48 months",
        "population": "patients with advanced melanoma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047.",
        "journal": "Journal for immunotherapy of cancer",
        "publication_date": "2025-09-12",
        "pubmed_id": "40940136",
        "doi": "10.1136/jitc-2025-012747"
      },
      "supporting_quote": "This analysis compared TFS for nivolumab plus relatlimab and nivolumab monotherapy in patients with advanced melanoma.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:03:05"
    },
    {
      "id": 1053,
      "intervention": {
        "name": "Nucleos(t)ide analogues (NAs)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "chronic hepatitis B virus (HBV) infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 90,
        "duration": "144 weeks",
        "population": "Asian patients with chronic hepatitis B virus (HBV) infection",
        "adverse_effects": "38.6% and 20.2% patients experienced virological and clinical relapse after stopping NAs, with 16 patients retreated and no serious adverse events occurred",
        "cost_category": null
      },
      "paper": {
        "title": "Novel HBV biomarkers-guided NAs withdrawal strategy promotes HBsAg clearance in Asian CHB patients: a randomized controlled trial.",
        "journal": "Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association",
        "publication_date": "2025-09-13",
        "pubmed_id": "40953786",
        "doi": "10.1016/j.cgh.2025.09.009"
      },
      "supporting_quote": "Nucleos(t)ide analogues (NAs) discontinuation promotes hepatitis B surface antigen (HBsAg) clearance among European patients with chronic hepatitis B virus (HBV) infection.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:02:21"
    },
    {
      "id": 1050,
      "intervention": {
        "name": "surgical intervention",
        "canonical_name": "arthroscopic rotator cuff repair (RCR)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "esophageal atresia (EA)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "retrospective cohort study with a comparison group (Level III)",
        "sample_size": 97,
        "duration": "from January 2015 to December 2022",
        "population": "patients who underwent primary EA repair",
        "adverse_effects": "anastomotic leakage, anastomotic stricture, gastroesophageal reflux disease (GERD), eosinophilic esophagitis",
        "cost_category": null
      },
      "paper": {
        "title": "Outcome of esophageal atresia: What choice of suture material?",
        "journal": "Journal of pediatric surgery",
        "publication_date": "2025-09-15",
        "pubmed_id": "40962172",
        "doi": "10.1016/j.jpedsurg.2025.162669"
      },
      "supporting_quote": "The treatment relies on surgical intervention",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:01:44"
    },
    {
      "id": 1051,
      "intervention": {
        "name": "absorbable suture material",
        "canonical_name": "mesenchymal stem cell (MSC) augmentation",
        "category": "device",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "esophageal atresia (EA)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "retrospective cohort study with a comparison group (Level III)",
        "sample_size": 97,
        "duration": "from January 2015 to December 2022",
        "population": "patients who underwent primary EA repair",
        "adverse_effects": "anastomotic leakage",
        "cost_category": null
      },
      "paper": {
        "title": "Outcome of esophageal atresia: What choice of suture material?",
        "journal": "Journal of pediatric surgery",
        "publication_date": "2025-09-15",
        "pubmed_id": "40962172",
        "doi": "10.1016/j.jpedsurg.2025.162669"
      },
      "supporting_quote": "Anastomotic leakage occurred in 3 % of patients, exclusively in the absorbable suture group",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:01:44"
    },
    {
      "id": 1052,
      "intervention": {
        "name": "non-absorbable suture material",
        "canonical_name": "mesenchymal stem cell (MSC) augmentation",
        "category": "device",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "esophageal atresia (EA)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "retrospective cohort study with a comparison group (Level III)",
        "sample_size": 97,
        "duration": "from January 2015 to December 2022",
        "population": "patients who underwent primary EA repair",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Outcome of esophageal atresia: What choice of suture material?",
        "journal": "Journal of pediatric surgery",
        "publication_date": "2025-09-15",
        "pubmed_id": "40962172",
        "doi": "10.1016/j.jpedsurg.2025.162669"
      },
      "supporting_quote": "Anastomotic leakage occurred in 3 % of patients, exclusively in the absorbable suture group",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:01:44"
    },
    {
      "id": 1049,
      "intervention": {
        "name": "empirical antifungal treatment",
        "canonical_name": "empirical antifungal treatment",
        "category": "medication",
        "details": "{\"drug\": \"posaconazole\", \"dosage\": null, \"frequency\": null, \"duration\": null}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "influenza-associated pulmonary aspergillosis (IAPA)",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe"
      },
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "observational study",
        "sample_size": 172,
        "duration": null,
        "population": "ICU patients with influenza-induced ARDS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study.",
        "journal": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
        "publication_date": "2025-09-15",
        "pubmed_id": "40971881",
        "doi": "10.1093/cid/ciaf507"
      },
      "supporting_quote": "In ICU patients with influenza ARDS, empirical antifungal treatment was associated with significantly reduced IAPA incidence",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 10:00:18"
    },
    {
      "id": 1048,
      "intervention": {
        "name": "Azetukalner",
        "canonical_name": null,
        "category": "emerging",
        "details": "{\"dosage\": \"20 mg orally once daily with food\", \"duration\": \"8 weeks\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Major Depressive Disorder and Anhedonia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized, controlled trial",
        "sample_size": 60,
        "duration": "8 weeks",
        "population": "individuals with Major Depressive Disorder and anhedonia in a current major depressive episode",
        "adverse_effects": "low discontinuation rates due to adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "A Randomized, Controlled Trial of the Novel, Potent Kv7 Channel Opener Azetukalner in Individuals with Major Depressive Disorder and Anhedonia: Neural Response to Reward, Clinical Outcomes, and Safety.",
        "journal": "Research square",
        "publication_date": "2025-09-15",
        "pubmed_id": "41001561",
        "doi": "10.21203/rs.3.rs-7448148/v1"
      },
      "supporting_quote": "Participants were randomized 1:1 to receive azetukalner (20 mg orally once daily with food) or placebo for 8 weeks.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:59:42"
    },
    {
      "id": 1046,
      "intervention": {
        "name": "starch- and sucrose-reduced diet (SSRD)",
        "canonical_name": "dextran sulfate sodium (DSS)-induced diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "Irritable bowel syndrome",
        "canonical_name": null,
        "category": "digestive",
        "severity": "moderate"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized clinical trials",
        "sample_size": 237,
        "duration": null,
        "population": "IBS patients with moderate or severe symptoms, half of them were overweight/obese",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Dietary Modifications in IBS Leads to Reduced Symptoms, Weight, and Lipid Levels: Two Randomized Clinical Trials.",
        "journal": "Nutrients",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010496",
        "doi": "10.3390/nu17182966"
      },
      "supporting_quote": "The SSRD in the second cohort and low FODMAP rendered lower levels of total cholesterol, low-density lipoprotein, and non-high-density lipoprotein levels.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:59:07"
    },
    {
      "id": 1047,
      "intervention": {
        "name": "low fermentable oligo-, di-, and monosaccharides and polyols (FODMAP) diet",
        "canonical_name": "dextran sulfate sodium (DSS)-induced diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "Irritable bowel syndrome",
        "canonical_name": null,
        "category": "digestive",
        "severity": "moderate"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized clinical trials",
        "sample_size": 237,
        "duration": null,
        "population": "IBS patients with moderate or severe symptoms, half of them were overweight/obese",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Dietary Modifications in IBS Leads to Reduced Symptoms, Weight, and Lipid Levels: Two Randomized Clinical Trials.",
        "journal": "Nutrients",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010496",
        "doi": "10.3390/nu17182966"
      },
      "supporting_quote": "The SSRD in the second cohort and low FODMAP rendered lower levels of total cholesterol, low-density lipoprotein, and non-high-density lipoprotein levels.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:59:07"
    },
    {
      "id": 1045,
      "intervention": {
        "name": "hydroxychloroquine",
        "canonical_name": null,
        "category": "medication",
        "details": "{\"dosage\": null, \"frequency\": null, \"duration\": \"24 months\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "incomplete lupus (ILE)",
        "canonical_name": null,
        "category": "immunological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": 0.0,
        "extraction_confidence": 1.0,
        "study_confidence": 0.98
      },
      "study": {
        "type": "randomized, placebo-controlled trial",
        "sample_size": 187,
        "duration": "24 months",
        "population": "patients 15-49 years old with incomplete lupus (ILE)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomized, placebo-controlled trial of hydroxychloroquine in incomplete lupus.",
        "journal": "Arthritis & rheumatology (Hoboken, N.J.)",
        "publication_date": "2025-09-16",
        "pubmed_id": "40955637",
        "doi": "10.1002/art.43391"
      },
      "supporting_quote": "Hydroxychloroquine was chosen as an ILE intervention for a randomized, double-blind trial to determine whether rate of accumulation of SLE features defined by the 2012 SLICC criteria could be reduced.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:55:18"
    },
    {
      "id": 1043,
      "intervention": {
        "name": "tenofovir alafenamide (TAF)",
        "canonical_name": "empirical antifungal treatment",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "hepatitis B virus recurrence after liver transplantation",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 26,
        "duration": "48 weeks",
        "population": "patients with chronic kidney disease maintained on tenofovir disoproxil fumarate post-OLT",
        "adverse_effects": "no grade 3/4 adverse event or serious AE deemed treatment-related",
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of tenofovir alafenamide in preventing hepatitis B virus recurrence after liver transplantation in patients with chronic kidney disease maintained on tenofovir disoproxil fumarate: results from a phase 2 randomized trial.",
        "journal": "American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons",
        "publication_date": "2025-09-17",
        "pubmed_id": "40972902",
        "doi": "10.1016/j.ajt.2025.09.012"
      },
      "supporting_quote": "TAF was safe and effective through W192 post-OLT",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:54:42"
    },
    {
      "id": 1044,
      "intervention": {
        "name": "tenofovir disoproxil fumarate (TDF)",
        "canonical_name": "tenofovir disoproxil fumarate (TDF)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "hepatitis B virus recurrence after liver transplantation",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 25,
        "duration": "48 weeks",
        "population": "patients with chronic kidney disease maintained on tenofovir disoproxil fumarate post-OLT",
        "adverse_effects": "no grade 3/4 adverse event or serious AE deemed treatment-related",
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of tenofovir alafenamide in preventing hepatitis B virus recurrence after liver transplantation in patients with chronic kidney disease maintained on tenofovir disoproxil fumarate: results from a phase 2 randomized trial.",
        "journal": "American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons",
        "publication_date": "2025-09-17",
        "pubmed_id": "40972902",
        "doi": "10.1016/j.ajt.2025.09.012"
      },
      "supporting_quote": "TDF effectively prevents hepatitis B virus (HBV) reactivation after orthotopic liver transplantation",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:54:42"
    },
    {
      "id": 1042,
      "intervention": {
        "name": "probiotics",
        "canonical_name": "Eggshell membrane (ESM)",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "inflammatory bowel disease (IBD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trials",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Probiotics in IBD: Evidence and Perspectives on Patient Health and Disease Management.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-17",
        "pubmed_id": "41009629",
        "doi": "10.3390/ijms26189065"
      },
      "supporting_quote": "Gut modulation by probiotics application represents one of the potential strategies for the prevention or treatment of IBD.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:53:41"
    },
    {
      "id": 1039,
      "intervention": {
        "name": "methylphenidate",
        "canonical_name": "methylphenidate",
        "category": "medication",
        "details": "{\"dosage\": null, \"duration\": \"8 weeks\", \"frequency\": null, \"intensity\": null}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "attention-deficit/hyperactivity disorder (ADHD)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 102,
        "duration": "8 weeks",
        "population": "preschool children (<6 years) in Brazil",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Moderators of Response to Stimulants for Preschool Attention-Deficit/Hyperactivity Disorder.",
        "journal": "Journal of the American Academy of Child and Adolescent Psychiatry",
        "publication_date": "2025-09-18",
        "pubmed_id": "40975435",
        "doi": "10.1016/j.jaac.2025.09.012"
      },
      "supporting_quote": "We acquired individual-level participant data from two randomized placebo-controlled trials (RCTs) of preschool ADHD: MAPPA (8-week methylphenidate, 102 participants, Brazil)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:53:13"
    },
    {
      "id": 1040,
      "intervention": {
        "name": "lisdexamfetamine",
        "canonical_name": "methylphenidate",
        "category": "medication",
        "details": "{\"dosage\": null, \"duration\": \"6 weeks\", \"frequency\": null, \"intensity\": null}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "attention-deficit/hyperactivity disorder (ADHD)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 148,
        "duration": "6 weeks",
        "population": "preschool children (<6 years) in the US",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Moderators of Response to Stimulants for Preschool Attention-Deficit/Hyperactivity Disorder.",
        "journal": "Journal of the American Academy of Child and Adolescent Psychiatry",
        "publication_date": "2025-09-18",
        "pubmed_id": "40975435",
        "doi": "10.1016/j.jaac.2025.09.012"
      },
      "supporting_quote": "We acquired individual-level participant data from two randomized placebo-controlled trials (RCTs) of preschool ADHD: SPD489-347 (6-week lisdexamfetamine, 148 participants, US)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:53:13"
    },
    {
      "id": 1041,
      "intervention": {
        "name": "methylphenidate",
        "canonical_name": "methylphenidate",
        "category": "medication",
        "details": "{\"dosage\": null, \"duration\": \"5 weeks\", \"frequency\": null, \"intensity\": null}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "attention-deficit/hyperactivity disorder (ADHD)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 165,
        "duration": "5 weeks",
        "population": "preschool children (<6 years) in the US",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Moderators of Response to Stimulants for Preschool Attention-Deficit/Hyperactivity Disorder.",
        "journal": "Journal of the American Academy of Child and Adolescent Psychiatry",
        "publication_date": "2025-09-18",
        "pubmed_id": "40975435",
        "doi": "10.1016/j.jaac.2025.09.012"
      },
      "supporting_quote": "For categorical variables, we also computed treatment effects (i.e., stimulants versus placebo) within subgroups and, when possible, pooled them alongside subgroup data from PATS (5-week methylphenidate, 165 participants, US)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:53:13"
    },
    {
      "id": 1038,
      "intervention": {
        "name": "Benzoyl peroxide (BPO) wash preparation",
        "canonical_name": null,
        "category": "test",
        "details": "{\"dosage\": \"10%\", \"duration\": \"2 days\", \"frequency\": \"daily\"}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "Cutibacterium acnes burden in shoulder arthroplasty",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.42,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 82,
        "duration": null,
        "population": "patients undergoing shoulder arthroplasty",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Pretreatment of the Pilosebaceous Unit on Cutibacterium acnes Burden during Shoulder Arthroplasty: A Randomized Controlled Trial.",
        "journal": "Journal of shoulder and elbow surgery",
        "publication_date": "2025-09-18",
        "pubmed_id": "40975210",
        "doi": "10.1016/j.jse.2025.08.008"
      },
      "supporting_quote": "Overall culture positivity was decreased in the BPO/BLT group compared to the control (13.3% vs 26.8%, P=0.026)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:51:34"
    },
    {
      "id": 1037,
      "intervention": {
        "name": "continuous positive airway pressure (CPAP)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "Refractory hypertension",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Refractory hypertension and obstructive sleep apnea.",
        "journal": "Journal of hypertension",
        "publication_date": "2025-09-18",
        "pubmed_id": "41036995",
        "doi": "10.1097/HJH.0000000000004166"
      },
      "supporting_quote": "Treatment of OSA with continuous positive airway pressure (CPAP) significantly reduces blood pressure by 8-10 mmHg in patients with RfH.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:50:27"
    },
    {
      "id": 1035,
      "intervention": {
        "name": "Vonoprazan",
        "canonical_name": "Vonoprazan",
        "category": "device",
        "details": "{\"dosage\": \"10 mg\", \"frequency\": \"daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Non-erosive reflux disease (NERD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2540,
        "duration": null,
        "population": "patients with NERD",
        "adverse_effects": "no significant adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "Reassessing Vonoprazan for Endoscopy-Negative Reflux Disease: A Systematic Review and Meta-Analysis.",
        "journal": "Digestive diseases and sciences",
        "publication_date": "2025-09-18",
        "pubmed_id": "40965559",
        "doi": "10.1007/s10620-025-09399-9"
      },
      "supporting_quote": "Vonoprazan 10 mg showed no benefit over placebo in NERD.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:50:00"
    },
    {
      "id": 1036,
      "intervention": {
        "name": "Vonoprazan",
        "canonical_name": "Vonoprazan",
        "category": "medication",
        "details": "{\"dosage\": \"20 mg\", \"frequency\": \"daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Non-erosive reflux disease (NERD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.6,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2540,
        "duration": null,
        "population": "patients with NERD",
        "adverse_effects": "no significant adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "Reassessing Vonoprazan for Endoscopy-Negative Reflux Disease: A Systematic Review and Meta-Analysis.",
        "journal": "Digestive diseases and sciences",
        "publication_date": "2025-09-18",
        "pubmed_id": "40965559",
        "doi": "10.1007/s10620-025-09399-9"
      },
      "supporting_quote": "Vonoprazan 20 mg was superior to placebo in terms of mean proportion of days without heartburn.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:50:00"
    },
    {
      "id": 1034,
      "intervention": {
        "name": "metacognitive training",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "bipolar disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 55,
        "duration": "10 weeks",
        "population": "euthymic patients with bipolar disorder",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The causal relationship between social cognition and psychosocial functional outcome over time in bipolar disorder: A latent change score model approach.",
        "journal": "Journal of affective disorders",
        "publication_date": "2025-09-19",
        "pubmed_id": "40976343",
        "doi": "10.1016/j.jad.2025.120346"
      },
      "supporting_quote": "We used a latent change score model to analyze data from a randomized controlled trial comparing metacognitive training to treatment as usual.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:49:00"
    },
    {
      "id": 1030,
      "intervention": {
        "name": "Curcuma longa",
        "canonical_name": "Curcuma longa",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review of clinical trials",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Phytotherapy as an adjunct to the treatment of rheumatoid arthritis - a systematic review of clinical trials.",
        "journal": "Phytomedicine : international journal of phytotherapy and phytopharmacology",
        "publication_date": "2025-09-19",
        "pubmed_id": "41005054",
        "doi": "10.1016/j.phymed.2025.157285"
      },
      "supporting_quote": "Analysis of the available data indicates positive effects of Curcuma longa in supportive therapy for RA patients.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:48:32"
    },
    {
      "id": 1031,
      "intervention": {
        "name": "Zingiber officinale",
        "canonical_name": "Curcuma longa",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review of clinical trials",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Phytotherapy as an adjunct to the treatment of rheumatoid arthritis - a systematic review of clinical trials.",
        "journal": "Phytomedicine : international journal of phytotherapy and phytopharmacology",
        "publication_date": "2025-09-19",
        "pubmed_id": "41005054",
        "doi": "10.1016/j.phymed.2025.157285"
      },
      "supporting_quote": "Analysis of the available data indicates positive effects of Zingiber officinale in supportive therapy for RA patients.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:48:32"
    },
    {
      "id": 1032,
      "intervention": {
        "name": "Tripterygium wilfordii",
        "canonical_name": "Salvia miltiorrhiza",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review of clinical trials",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Phytotherapy as an adjunct to the treatment of rheumatoid arthritis - a systematic review of clinical trials.",
        "journal": "Phytomedicine : international journal of phytotherapy and phytopharmacology",
        "publication_date": "2025-09-19",
        "pubmed_id": "41005054",
        "doi": "10.1016/j.phymed.2025.157285"
      },
      "supporting_quote": "Analysis of the available data indicates positive effects of Tripterygium wilfordii in supportive therapy for RA patients.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:48:32"
    },
    {
      "id": 1033,
      "intervention": {
        "name": "Salvia miltiorrhiza",
        "canonical_name": "Salvia miltiorrhiza",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review of clinical trials",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Phytotherapy as an adjunct to the treatment of rheumatoid arthritis - a systematic review of clinical trials.",
        "journal": "Phytomedicine : international journal of phytotherapy and phytopharmacology",
        "publication_date": "2025-09-19",
        "pubmed_id": "41005054",
        "doi": "10.1016/j.phymed.2025.157285"
      },
      "supporting_quote": "Analysis of the available data indicates positive effects of Salvia miltiorrhiza in supportive therapy for RA patients.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:48:32"
    },
    {
      "id": 1028,
      "intervention": {
        "name": "aerobic training",
        "canonical_name": "aerobic exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "liver cirrhosis",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trial (RCT)",
        "sample_size": null,
        "duration": null,
        "population": "patients with liver cirrhosis, Child-Pugh stages A, B, or C",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of aerobic and resistance training on body composition, functional capacity, and quality of life in patients with liver cirrhosis: a systematic review with meta-analysis.",
        "journal": "Clinics (Sao Paulo, Brazil)",
        "publication_date": "2025-09-20",
        "pubmed_id": "40976129",
        "doi": "10.1016/j.clinsp.2025.100748"
      },
      "supporting_quote": "Aerobic and resistance physical training appear to improve the QoL and functional capacity without changing body composition in patients with liver cirrhosis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:47:07"
    },
    {
      "id": 1029,
      "intervention": {
        "name": "resistance training",
        "canonical_name": null,
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "liver cirrhosis",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trial (RCT)",
        "sample_size": null,
        "duration": null,
        "population": "patients with liver cirrhosis, Child-Pugh stages A, B, or C",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of aerobic and resistance training on body composition, functional capacity, and quality of life in patients with liver cirrhosis: a systematic review with meta-analysis.",
        "journal": "Clinics (Sao Paulo, Brazil)",
        "publication_date": "2025-09-20",
        "pubmed_id": "40976129",
        "doi": "10.1016/j.clinsp.2025.100748"
      },
      "supporting_quote": "Aerobic and resistance physical training appear to improve the QoL and functional capacity without changing body composition in patients with liver cirrhosis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:47:07"
    },
    {
      "id": 1025,
      "intervention": {
        "name": "PD-1 antibody",
        "canonical_name": "PD-1 antibody",
        "category": "biologics",
        "details": "{\"dosage\": \"intravenously once per 3 weeks for 24 weeks\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "chronic hepatitis B (CHB)",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "multicentre randomised controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "virologically suppressed CHB patients by NAs therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-09-21",
        "pubmed_id": "40976664",
        "doi": "10.1136/bmjopen-2025-105710"
      },
      "supporting_quote": "PD-1 antibody will be injected intravenously once per 3 weeks for 24 weeks",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:46:14"
    },
    {
      "id": 1026,
      "intervention": {
        "name": "pegylated interferon α (PEG-IFNα)",
        "canonical_name": "pegylated interferon α (PEG-IFNα)",
        "category": "therapy",
        "details": "{\"dosage\": \"subcutaneously once a week for 48 weeks\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "chronic hepatitis B (CHB)",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "multicentre randomised controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "virologically suppressed CHB patients by NAs therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-09-21",
        "pubmed_id": "40976664",
        "doi": "10.1136/bmjopen-2025-105710"
      },
      "supporting_quote": "PEG-IFNα will be injected subcutaneously once a week for 48 weeks",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:46:14"
    },
    {
      "id": 1027,
      "intervention": {
        "name": "PD-1 antibody combined with PEG-IFNα",
        "canonical_name": "pegylated interferon α (PEG-IFNα)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "chronic hepatitis B (CHB)",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "multicentre randomised controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "virologically suppressed CHB patients by NAs therapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-09-21",
        "pubmed_id": "40976664",
        "doi": "10.1136/bmjopen-2025-105710"
      },
      "supporting_quote": "PD-1 antibody combined with PEG-IFNα for promoting functional cure",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:46:14"
    },
    {
      "id": 1022,
      "intervention": {
        "name": "levofloxacin-based TB preventive treatment (TPT)",
        "canonical_name": "levofloxacin-based TB preventive treatment (TPT)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "multidrug-resistant tuberculosis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "close contacts of people with multidrug-resistant tuberculosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.",
        "journal": "Contemporary clinical trials",
        "publication_date": "2025-09-22",
        "pubmed_id": "40992540",
        "doi": "10.1016/j.cct.2025.108084"
      },
      "supporting_quote": "While levofloxacin-based TPT has been shown safe and efficacious, alternatives are needed for those exposed to fluoroquinolone-resistant Mycobacterium tuberculosis (M. tb).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:44:51"
    },
    {
      "id": 1023,
      "intervention": {
        "name": "delamanid",
        "canonical_name": "levofloxacin-based TB preventive treatment (TPT)",
        "category": "emerging",
        "details": "{\"duration\": \"26 weeks\", \"dosage\": null, \"frequency\": null}",
        "delivery_method": null
      },
      "condition": {
        "name": "multidrug-resistant tuberculosis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "phase 3, open-label, multicenter clinical trial with a cluster-randomized superiority design",
        "sample_size": 3452,
        "duration": "96 weeks of follow-up",
        "population": "high-risk household contacts (HHCs) of adults with pulmonary MDR-TB",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.",
        "journal": "Contemporary clinical trials",
        "publication_date": "2025-09-22",
        "pubmed_id": "40992540",
        "doi": "10.1016/j.cct.2025.108084"
      },
      "supporting_quote": "The PHOENIx trial evaluates whether using a novel nitroimidazole, delamanid, in high-risk household contacts (HHCs) of patients with MDR-TB reduces their risk of developing active TB.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:44:51"
    },
    {
      "id": 1024,
      "intervention": {
        "name": "isoniazid",
        "canonical_name": "levofloxacin-based TB preventive treatment (TPT)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "multidrug-resistant tuberculosis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "phase 3, open-label, multicenter clinical trial with a cluster-randomized superiority design",
        "sample_size": 3452,
        "duration": "96 weeks of follow-up",
        "population": "high-risk household contacts (HHCs) of adults with pulmonary MDR-TB",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.",
        "journal": "Contemporary clinical trials",
        "publication_date": "2025-09-22",
        "pubmed_id": "40992540",
        "doi": "10.1016/j.cct.2025.108084"
      },
      "supporting_quote": "The study objectives are to compare efficacy and safety of 26 weeks of delamanid versus isoniazid for preventing confirmed or probable TB during 96 weeks of follow-up among HHCs of adults with pulmonary MDR-TB.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:44:51"
    },
    {
      "id": 1021,
      "intervention": {
        "name": "second-generation virtual reality intervention (SG-VRI)",
        "canonical_name": null,
        "category": "emerging",
        "details": "{\"duration\": \"8 weeks\", \"frequency\": \"2 sessions per week\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "attention-deficit/hyperactivity disorder (ADHD)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.95,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled study",
        "sample_size": 35,
        "duration": "8 weeks",
        "population": "children with ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Investigation of the Effect of Second-Generation Virtual Reality Interventions on Hot and Cold Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder: Single-Blind Randomized Controlled Study.",
        "journal": "Games for health journal",
        "publication_date": "2025-09-22",
        "pubmed_id": "40977258",
        "doi": "10.1177/2161783X251378645"
      },
      "supporting_quote": "The final results showed that the SG-VRI was effective in improving hot and cold EF skills of children with ADHD (P < 0.05).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:43:18"
    },
    {
      "id": 1020,
      "intervention": {
        "name": "intermittent theta burst stimulation (iTBS)",
        "canonical_name": "intermittent theta burst stimulation (iTBS)",
        "category": "therapy",
        "details": "{\"duration\": \"five consecutive days\", \"frequency\": \"four daily sessions\", \"dosage\": \"600 pulses per session\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "schizophrenia with negative symptoms",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "moderate"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized, double-blind, sham-controlled study",
        "sample_size": 60,
        "duration": "not specified in abstract",
        "population": "participants with schizophrenia (30 active and 30 sham) with moderate negative symptoms",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Accelerated Optimized Protocol of Intermittent Theta-Burst Stimulation for Negative Symptoms in Schizophrenia (ACTh-NS): A Randomized, Double-Blind, Sham-Controlled Study Design.",
        "journal": "Brain sciences",
        "publication_date": "2025-09-22",
        "pubmed_id": "41008381",
        "doi": "10.3390/brainsci15091021"
      },
      "supporting_quote": "A double-blind, randomized, sham-controlled clinical trial design will be conducted to test the effects of the accelerated iTBS protocol in 60 participants with schizophrenia (30 active and 30 sham) with moderate NSs.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:42:45"
    },
    {
      "id": 1019,
      "intervention": {
        "name": "Percutaneous Mechanical Aspiration (PMA)",
        "canonical_name": "Percutaneous Mechanical Aspiration (PMA)",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "right-sided infective endocarditis (RSIE)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "retrospective registry",
        "sample_size": 256,
        "duration": "January 2014 to January 2024",
        "population": "consecutive patients with RSIE who have undergone PMA",
        "adverse_effects": "procedure-related complications in 13.1%",
        "cost_category": null
      },
      "paper": {
        "title": "Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: A Multicenter Registry.",
        "journal": "Journal of the American College of Cardiology",
        "publication_date": "2025-09-23",
        "pubmed_id": "40864007",
        "doi": "10.1016/j.jacc.2025.06.054"
      },
      "supporting_quote": "Percutaneous mechanical aspiration (PMA) is an emerging acute intervention for debulking infective vegetations in right-sided infective endocarditis (RSIE)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:41:39"
    },
    {
      "id": 1015,
      "intervention": {
        "name": "Robot-assisted gait training (RAGT)",
        "canonical_name": null,
        "category": "exercise",
        "details": "{\"duration\": \"two hours\", \"frequency\": null, \"intensity\": \"continuous mode\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "multiple sclerosis",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 24,
        "duration": null,
        "population": "people with progressive multiple sclerosis and severe gait impairment",
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Low intensity interval robot-assisted gait training improves mobility in people with progressive multiple sclerosis: the PROGR-EX randomized controlled trial.",
        "journal": "Multiple sclerosis and related disorders",
        "publication_date": "2025-09-23",
        "pubmed_id": "41005019",
        "doi": "10.1016/j.msard.2025.106777"
      },
      "supporting_quote": "Robot-assisted gait training (RAGT) is an effective strategy for rehabilitation of people with MS (PwMS) and severe gait impairment",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:41:04"
    },
    {
      "id": 1016,
      "intervention": {
        "name": "Low-intensity interval robot-assisted gait training (LowRAGT)",
        "canonical_name": null,
        "category": "exercise",
        "details": "{\"duration\": null, \"frequency\": null, \"intensity\": \"low intensity, progressively increasing\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "multiple sclerosis",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 24,
        "duration": null,
        "population": "people with progressive multiple sclerosis and severe gait impairment",
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Low intensity interval robot-assisted gait training improves mobility in people with progressive multiple sclerosis: the PROGR-EX randomized controlled trial.",
        "journal": "Multiple sclerosis and related disorders",
        "publication_date": "2025-09-23",
        "pubmed_id": "41005019",
        "doi": "10.1016/j.msard.2025.106777"
      },
      "supporting_quote": "A LowRAGT is effective in improving gait speed in PwMS",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:41:04"
    },
    {
      "id": 1017,
      "intervention": {
        "name": "Continuous robot-assisted gait training (RAGT)",
        "canonical_name": null,
        "category": "exercise",
        "details": "{\"duration\": null, \"frequency\": null, \"intensity\": \"continuous mode\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "multiple sclerosis",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 24,
        "duration": null,
        "population": "people with progressive multiple sclerosis and severe gait impairment",
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Low intensity interval robot-assisted gait training improves mobility in people with progressive multiple sclerosis: the PROGR-EX randomized controlled trial.",
        "journal": "Multiple sclerosis and related disorders",
        "publication_date": "2025-09-23",
        "pubmed_id": "41005019",
        "doi": "10.1016/j.msard.2025.106777"
      },
      "supporting_quote": "The use in continuous mode may impose high internal load and physiological stress, potentially limiting its wide applicability",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:41:04"
    },
    {
      "id": 1018,
      "intervention": {
        "name": "Self-paced overground gait training (OGT)",
        "canonical_name": null,
        "category": "exercise",
        "details": "null",
        "delivery_method": null
      },
      "condition": {
        "name": "multiple sclerosis",
        "canonical_name": null,
        "category": "neurological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 24,
        "duration": null,
        "population": "people with progressive multiple sclerosis and severe gait impairment",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Low intensity interval robot-assisted gait training improves mobility in people with progressive multiple sclerosis: the PROGR-EX randomized controlled trial.",
        "journal": "Multiple sclerosis and related disorders",
        "publication_date": "2025-09-23",
        "pubmed_id": "41005019",
        "doi": "10.1016/j.msard.2025.106777"
      },
      "supporting_quote": "To evaluate whether a low-intensity RAGT at progressively increasing intensity (LowRAGT) improves walking function more than continuous RAGT or self-paced overground gait training (OGT)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:41:04"
    },
    {
      "id": 1014,
      "intervention": {
        "name": "suprascapular nerve block",
        "canonical_name": null,
        "category": "procedure",
        "details": "{\"method\": \"ultrasound-guided\", \"duration\": \"procedure time\", \"frequency\": \"single administration\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "traumatic scapular fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.95,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "case series",
        "sample_size": 10,
        "duration": "2 hours post-procedure",
        "population": "adult patients with severe pain (Defense and Veterans Pain Rating Scale ≥7) and a mean Injury Severity Score (ISS) of 30",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Suprascapular nerve block for analgesia in traumatic scapular fractures performed by emergency physicians: A case series.",
        "journal": "The American journal of emergency medicine",
        "publication_date": "2025-09-23",
        "pubmed_id": "41016085",
        "doi": "10.1016/j.ajem.2025.09.041"
      },
      "supporting_quote": "All patients achieved at least a 50 % reduction in pain within 30 min",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:39:08"
    },
    {
      "id": 1012,
      "intervention": {
        "name": "denosumab biosimilar",
        "canonical_name": "denosumab biosimilar",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "postmenopausal osteoporosis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "meta-analysis of randomized controlled trials",
        "sample_size": 1784,
        "duration": null,
        "population": "postmenopausal women with osteoporosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative efficacy and safety of denosumab biosimilar and originator in postmenopausal osteoporosis: a meta-analysis of randomized controlled trials.",
        "journal": "Zeitschrift fur Rheumatologie",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993439",
        "doi": "10.1007/s00393-025-01737-6"
      },
      "supporting_quote": "The denosumab biosimilars demonstrated efficacy and safety profiles comparable to the originator in the treatment of postmenopausal osteoporosis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:37:58"
    },
    {
      "id": 1013,
      "intervention": {
        "name": "originator denosumab",
        "canonical_name": "denosumab biosimilar",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "postmenopausal osteoporosis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "meta-analysis of randomized controlled trials",
        "sample_size": 1784,
        "duration": null,
        "population": "postmenopausal women with osteoporosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative efficacy and safety of denosumab biosimilar and originator in postmenopausal osteoporosis: a meta-analysis of randomized controlled trials.",
        "journal": "Zeitschrift fur Rheumatologie",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993439",
        "doi": "10.1007/s00393-025-01737-6"
      },
      "supporting_quote": "The denosumab biosimilars demonstrated efficacy and safety profiles comparable to the originator in the treatment of postmenopausal osteoporosis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:37:58"
    },
    {
      "id": 1011,
      "intervention": {
        "name": "cognitive behavioral therapy",
        "canonical_name": "cognitive behavioral therapy",
        "category": "therapy",
        "details": "{\"delivery_method\": \"videoconference-delivered\", \"duration\": \"16 weeks\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "panic disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.98
      },
      "study": {
        "type": "randomized, assessor-blinded, controlled trial",
        "sample_size": 30,
        "duration": "16 weeks",
        "population": "symptomatic patients with panic disorder following primary pharmacotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Videoconference-delivered cognitive behavioral therapy in patients with symptomatic panic disorder following primary pharmacotherapy: a randomized, assessor-blinded, controlled trial.",
        "journal": "BMC psychiatry",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993573",
        "doi": "10.1186/s12888-025-07320-2"
      },
      "supporting_quote": "After 16 weeks, the adjusted mean changes in Panic Disorder Severity Scale score from baseline were -7.92 and 0.75 in the videoconference-based cognitive behavioral therapy (n=15) and usual care (n=15) groups, respectively",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:37:01"
    },
    {
      "id": 1010,
      "intervention": {
        "name": "synbiotics",
        "canonical_name": "Moringa oleifera (MO) supplementation",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Alzheimer's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Synbiotics in Alzheimer's disease: mechanisms, clinical evidence, and therapeutic prospects.",
        "journal": "Journal of translational medicine",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993787",
        "doi": "10.1186/s12967-025-07064-3"
      },
      "supporting_quote": "Synbiotics demonstrate significant potential, particularly in early AD, by improving cognitive domains, reducing neuroinflammation and AD biomarkers, and modulating beneficial microbial metabolites.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:36:26"
    },
    {
      "id": 1004,
      "intervention": {
        "name": "Noninvasive brain stimulation (NIBS)",
        "canonical_name": "active video games (AVGs)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "psychiatric disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "network meta-analysis",
        "sample_size": 1651,
        "duration": null,
        "population": "psychiatric populations",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of individualized noninvasive brain stimulation targets in treating psychiatric disorders: A network meta-analysis.",
        "journal": "Journal of psychiatric research",
        "publication_date": "2025-09-24",
        "pubmed_id": "41033274",
        "doi": "10.1016/j.jpsychires.2025.09.029"
      },
      "supporting_quote": "Noninvasive brain stimulation (NIBS) techniques have gained increasing attention in psychiatric research and treatment.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:35:23"
    },
    {
      "id": 1005,
      "intervention": {
        "name": "Individualized targeting",
        "canonical_name": "EEG",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "psychiatric disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "network meta-analysis",
        "sample_size": 1651,
        "duration": null,
        "population": "psychiatric populations",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of individualized noninvasive brain stimulation targets in treating psychiatric disorders: A network meta-analysis.",
        "journal": "Journal of psychiatric research",
        "publication_date": "2025-09-24",
        "pubmed_id": "41033274",
        "doi": "10.1016/j.jpsychires.2025.09.029"
      },
      "supporting_quote": "Surface under the cumulative ranking (SUCRA) plot showed that individualized targeting ranked highest among the three approaches",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:35:23"
    },
    {
      "id": 1006,
      "intervention": {
        "name": "PET-guided targeting",
        "canonical_name": "EEG",
        "category": "test",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "psychiatric disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "network meta-analysis",
        "sample_size": 1651,
        "duration": null,
        "population": "psychiatric populations",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of individualized noninvasive brain stimulation targets in treating psychiatric disorders: A network meta-analysis.",
        "journal": "Journal of psychiatric research",
        "publication_date": "2025-09-24",
        "pubmed_id": "41033274",
        "doi": "10.1016/j.jpsychires.2025.09.029"
      },
      "supporting_quote": "PET-guided targeting demonstrated significant superiority compared to both sham and group-based targets",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:35:23"
    },
    {
      "id": 1007,
      "intervention": {
        "name": "Structural MRI",
        "canonical_name": "EEG",
        "category": "test",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "psychiatric disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of individualized noninvasive brain stimulation targets in treating psychiatric disorders: A network meta-analysis.",
        "journal": "Journal of psychiatric research",
        "publication_date": "2025-09-24",
        "pubmed_id": "41033274",
        "doi": "10.1016/j.jpsychires.2025.09.029"
      },
      "supporting_quote": "From a clinical perspective, structural MRI provides a practical option for anatomical targeting",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:35:23"
    },
    {
      "id": 1008,
      "intervention": {
        "name": "EEG",
        "canonical_name": "EEG",
        "category": "test",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "psychiatric disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of individualized noninvasive brain stimulation targets in treating psychiatric disorders: A network meta-analysis.",
        "journal": "Journal of psychiatric research",
        "publication_date": "2025-09-24",
        "pubmed_id": "41033274",
        "doi": "10.1016/j.jpsychires.2025.09.029"
      },
      "supporting_quote": "EEG and fMRI offer promising, cost-effective alternatives for capturing functional dynamics",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:35:23"
    },
    {
      "id": 1009,
      "intervention": {
        "name": "fMRI",
        "canonical_name": "EEG",
        "category": "test",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "psychiatric disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of individualized noninvasive brain stimulation targets in treating psychiatric disorders: A network meta-analysis.",
        "journal": "Journal of psychiatric research",
        "publication_date": "2025-09-24",
        "pubmed_id": "41033274",
        "doi": "10.1016/j.jpsychires.2025.09.029"
      },
      "supporting_quote": "EEG and fMRI offer promising, cost-effective alternatives for capturing functional dynamics",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:35:23"
    },
    {
      "id": 1002,
      "intervention": {
        "name": "pelvic lymph node dissection (PLND)",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "prospective, randomized study",
        "sample_size": 120,
        "duration": "between September 2022 and August 2023",
        "population": "biopsy-confirmed prostate cancer patients with intermediate or high risk",
        "adverse_effects": "longer surgical times, hospital stays, and higher complication rates",
        "cost_category": null
      },
      "paper": {
        "title": "Lymph node dissection based on 18F-PSMA PET/CT during radical prostatectomy for intermediate and high risk prostate cancer: interim results of a prospective, randomized study.",
        "journal": "Prostate cancer and prostatic diseases",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999072",
        "doi": "10.1038/s41391-025-01029-9"
      },
      "supporting_quote": "There were no significant differences in clinical parameters, progression-free survival (PFS) or PSA persistence between Groups B and C. However, PLND patients had longer surgical times, hospital stays, and higher complication rates.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:32:22"
    },
    {
      "id": 1003,
      "intervention": {
        "name": "18F-PSMA PET/CT",
        "canonical_name": null,
        "category": "test",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "prostate cancer with lymph node metastasis detection",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.65,
        "extraction_confidence": 0.9,
        "study_confidence": 0.8
      },
      "study": {
        "type": "prospective, randomized study",
        "sample_size": 120,
        "duration": "between September 2022 and August 2023",
        "population": "biopsy-confirmed prostate cancer patients with intermediate or high risk",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Lymph node dissection based on 18F-PSMA PET/CT during radical prostatectomy for intermediate and high risk prostate cancer: interim results of a prospective, randomized study.",
        "journal": "Prostate cancer and prostatic diseases",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999072",
        "doi": "10.1038/s41391-025-01029-9"
      },
      "supporting_quote": "PSMA PET/CT offers high specificity and NPV in detecting LNM.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:32:22"
    },
    {
      "id": 1001,
      "intervention": {
        "name": "continuous care model (CCM)",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{\"duration\": \"nine-week period\", \"stages\": [\"familiarization\", \"sensitization\", \"control\", \"evaluation\"]}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "Parkinson's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 80,
        "duration": "three time points: before the intervention, immediately after, and 1 month later",
        "population": "patients with PD in Isfahan, Iran",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of a continuous care model-based program on fatigue, self-efficacy, and quality of life in patients with Parkinson's disease: study protocol for a randomized controlled trial.",
        "journal": "Trials",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999495",
        "doi": "10.1186/s13063-025-09057-5"
      },
      "supporting_quote": "The continuous care model (CCM), designed as an indigenous approach based on Iran's cultural and social characteristics, can serve as an effective strategy for managing complications associated with PD.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:31:21"
    },
    {
      "id": 998,
      "intervention": {
        "name": "androgen-receptor pathway inhibitors (ARPI)",
        "canonical_name": "androgen deprivation therapy (ADT)",
        "category": "biologics",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "metastatic hormone-sensitive prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with metastatic hormone-sensitive prostate cancer",
        "adverse_effects": "hypertension, any grade cardiac adverse events",
        "cost_category": null
      },
      "paper": {
        "title": "Addition of androgen-receptor pathway inhibitors to standard of care in metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.",
        "journal": "Urologic oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41006128",
        "doi": "10.1016/j.urolonc.2025.08.017"
      },
      "supporting_quote": "The combination of ARPI and SOC significantly improved OS (HR = 0.74; P < 0.00001) and PFS (HR = 0.50 for clinical PFS, HR = 0.49 for radiological PFS; P < 0.0001)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:30:45"
    },
    {
      "id": 999,
      "intervention": {
        "name": "androgen deprivation therapy (ADT)",
        "canonical_name": "androgen deprivation therapy (ADT)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "metastatic hormone-sensitive prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with metastatic hormone-sensitive prostate cancer",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Addition of androgen-receptor pathway inhibitors to standard of care in metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.",
        "journal": "Urologic oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41006128",
        "doi": "10.1016/j.urolonc.2025.08.017"
      },
      "supporting_quote": "Several randomized clinical trials (RCTs) have evaluated different agents in this setting",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:30:45"
    },
    {
      "id": 1000,
      "intervention": {
        "name": "docetaxel",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "metastatic hormone-sensitive prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with metastatic hormone-sensitive prostate cancer",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Addition of androgen-receptor pathway inhibitors to standard of care in metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.",
        "journal": "Urologic oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41006128",
        "doi": "10.1016/j.urolonc.2025.08.017"
      },
      "supporting_quote": "androgen deprivation therapy (ADT) alone or with docetaxel",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:30:45"
    },
    {
      "id": 997,
      "intervention": {
        "name": "aerobic exercise",
        "canonical_name": "aerobic exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "polycystic ovary syndrome (PCOS)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 316,
        "duration": null,
        "population": "women with PCOS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Physical Exercise on Cardiovascular Autonomic Modulation in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.",
        "journal": "Clinical endocrinology",
        "publication_date": "2025-09-25",
        "pubmed_id": "40995853",
        "doi": "10.1111/cen.70042"
      },
      "supporting_quote": "The benefits of aerobic exercise on cardiovascular autonomic modulation appear to extend to women with PCOS, increasing vagal modulation and reducing sympathetic modulation.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:29:24"
    },
    {
      "id": 991,
      "intervention": {
        "name": "linaclotide",
        "canonical_name": "elobixibat",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": "Randomized controlled trials have confirmed the safety and efficacy of newer prescription laxative agents including secretagogues (linaclotide, lubiprostone, plecanatide)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:28:56"
    },
    {
      "id": 992,
      "intervention": {
        "name": "lubiprostone",
        "canonical_name": "elobixibat",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": "Randomized controlled trials have confirmed the safety and efficacy of newer prescription laxative agents including secretagogues (linaclotide, lubiprostone, plecanatide)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:28:56"
    },
    {
      "id": 993,
      "intervention": {
        "name": "plecanatide",
        "canonical_name": "elobixibat",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": "Randomized controlled trials have confirmed the safety and efficacy of newer prescription laxative agents including secretagogues (linaclotide, lubiprostone, plecanatide)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:28:56"
    },
    {
      "id": 994,
      "intervention": {
        "name": "tenapanor",
        "canonical_name": "elobixibat",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": "Randomized controlled trials have confirmed the safety and efficacy of newer prescription laxative agents including sodium/hydrogen exchanger isoform 3 (NHE3) inhibitors (tenapanor)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:28:56"
    },
    {
      "id": 995,
      "intervention": {
        "name": "prucalopride",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": "Randomized controlled trials have confirmed the safety and efficacy of newer prescription laxative agents including serotonin 5-hydroxytryptamine receptor agonists (prucalopride)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:28:56"
    },
    {
      "id": 996,
      "intervention": {
        "name": "elobixibat",
        "canonical_name": "elobixibat",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "constipation",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Laxative logic: when lifestyle is not enough.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41017482",
        "doi": "10.1097/MOG.0000000000001137"
      },
      "supporting_quote": "Randomized controlled trials have confirmed the safety and efficacy of newer prescription laxative agents including bile acid reabsorption inhibitors (elobixibat)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:28:56"
    },
    {
      "id": 990,
      "intervention": {
        "name": "cognitive behavioral therapy for insomnia (CBT-I)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{\"duration\": null, \"frequency\": null, \"intensity\": null}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "Crohn's disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 26,
        "duration": "12 weeks",
        "population": "patients with insomnia and mild-to-moderate CD symptoms",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cognitive Behavioral Therapy for Insomnia May Improve Sleep and Pain in Crohn's Disease: A Waitlist Control Pilot Trial.",
        "journal": "Inflammatory bowel diseases",
        "publication_date": "2025-09-25",
        "pubmed_id": "40997125",
        "doi": "10.1093/ibd/izaf210"
      },
      "supporting_quote": "CBT-I led to greater reductions in insomnia severity (P < .001) and wake after sleep onset (P = .02) than waitlist.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:26:44"
    },
    {
      "id": 989,
      "intervention": {
        "name": "self-care education based on conceptual mapping",
        "canonical_name": null,
        "category": "therapy",
        "details": "{\"duration\": \"two face-to-face sessions and weekly phone calls for one month\", \"frequency\": \"face-to-face sessions twice, weekly follow-up\"}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "non-randomized quasi-experimental study",
        "sample_size": 35,
        "duration": "4 months (September to December)",
        "population": "patients with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Studying the effect of self-care education based on conceptual mapping on the pain severity of patients with rheumatoid arthritis: A non-randomized quasi-experimental study.",
        "journal": "BMC rheumatology",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999538",
        "doi": "10.1186/s41927-025-00553-4"
      },
      "supporting_quote": "The intervention group received two face-to-face, individualized self-care education sessions using concept maps and followed up with weekly phone calls for one month",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:26:06"
    },
    {
      "id": 988,
      "intervention": {
        "name": "AKI care bundles",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Acute kidney injury (AKI)",
        "canonical_name": null,
        "category": "renal",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 30152,
        "duration": null,
        "population": "hospitalized patients with AKI",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of acute kidney injury care bundles on patient prognosis: a systematic review and meta-analysis.",
        "journal": "BMC nephrology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013306",
        "doi": "10.1186/s12882-025-04349-z"
      },
      "supporting_quote": "the AKI care bundles significantly improved the AKI severity and the need for renal replacement therapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:23:56"
    },
    {
      "id": 986,
      "intervention": {
        "name": "fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI)",
        "canonical_name": "fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI)",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "multivessel coronary artery disease (CAD)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "meta-analysis of randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with multivessel CAD",
        "adverse_effects": "higher rates of major adverse cardiac events (MACEs), myocardial infarction, and repeat revascularization compared to CABG",
        "cost_category": null
      },
      "paper": {
        "title": "Fractional flow reserve guided percutaneous coronary intervention",
        "journal": "World journal of cardiology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41024968",
        "doi": "10.4330/wjc.v17.i9.111044"
      },
      "supporting_quote": "FFR-guided PCI showed higher rates of major adverse cardiac events (MACEs; RR = 1.30, 95%CI: 1.11-1.52, P = 0.001), myocardial infarction (RR = 1.49, 95%CI: 1.11-2.01, P = 0.009), and repeat revascularization (RR = 2.25, 95%CI: 1.78-2.85, P < 0.00001)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:23:28"
    },
    {
      "id": 987,
      "intervention": {
        "name": "coronary artery bypass grafting (CABG)",
        "canonical_name": "coronary artery bypass grafting (CABG)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "multivessel coronary artery disease (CAD)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "meta-analysis of randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with multivessel CAD",
        "adverse_effects": "similar rates of all-cause mortality and stroke compared to FFR-guided PCI, but fewer MACEs, myocardial infarctions, and repeat procedures",
        "cost_category": null
      },
      "paper": {
        "title": "Fractional flow reserve guided percutaneous coronary intervention",
        "journal": "World journal of cardiology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41024968",
        "doi": "10.4330/wjc.v17.i9.111044"
      },
      "supporting_quote": "CABG results in fewer MACEs, myocardial infarctions, and repeat procedures",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:23:28"
    },
    {
      "id": 983,
      "intervention": {
        "name": "Deprescribing model",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "injurious falls",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "cluster crossover randomized controlled trial",
        "sample_size": null,
        "duration": "6 months",
        "population": "patients with recent fractures admitted to participating SNFs for post-acute care",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "PReventing Injury in Skilled nursing facilities through optimizing Medications (PRISM), a protocol for a cluster randomized trial to reduce injurious falls in post-acute care.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013714",
        "doi": "10.1186/s13063-025-09122-z"
      },
      "supporting_quote": "Over 6-month periods, in random order, the participating SNFs will sequentially implement three evidence-based care models in a random order: a Deprescribing model",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:22:17"
    },
    {
      "id": 984,
      "intervention": {
        "name": "Bone Health model",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "injurious falls",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "cluster crossover randomized controlled trial",
        "sample_size": null,
        "duration": "6 months",
        "population": "patients with recent fractures admitted to participating SNFs for post-acute care",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "PReventing Injury in Skilled nursing facilities through optimizing Medications (PRISM), a protocol for a cluster randomized trial to reduce injurious falls in post-acute care.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013714",
        "doi": "10.1186/s13063-025-09122-z"
      },
      "supporting_quote": "Over 6-month periods, in random order, the participating SNFs will sequentially implement three evidence-based care models in a random order: ... Bone Health model",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:22:17"
    },
    {
      "id": 985,
      "intervention": {
        "name": "Injury Prevention model",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "injurious falls",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "cluster crossover randomized controlled trial",
        "sample_size": null,
        "duration": "6 months",
        "population": "patients with recent fractures admitted to participating SNFs for post-acute care",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "PReventing Injury in Skilled nursing facilities through optimizing Medications (PRISM), a protocol for a cluster randomized trial to reduce injurious falls in post-acute care.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013714",
        "doi": "10.1186/s13063-025-09122-z"
      },
      "supporting_quote": "Over 6-month periods, in random order, the participating SNFs will sequentially implement three evidence-based care models in a random order: ... Injury Prevention model",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:22:17"
    },
    {
      "id": 981,
      "intervention": {
        "name": "coronary computed tomography angiography (CCTA)",
        "canonical_name": "fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI)",
        "category": "test",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "stable angina pectoris",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 5551,
        "duration": null,
        "population": "adult patients (≥ 18 years) with stable angina or low-risk chest pain",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Coronary computed tomography angiography",
        "journal": "World journal of cardiology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41024970",
        "doi": "10.4330/wjc.v17.i9.110061"
      },
      "supporting_quote": "CCTA demonstrated superior diagnostic accuracy and prognostic capability across multiple studies. It was more effective in predicting major adverse cardiac events, including myocardial infarction and cardiac death",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:20:57"
    },
    {
      "id": 982,
      "intervention": {
        "name": "stress testing modalities",
        "canonical_name": "stress testing modalities",
        "category": "test",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "stable angina pectoris",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 5551,
        "duration": null,
        "population": "adult patients (≥ 18 years) with stable angina or low-risk chest pain",
        "adverse_effects": "limitations in sensitivity and downstream clinical decision-making",
        "cost_category": null
      },
      "paper": {
        "title": "Coronary computed tomography angiography",
        "journal": "World journal of cardiology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41024970",
        "doi": "10.4330/wjc.v17.i9.110061"
      },
      "supporting_quote": "Stress testing, while useful, showed limitations in sensitivity and downstream clinical decision-making",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:20:57"
    },
    {
      "id": 979,
      "intervention": {
        "name": "dexamethasone",
        "canonical_name": "dexamethasone",
        "category": "medication",
        "details": "{\"dosage\": \"6 mg capsule\", \"duration\": \"7 days\", \"frequency\": \"once daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "severe influenza infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 243,
        "duration": "7 days or longer",
        "population": "adult patients over 18 years of age",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of dexamethasone compared to placebo in patients with severe influenza infection. (FLUDEX study): a study protocol for a randomised controlled trial in Spain.",
        "journal": "BMJ open",
        "publication_date": "2025-09-26",
        "pubmed_id": "41005772",
        "doi": "10.1136/bmjopen-2025-103119"
      },
      "supporting_quote": "One arm will receive one capsule of 6 mg of dexamethasone for 7 days",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:19:58"
    },
    {
      "id": 980,
      "intervention": {
        "name": "oseltamivir",
        "canonical_name": "dexamethasone",
        "category": "medication",
        "details": "{\"dosage\": \"75 mg\", \"duration\": \"5 days, extendable to 10 days\", \"frequency\": \"every 12 hours orally\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "severe influenza infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of dexamethasone compared to placebo in patients with severe influenza infection. (FLUDEX study): a study protocol for a randomised controlled trial in Spain.",
        "journal": "BMJ open",
        "publication_date": "2025-09-26",
        "pubmed_id": "41005772",
        "doi": "10.1136/bmjopen-2025-103119"
      },
      "supporting_quote": "Both groups will receive oseltamivir (75 mg/12 hours orally) for 5 days, extendable to 10 days depending on the investigator decision",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:19:58"
    },
    {
      "id": 977,
      "intervention": {
        "name": "continuous infusion of β-lactam antibiotics",
        "canonical_name": "continuous infusion of β-lactam antibiotics",
        "category": "medication",
        "details": "{}",
        "delivery_method": "intravenous"
      },
      "condition": {
        "name": "sepsis or septic shock",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 9166,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Continuous versus intermittent infusion of β-lactams in patients with sepsis and septic shock: a systematic review and meta-analysis.",
        "journal": "BMC infectious diseases",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013406",
        "doi": "10.1186/s12879-025-11504-2"
      },
      "supporting_quote": "Continuous infusion was associated with lower hospital mortality and higher clinical cure rate in critically ill patients",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:18:56"
    },
    {
      "id": 978,
      "intervention": {
        "name": "intermittent infusion of β-lactam antibiotics",
        "canonical_name": "continuous infusion of β-lactam antibiotics",
        "category": "medication",
        "details": "{}",
        "delivery_method": "intravenous"
      },
      "condition": {
        "name": "sepsis or septic shock",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 9166,
        "duration": null,
        "population": "adult patients with sepsis or septic shock",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Continuous versus intermittent infusion of β-lactams in patients with sepsis and septic shock: a systematic review and meta-analysis.",
        "journal": "BMC infectious diseases",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013406",
        "doi": "10.1186/s12879-025-11504-2"
      },
      "supporting_quote": "There was no significant difference in overall mortality between continuous and intermittent infusion of β-lactam antibiotics",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:18:56"
    },
    {
      "id": 975,
      "intervention": {
        "name": "assertive community treatment (ACT)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "severe mental disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "7 years",
        "population": "individuals with severe mental illness",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Long-term outcomes of assertive community treatment in Japan: 7-year follow-up of a randomized controlled trial.",
        "journal": "BMC psychiatry",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013335",
        "doi": "10.1186/s12888-025-07311-3"
      },
      "supporting_quote": "In the Japanese medical landscape, an ACT program for individuals with severe mental illness might help mitigate the frequency of readmission compared with TAU over the long term.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:18:00"
    },
    {
      "id": 976,
      "intervention": {
        "name": "treatment-as-usual (TAU)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "severe mental disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": "severe"
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "7 years",
        "population": "individuals with severe mental illness",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Long-term outcomes of assertive community treatment in Japan: 7-year follow-up of a randomized controlled trial.",
        "journal": "BMC psychiatry",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013335",
        "doi": "10.1186/s12888-025-07311-3"
      },
      "supporting_quote": "In the Japanese medical landscape, an ACT program for individuals with severe mental illness might help mitigate the frequency of readmission compared with TAU over the long term.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:18:00"
    },
    {
      "id": 973,
      "intervention": {
        "name": "Orem's self-care model nursing",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "colorectal cancer (CRC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 42,
        "duration": null,
        "population": "postoperative CRC patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of Orem's self-care model nursing combined with nutritional intervention in postoperative patients with colorectal cancer.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-09-27",
        "pubmed_id": "41014371",
        "doi": "10.1007/s00520-025-09944-2"
      },
      "supporting_quote": "The observation group achieved shorter times to first flatus, first oral intake, and first ambulation, and shorter hospital stay compared to the control group (P < 0.05).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:17:00"
    },
    {
      "id": 974,
      "intervention": {
        "name": "nutritional intervention",
        "canonical_name": "Yiqi Chupi powder",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "colorectal cancer (CRC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 42,
        "duration": null,
        "population": "postoperative CRC patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of Orem's self-care model nursing combined with nutritional intervention in postoperative patients with colorectal cancer.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-09-27",
        "pubmed_id": "41014371",
        "doi": "10.1007/s00520-025-09944-2"
      },
      "supporting_quote": "After nursing, PA, ALB, TP, and BMI increased significantly in both groups, with higher levels in the observation group (P < 0.05).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:17:00"
    },
    {
      "id": 972,
      "intervention": {
        "name": "human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)",
        "canonical_name": "human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)",
        "category": "biologics",
        "details": "{\"dosage\": \"different amounts\", \"frequency\": \"3 times\", \"delivery_method\": \"injection\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "hepatitis B virus-associated decompensated liver cirrhosis",
        "canonical_name": null,
        "category": "endocrine",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "clinical trial",
        "sample_size": 24,
        "duration": "2 years",
        "population": "participants with decompensated liver cirrhosis associated with HBV",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial.",
        "journal": "World journal of gastrointestinal surgery",
        "publication_date": "2025-09-27",
        "pubmed_id": "41024792",
        "doi": "10.4240/wjgs.v17.i9.109980"
      },
      "supporting_quote": "hUC-MSCs can be considered a safe treatment for patients with decompensated liver cirrhosis associated with HBV.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:16:04"
    },
    {
      "id": 970,
      "intervention": {
        "name": "asthma treatment guided by spirometry plus symptoms",
        "canonical_name": "asthma treatment guided by spirometry plus symptoms",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 1.0
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": null,
        "duration": "12 months",
        "population": "Children aged 6-15 years with a diagnosis of asthma and have had an exacerbation requiring oral or intravenous corticosteroids in the previous 12 months",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Spirometry to manage asthma in children: study protocol for a randomised controlled trial (SPIROMAC).",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023717",
        "doi": "10.1186/s13063-025-09104-1"
      },
      "supporting_quote": "Participants will be randomised to either receive asthma treatment guided by spirometry plus symptoms (intervention group) or asthma treatment guided by symptoms only (standard care group)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:14:55"
    },
    {
      "id": 971,
      "intervention": {
        "name": "asthma treatment guided by symptoms only",
        "canonical_name": "asthma treatment guided by spirometry plus symptoms",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 1.0
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": null,
        "duration": "12 months",
        "population": "Children aged 6-15 years with a diagnosis of asthma and have had an exacerbation requiring oral or intravenous corticosteroids in the previous 12 months",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Spirometry to manage asthma in children: study protocol for a randomised controlled trial (SPIROMAC).",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023717",
        "doi": "10.1186/s13063-025-09104-1"
      },
      "supporting_quote": "Participants will be randomised to either receive asthma treatment guided by spirometry plus symptoms (intervention group) or asthma treatment guided by symptoms only (standard care group)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:14:55"
    },
    {
      "id": 965,
      "intervention": {
        "name": "shared decision making (SDM)",
        "canonical_name": "shared decision making (SDM)",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "stepped-wedge, cluster-randomized trial",
        "sample_size": null,
        "duration": null,
        "population": "veterans with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of shared decision making in rheumatoid arthritis: study protocol for RAiSeD (Rheumatoid Arthritis Shared Decision Making) stepped wedge, cluster-randomized trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024266",
        "doi": "10.1186/s13063-025-09015-1"
      },
      "supporting_quote": "We aim to evaluate the effectiveness of a multicomponent SDM intervention on RA disease activity",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:12:44"
    },
    {
      "id": 966,
      "intervention": {
        "name": "rheumatology clinician training",
        "canonical_name": "rheumatology clinician training",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "educational"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "stepped-wedge, cluster-randomized trial",
        "sample_size": null,
        "duration": null,
        "population": "clinicians in rheumatology clinics",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of shared decision making in rheumatoid arthritis: study protocol for RAiSeD (Rheumatoid Arthritis Shared Decision Making) stepped wedge, cluster-randomized trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024266",
        "doi": "10.1186/s13063-025-09015-1"
      },
      "supporting_quote": "The multicomponent SDM intervention consists of three parts: (1) rheumatology clinician training and a pocket card on SDM",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:12:44"
    },
    {
      "id": 967,
      "intervention": {
        "name": "AskShareKnow questions",
        "canonical_name": "shared decision making (SDM)",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "stepped-wedge, cluster-randomized trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of shared decision making in rheumatoid arthritis: study protocol for RAiSeD (Rheumatoid Arthritis Shared Decision Making) stepped wedge, cluster-randomized trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024266",
        "doi": "10.1186/s13063-025-09015-1"
      },
      "supporting_quote": "(2) RA patient activation using the AskShareKnow questions",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:12:44"
    },
    {
      "id": 968,
      "intervention": {
        "name": "point-of-care decision aid (RA Choice)",
        "canonical_name": "medication summary guide",
        "category": "test",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "stepped-wedge, cluster-randomized trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of shared decision making in rheumatoid arthritis: study protocol for RAiSeD (Rheumatoid Arthritis Shared Decision Making) stepped wedge, cluster-randomized trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024266",
        "doi": "10.1186/s13063-025-09015-1"
      },
      "supporting_quote": "(3) a point-of-care decision aid (RA Choice)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:12:44"
    },
    {
      "id": 969,
      "intervention": {
        "name": "medication summary guide",
        "canonical_name": "medication summary guide",
        "category": "medication",
        "details": "{}",
        "delivery_method": "educational"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "stepped-wedge, cluster-randomized trial",
        "sample_size": null,
        "duration": null,
        "population": "patients with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of shared decision making in rheumatoid arthritis: study protocol for RAiSeD (Rheumatoid Arthritis Shared Decision Making) stepped wedge, cluster-randomized trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024266",
        "doi": "10.1186/s13063-025-09015-1"
      },
      "supporting_quote": "(3) a point-of-care decision aid (RA Choice) and medication summary guide",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:12:44"
    },
    {
      "id": 964,
      "intervention": {
        "name": "immune checkpoint inhibitor therapy",
        "canonical_name": "immune checkpoint inhibitor therapy",
        "category": "biologics",
        "details": "{\"duration\": \"up to 2 years (fixed cohort) or continuous beyond 2 years\", \"dosage\": null, \"frequency\": null}",
        "delivery_method": null
      },
      "condition": {
        "name": "advanced or metastatic non-small cell lung cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "systematic review of RCTs and RWEs",
        "sample_size": 5027,
        "duration": "up to August 24, 2024",
        "population": "adults with amNSCLC",
        "adverse_effects": "immune-related adverse events (irAEs)",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of two-year fixed versus continuous immune checkpoint inhibitor therapy in advanced or metastatic non-small cell lung cancer: a systematic review.",
        "journal": "Cancer immunology, immunotherapy : CII",
        "publication_date": "2025-09-29",
        "pubmed_id": "41021040",
        "doi": "10.1007/s00262-025-04143-8"
      },
      "supporting_quote": "The optimal duration of immune checkpoint inhibitor therapy in advanced or metastatic non-small cell lung cancer is unknown.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:10:45"
    },
    {
      "id": 963,
      "intervention": {
        "name": "Stress First Aid (SFA)",
        "canonical_name": "Stress First Aid (SFA)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "chronic stress",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "cluster randomized controlled trial (cRCT)",
        "sample_size": 862,
        "duration": "March 2021 - October 2022",
        "population": "health care workers (HCWs) in hospitals and Federally Qualified Health Centers (FQHCs)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Health care worker experiences with a brief peer support and well-being intervention during the COVID-19 pandemic.",
        "journal": "BMC health services research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029307",
        "doi": "10.1186/s12913-025-13268-6"
      },
      "supporting_quote": "SFA is an evidence-informed intervention adapted to mitigate the psychosocial impact of COVID-19 on HCWs through individual peer support actions.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:10:09"
    },
    {
      "id": 962,
      "intervention": {
        "name": "Mavacamten",
        "canonical_name": "FenuflakesTM",
        "category": "medication",
        "details": "{\"dosage\": \"2.5 mg/day or 5 mg/day\", \"duration\": \"28 weeks initial period, followed by a 28-week active-treatment period and an open-label long-term extension period for \\u2264 144 weeks\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "obstructive hypertrophic cardiomyopathy (HCM)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "phase 3, randomized, placebo-controlled, double-blind, parallel-group, multicenter, international study",
        "sample_size": null,
        "duration": "up to ≤ 144 weeks",
        "population": "symptomatic adolescent patients (12 years to < 18 years old)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial.",
        "journal": "American heart journal",
        "publication_date": "2025-09-30",
        "pubmed_id": "41038603",
        "doi": "10.1016/j.ahj.2025.107283"
      },
      "supporting_quote": "Mavacamten is a first-in-class cardiac myosin inhibitor, approved internationally for the treatment of symptomatic adult patients with obstructive hypertrophic cardiomyopathy (HCM) and has been shown to improve cardiac function and symptoms in adult patients across multiple phase 3 trials.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:08:49"
    },
    {
      "id": 958,
      "intervention": {
        "name": "catechin",
        "canonical_name": "catechin",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "respiratory tract infections (RTIs)",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.83
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": 5,
        "duration": null,
        "population": "adults",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative effectiveness of oral nutritional supplements in preventing respiratory tract infections among adults: a systematic review and network meta-analysis.",
        "journal": "EClinicalMedicine",
        "publication_date": "2025-10",
        "pubmed_id": "40969681",
        "doi": "10.1016/j.eclinm.2025.103479"
      },
      "supporting_quote": "Compared with placebo, catechin (RR = 0.79, 95% CI: 0.66, 0.95; n = 5; high certainty)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:07:58"
    },
    {
      "id": 959,
      "intervention": {
        "name": "Bifidobacterium animalis",
        "canonical_name": "high-dose vitamin D",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "respiratory tract infections (RTIs)",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.67
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": 3,
        "duration": null,
        "population": "adults",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative effectiveness of oral nutritional supplements in preventing respiratory tract infections among adults: a systematic review and network meta-analysis.",
        "journal": "EClinicalMedicine",
        "publication_date": "2025-10",
        "pubmed_id": "40969681",
        "doi": "10.1016/j.eclinm.2025.103479"
      },
      "supporting_quote": "Bifidobacterium animalis (RR = 0.79, 95% CI: 0.63, 0.99; n = 3; moderate certainty)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:07:58"
    },
    {
      "id": 960,
      "intervention": {
        "name": "multi-strain probiotics",
        "canonical_name": "high-dose vitamin D",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "respiratory tract infections (RTIs)",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": 16,
        "duration": null,
        "population": "adults",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative effectiveness of oral nutritional supplements in preventing respiratory tract infections among adults: a systematic review and network meta-analysis.",
        "journal": "EClinicalMedicine",
        "publication_date": "2025-10",
        "pubmed_id": "40969681",
        "doi": "10.1016/j.eclinm.2025.103479"
      },
      "supporting_quote": "multi-strain probiotics (RR = 0.90, 95% CI: 0.82, 0.98; n = 16; moderate certainty)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:07:58"
    },
    {
      "id": 961,
      "intervention": {
        "name": "high-dose vitamin D",
        "canonical_name": "high-dose vitamin D",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "COVID-19 or influenza prevention",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.75
      },
      "study": {
        "type": "randomized controlled trials (RCTs)",
        "sample_size": 9,
        "duration": null,
        "population": "adults",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparative effectiveness of oral nutritional supplements in preventing respiratory tract infections among adults: a systematic review and network meta-analysis.",
        "journal": "EClinicalMedicine",
        "publication_date": "2025-10",
        "pubmed_id": "40969681",
        "doi": "10.1016/j.eclinm.2025.103479"
      },
      "supporting_quote": "high-dose vitamin D was highly effective (RR = 0.66, 95% CI: 0.51, 0.86; n = 9; moderate certainty)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:07:58"
    },
    {
      "id": 957,
      "intervention": {
        "name": "FenuflakesTM",
        "canonical_name": "FenuflakesTM",
        "category": "diet",
        "details": "{\"dosage\": \"30 g per day\", \"duration\": \"14 days\", \"frequency\": \"daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "type 2 diabetes",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized crossover trial",
        "sample_size": 21,
        "duration": "14 days",
        "population": "adults aged 42 to 50 years with type 2 diabetes",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of 'FenuflakesTM' on 24-hour glycemic variability in adults with type 2 diabetes: A randomized crossover continuous glucose monitoring study.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038677",
        "doi": "10.6133/apjcn.202510_34(5).0003"
      },
      "supporting_quote": "The inclusion of FenuflakesTM into regular dietary practices may effectively reduce glucose levels and enhance glycemic control in Asian Indian adults with type 2 diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:06:07"
    },
    {
      "id": 955,
      "intervention": {
        "name": "Yiqi Chupi powder",
        "canonical_name": "Yiqi Chupi powder",
        "category": "diet",
        "details": "{\"duration\": \"12 weeks\", \"dosage\": null, \"frequency\": null}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "cancer-related fatigue in patients following colorectal cancer surgery",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.95,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 78,
        "duration": "12 weeks",
        "population": "patients with colorectal cancer undergoing chemotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of Yiqi Chupi powder for alleviating cancer-related fatigue in patients following colorectal cancer surgery: a randomized controlled trial.",
        "journal": "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan",
        "publication_date": "2025-10",
        "pubmed_id": "41015810",
        "doi": "10.19852/j.cnki.jtcm.2025.05.017"
      },
      "supporting_quote": "The experimental group exhibited significantly lower PFS scores (P <0.05) compared to the control group across all four subscales and total scores at 6, 9, and 12 weeks",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:05:32"
    },
    {
      "id": 956,
      "intervention": {
        "name": "capecitabine plus oxaliplatin (XELOX)",
        "canonical_name": "capecitabine plus oxaliplatin (XELOX)",
        "category": "medication",
        "details": "{\"duration\": \"12 weeks\", \"dosage\": null, \"frequency\": null}",
        "delivery_method": null
      },
      "condition": {
        "name": "colorectal cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": 0.5,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 78,
        "duration": "12 weeks",
        "population": "patients with colorectal cancer undergoing chemotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of Yiqi Chupi powder for alleviating cancer-related fatigue in patients following colorectal cancer surgery: a randomized controlled trial.",
        "journal": "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan",
        "publication_date": "2025-10",
        "pubmed_id": "41015810",
        "doi": "10.19852/j.cnki.jtcm.2025.05.017"
      },
      "supporting_quote": "Eligible patients were randomly assigned to either the experimental group, receiving a 12-week regimen of YQCPP and capecitabine plus oxaliplatin (XELOX) chemotherapy, or the control group, receiving a 12-week XELOX chemotherapy alone",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:05:32"
    },
    {
      "id": 941,
      "intervention": {
        "name": "traditional Asian nutraceuticals",
        "canonical_name": "traditional Asian nutraceuticals",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "This review will explore traditional nutraceuticals with antidiabetic properties with a focus on traditional Asian nutraceuticals and their antioxidant effects on gene expression associated to T2DM.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 942,
      "intervention": {
        "name": "Galohgor",
        "canonical_name": "Bir Pletok",
        "category": "emerging",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Nutraceuticals sourced from traditional Indonesian herbal beverages, including Galohgor, Bir Pletok, and Wedang Uwuh, have shown potential efficacy in reducing hyperglycemia, oxidative stress, and obesity in T2DM.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 943,
      "intervention": {
        "name": "Bir Pletok",
        "canonical_name": "Bir Pletok",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Nutraceuticals sourced from traditional Indonesian herbal beverages, including Galohgor, Bir Pletok, and Wedang Uwuh, have shown potential efficacy in reducing hyperglycemia, oxidative stress, and obesity in T2DM.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 944,
      "intervention": {
        "name": "Wedang Uwuh",
        "canonical_name": "Bir Pletok",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Nutraceuticals sourced from traditional Indonesian herbal beverages, including Galohgor, Bir Pletok, and Wedang Uwuh, have shown potential efficacy in reducing hyperglycemia, oxidative stress, and obesity in T2DM.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 945,
      "intervention": {
        "name": "curcumin",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Multiple Asian plants and their bioactive compounds, such as curcumin, kaempferol, cinnamon, saponin, quercetin, myricetin, anthocyanin, terpenoid, alkaloid, and gallic acid, have been shown to beneficially influence glucose homeostasis, insulin sensitivity, and problems associated with diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 946,
      "intervention": {
        "name": "kaempferol",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Multiple Asian plants and their bioactive compounds, such as curcumin, kaempferol, cinnamon, saponin, quercetin, myricetin, anthocyanin, terpenoid, alkaloid, and gallic acid, have been shown to beneficially influence glucose homeostasis, insulin sensitivity, and problems associated with diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 947,
      "intervention": {
        "name": "cinnamon",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Multiple Asian plants and their bioactive compounds, such as curcumin, kaempferol, cinnamon, saponin, quercetin, myricetin, anthocyanin, terpenoid, alkaloid, and gallic acid, have been shown to beneficially influence glucose homeostasis, insulin sensitivity, and problems associated with diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 948,
      "intervention": {
        "name": "saponin",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Multiple Asian plants and their bioactive compounds, such as curcumin, kaempferol, cinnamon, saponin, quercetin, myricetin, anthocyanin, terpenoid, alkaloid, and gallic acid, have been shown to beneficially influence glucose homeostasis, insulin sensitivity, and problems associated with diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 949,
      "intervention": {
        "name": "quercetin",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Multiple Asian plants and their bioactive compounds, such as curcumin, kaempferol, cinnamon, saponin, quercetin, myricetin, anthocyanin, terpenoid, alkaloid, and gallic acid, have been shown to beneficially influence glucose homeostasis, insulin sensitivity, and problems associated with diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 950,
      "intervention": {
        "name": "myricetin",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Multiple Asian plants and their bioactive compounds, such as curcumin, kaempferol, cinnamon, saponin, quercetin, myricetin, anthocyanin, terpenoid, alkaloid, and gallic acid, have been shown to beneficially influence glucose homeostasis, insulin sensitivity, and problems associated with diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 951,
      "intervention": {
        "name": "anthocyanin",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Multiple Asian plants and their bioactive compounds, such as curcumin, kaempferol, cinnamon, saponin, quercetin, myricetin, anthocyanin, terpenoid, alkaloid, and gallic acid, have been shown to beneficially influence glucose homeostasis, insulin sensitivity, and problems associated with diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 952,
      "intervention": {
        "name": "terpenoid",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Multiple Asian plants and their bioactive compounds, such as curcumin, kaempferol, cinnamon, saponin, quercetin, myricetin, anthocyanin, terpenoid, alkaloid, and gallic acid, have been shown to beneficially influence glucose homeostasis, insulin sensitivity, and problems associated with diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 953,
      "intervention": {
        "name": "alkaloid",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Multiple Asian plants and their bioactive compounds, such as curcumin, kaempferol, cinnamon, saponin, quercetin, myricetin, anthocyanin, terpenoid, alkaloid, and gallic acid, have been shown to beneficially influence glucose homeostasis, insulin sensitivity, and problems associated with diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 954,
      "intervention": {
        "name": "gallic acid",
        "canonical_name": "alkaloid",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Type 2 diabetes mellitus (T2DM)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects.",
        "journal": "Asia Pacific journal of clinical nutrition",
        "publication_date": "2025-10",
        "pubmed_id": "41038680",
        "doi": "10.6133/apjcn.202510_34(5).0006"
      },
      "supporting_quote": "Multiple Asian plants and their bioactive compounds, such as curcumin, kaempferol, cinnamon, saponin, quercetin, myricetin, anthocyanin, terpenoid, alkaloid, and gallic acid, have been shown to beneficially influence glucose homeostasis, insulin sensitivity, and problems associated with diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 09:04:25"
    },
    {
      "id": 940,
      "intervention": {
        "name": "Interferon Gamma Injection",
        "canonical_name": "lymph node boost",
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "hospital-acquired pneumonia (HAP)",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "placebo-controlled randomized clinical trial",
        "sample_size": 94,
        "duration": "one week under invasive mechanical ventilation",
        "population": "ICU ventilated patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interferon Gamma Injection and Its Effect on the Respiratory Anelloviridae Population in ICU Ventilated Patients.",
        "journal": "Journal of medical virology",
        "publication_date": "2025-10",
        "pubmed_id": "41036698",
        "doi": "10.1002/jmv.70612"
      },
      "supporting_quote": "We investigated the respiratory viral landscape of 94 patients during the first week under invasive mechanical ventilation using quantitative PCR and targeted metagenomics after capture probe enrichment. The patients were included in a placebo-controlled randomized clinical trial testing IFNγ for the prevention of HAP.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:57:38"
    },
    {
      "id": 938,
      "intervention": {
        "name": "high molecular weight non-cross-linked hyaluronic acid plus succinic acid mesotherapy",
        "canonical_name": "high molecular weight non-cross-linked hyaluronic acid plus succinic acid mesotherapy",
        "category": "supplement",
        "details": "{\"dosage\": \"2 mL per session, full face\", \"frequency\": \"once monthly for 3 sessions\", \"delivery_method\": \"injection\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "non-randomized, controlled interventional study",
        "sample_size": 20,
        "duration": "4 months with follow-up at 6 months",
        "population": "aged 40-45 years, Fitzpatrick skin types I-III, without comorbidities",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Efficacy and Effectiveness of High Molecular Weight Non-Cross-Linked Hyaluronic Acid Plus Succinic Acid Mesotherapy in Rosacea as Adjunct Therapy.",
        "journal": "Journal of cosmetic dermatology",
        "publication_date": "2025-10",
        "pubmed_id": "41039794",
        "doi": "10.1111/jocd.70484"
      },
      "supporting_quote": "Our results showed a reduction of 80% in the baseline erythema, an improvement of 30% in skin hydration, and a reduction of 20% in facial telangiectasia after three sessions",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:56:27"
    },
    {
      "id": 939,
      "intervention": {
        "name": "topical treatments",
        "canonical_name": "high molecular weight non-cross-linked hyaluronic acid plus succinic acid mesotherapy",
        "category": null,
        "details": "{\"dosage\": \"Ivermectin 1%, Metronidazole 0.75%\", \"frequency\": null, \"delivery_method\": \"topical\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Effectiveness of High Molecular Weight Non-Cross-Linked Hyaluronic Acid Plus Succinic Acid Mesotherapy in Rosacea as Adjunct Therapy.",
        "journal": "Journal of cosmetic dermatology",
        "publication_date": "2025-10",
        "pubmed_id": "41039794",
        "doi": "10.1111/jocd.70484"
      },
      "supporting_quote": "All patients were already undergoing topical treatment with Ivermectin 1%, Metronidazole 0.75%, and photoprotection, but without good results or clear improvement",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:56:27"
    },
    {
      "id": 935,
      "intervention": {
        "name": "clofarabine plus cytarabine",
        "canonical_name": "clofarabine plus cytarabine",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "pediatric AML",
        "canonical_name": null,
        "category": "hematological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized clinical trials (AML02 and AML08)",
        "sample_size": null,
        "duration": null,
        "population": "pediatric patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.",
        "journal": "JCO precision oncology",
        "publication_date": "2025-10",
        "pubmed_id": "41037765",
        "doi": "10.1200/PO-25-00634"
      },
      "supporting_quote": "Building on a recent article, we assessed how baseline factors and a pharmacogenomics score (ACS10) can affect the predicted overall survival (OS) and event-free survival (EFS) between patients assigned to induction regimens of clofarabine plus cytarabine or daunorubicin and etoposide combined with low-dose cytarabine or high-dose cytarabine.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:54:46"
    },
    {
      "id": 936,
      "intervention": {
        "name": "daunorubicin and etoposide combined with low-dose cytarabine",
        "canonical_name": "clofarabine plus cytarabine",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "pediatric AML",
        "canonical_name": null,
        "category": "hematological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized clinical trials (AML02 and AML08)",
        "sample_size": null,
        "duration": null,
        "population": "pediatric patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.",
        "journal": "JCO precision oncology",
        "publication_date": "2025-10",
        "pubmed_id": "41037765",
        "doi": "10.1200/PO-25-00634"
      },
      "supporting_quote": "Building on a recent article, we assessed how baseline factors and a pharmacogenomics score (ACS10) can affect the predicted overall survival (OS) and event-free survival (EFS) between patients assigned to induction regimens of clofarabine plus cytarabine or daunorubicin and etoposide combined with low-dose cytarabine or high-dose cytarabine.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:54:46"
    },
    {
      "id": 937,
      "intervention": {
        "name": "high-dose cytarabine",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "pediatric AML",
        "canonical_name": null,
        "category": "hematological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized clinical trials (AML02 and AML08)",
        "sample_size": null,
        "duration": null,
        "population": "pediatric patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.",
        "journal": "JCO precision oncology",
        "publication_date": "2025-10",
        "pubmed_id": "41037765",
        "doi": "10.1200/PO-25-00634"
      },
      "supporting_quote": "Building on a recent article, we assessed how baseline factors and a pharmacogenomics score (ACS10) can affect the predicted overall survival (OS) and event-free survival (EFS) between patients assigned to induction regimens of clofarabine plus cytarabine or daunorubicin and etoposide combined with low-dose cytarabine or high-dose cytarabine.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:54:46"
    },
    {
      "id": 934,
      "intervention": {
        "name": "non-invasive pulsed radiofrequency (NipRF)",
        "canonical_name": "non-invasive pulsed radiofrequency (NipRF)",
        "category": "device",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "diabetic neuropathic pain",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 64,
        "duration": "12 weeks",
        "population": "patients with diabetic neuropathic pain and distal symmetric polyneuropathy refractory to multiple medical therapies",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Non-invasive peripheral nerve neuromodulation in diabetic neuropathic pain: A randomised controlled trial.",
        "journal": "Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology",
        "publication_date": "2025-10",
        "pubmed_id": "41042046",
        "doi": "10.14744/agri.2025.28909"
      },
      "supporting_quote": "NipRF therapy may be a good option for DNP management. Its non-invasiveness and low risk of adverse events make it a good alternative to interventional and drug therapies.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:53:09"
    },
    {
      "id": 933,
      "intervention": {
        "name": "yellow information letter",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "vaccination status of liver transplant recipients",
        "canonical_name": null,
        "category": "immunological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 289,
        "duration": "2 years",
        "population": "liver transplant recipients and their family physicians",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of a Personal Vaccination Recommendation Letter to Liver Transplant Patients and Family Physicians for Improving the Vaccination Status: Improving Vaccinations: Whom to Contact?",
        "journal": "Clinical transplantation",
        "publication_date": "2025-10",
        "pubmed_id": "41004142",
        "doi": "10.1111/ctr.70239"
      },
      "supporting_quote": "The intervention consisted of a yellow information letter, which was personalized and sent to either the patient (1), the family physician (2), or both (3) in December 2016.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:52:38"
    },
    {
      "id": 932,
      "intervention": {
        "name": "Baduanjin",
        "canonical_name": null,
        "category": "exercise",
        "details": "{\"duration\": \"12 weeks\", \"frequency\": \"supervised sessions\", \"intensity\": null}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "chemotherapy-related cognitive impairment, upper limb dysfunction",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 70,
        "duration": "12 weeks",
        "population": "women diagnosed with breast cancer and scheduled for chemotherapy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Baduanjin on cognitive performance and upper limb function in patients receiving chemotherapy after breast cancer surgery: a randomized controlled trial.",
        "journal": "Complementary therapies in medicine",
        "publication_date": "2025-10-01",
        "pubmed_id": "41043592",
        "doi": "10.1016/j.ctim.2025.103252"
      },
      "supporting_quote": "A 12-week Baduanjin exercise intervention significantly improved subjective cognitive complaints and shoulder function in breast cancer patients undergoing post-operative chemotherapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:48:16"
    },
    {
      "id": 930,
      "intervention": {
        "name": "accelerated initiation of kidney replacement therapy (KRT)",
        "canonical_name": "accelerated initiation of kidney replacement therapy (KRT)",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "severe acute kidney injury (AKI) in critically ill patients",
        "canonical_name": null,
        "category": "renal",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "economic evaluation using state-transition model",
        "sample_size": 73,
        "duration": null,
        "population": "critically ill patients with severe AKI",
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Cost-Utility Analysis of Accelerated and Standard Strategies for Renal Replacement Therapy Initiation.",
        "journal": "JAMA network open",
        "publication_date": "2025-10-01",
        "pubmed_id": "41042508",
        "doi": "10.1001/jamanetworkopen.2025.35343"
      },
      "supporting_quote": "Initiation of KRT",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:47:42"
    },
    {
      "id": 931,
      "intervention": {
        "name": "standard initiation of kidney replacement therapy (KRT)",
        "canonical_name": "accelerated initiation of kidney replacement therapy (KRT)",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "severe acute kidney injury (AKI) in critically ill patients",
        "canonical_name": null,
        "category": "renal",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "economic evaluation using state-transition model",
        "sample_size": 73,
        "duration": null,
        "population": "critically ill patients with severe AKI",
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Cost-Utility Analysis of Accelerated and Standard Strategies for Renal Replacement Therapy Initiation.",
        "journal": "JAMA network open",
        "publication_date": "2025-10-01",
        "pubmed_id": "41042508",
        "doi": "10.1001/jamanetworkopen.2025.35343"
      },
      "supporting_quote": "Initiation of KRT",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:47:42"
    },
    {
      "id": 929,
      "intervention": {
        "name": "active video games (AVGs)",
        "canonical_name": "active video games (AVGs)",
        "category": "exercise",
        "details": "{\"duration\": \"30 minutes\", \"frequency\": \"twice per week\", \"duration_period\": \"6 weeks\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "schizophrenia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 82,
        "duration": "6 weeks",
        "population": "patients with schizophrenia",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Active Video Games to Improve Behavioral Intentions and Cognitive Function in Patients With Schizophrenia: Randomized Controlled Trial.",
        "journal": "JMIR serious games",
        "publication_date": "2025-10-01",
        "pubmed_id": "41032869",
        "doi": "10.2196/69116"
      },
      "supporting_quote": "Playing AVGs can effectively enhance the behavioral intention of patients with schizophrenia to participate in physical activity and exercise and significantly improve their orientation and language.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:46:55"
    },
    {
      "id": 928,
      "intervention": {
        "name": "SUGAR Handshake",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "hypoglycaemia",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9811
      },
      "study": {
        "type": "pragmatic randomized controlled trial",
        "sample_size": 104,
        "duration": "3 months",
        "population": "elderly people with type 2 diabetes mellitus (T2DM)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The SUGAR handshake intervention to prevent hypoglycaemia in elderly people with type 2 diabetes: process evaluation within a pragmatic randomised controlled trial.",
        "journal": "BMC geriatrics",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034834",
        "doi": "10.1186/s12877-025-06361-2"
      },
      "supporting_quote": "The intervention was well implemented: 104 of 106 participants (98.11%) continued the full intervention, with a 100% reach to those enrolled in the trial.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:46:19"
    },
    {
      "id": 926,
      "intervention": {
        "name": "web-based telerehabilitation monitoring",
        "canonical_name": "supervised sensorimotor training",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 52,
        "duration": "22 weeks",
        "population": "participants undergoing primary TKA",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Lifestyle Modification Through Web-Based Telerehabilitation Monitoring Combined With Supervised Sensorimotor Training After Total Knee Arthroplasty: Randomized Controlled Trial.",
        "journal": "JMIR mHealth and uHealth",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037782",
        "doi": "10.2196/64643"
      },
      "supporting_quote": "Home-based lifestyle modification program through telerehabilitation monitoring significantly improved functional and patient-reported outcomes in individuals following TKA.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:45:42"
    },
    {
      "id": 927,
      "intervention": {
        "name": "supervised sensorimotor training",
        "canonical_name": "supervised sensorimotor training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 52,
        "duration": "22 weeks",
        "population": "participants undergoing primary TKA",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Lifestyle Modification Through Web-Based Telerehabilitation Monitoring Combined With Supervised Sensorimotor Training After Total Knee Arthroplasty: Randomized Controlled Trial.",
        "journal": "JMIR mHealth and uHealth",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037782",
        "doi": "10.2196/64643"
      },
      "supporting_quote": "The intervention lasted 22 weeks, and participants were assessed at baseline (presurgery), 14 weeks, and 22 weeks postsurgery.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:45:42"
    },
    {
      "id": 924,
      "intervention": {
        "name": "pembrolizumab",
        "canonical_name": null,
        "category": "biologics",
        "details": "{\"dosage\": \"200 mg\", \"frequency\": \"Q3W (every 3 weeks)\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "metastatic triple-negative breast cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized, phase 3 study",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy.",
        "journal": "NPJ breast cancer",
        "publication_date": "2025-10-02",
        "pubmed_id": "41038856",
        "doi": "10.1038/s41523-025-00814-y"
      },
      "supporting_quote": "In the randomized, phase 3 KEYNOTE-119 study, overall survival (OS) was not significantly improved with pembrolizumab 200 mg Q3W versus investigator's choice of chemotherapy in participants with previously treated metastatic TNBC.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:44:47"
    },
    {
      "id": 925,
      "intervention": {
        "name": "chemotherapy",
        "canonical_name": "chemotherapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "metastatic triple-negative breast cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized, phase 3 study",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy.",
        "journal": "NPJ breast cancer",
        "publication_date": "2025-10-02",
        "pubmed_id": "41038856",
        "doi": "10.1038/s41523-025-00814-y"
      },
      "supporting_quote": "In the randomized, phase 119 study, overall survival (OS) was not significantly improved with pembrolizumab versus investigator's choice of chemotherapy in participants with previously treated metastatic TNBC.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:44:47"
    },
    {
      "id": 920,
      "intervention": {
        "name": "catheter ablation",
        "canonical_name": "catheter ablation",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "atrial flutter (AFl)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Management of Atrial Flutter (AFL) Using Intrinsic Antitachycardia Pacing (iATP) Protocol.",
        "journal": "Journal of cardiovascular electrophysiology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039805",
        "doi": "10.1111/jce.70115"
      },
      "supporting_quote": "Traditional management of atrial flutter (AFl) includes catheter ablation",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:43:51"
    },
    {
      "id": 921,
      "intervention": {
        "name": "pharmacological therapy",
        "canonical_name": "oral anticoagulation (OAC)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "atrial flutter (AFl)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Management of Atrial Flutter (AFL) Using Intrinsic Antitachycardia Pacing (iATP) Protocol.",
        "journal": "Journal of cardiovascular electrophysiology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039805",
        "doi": "10.1111/jce.70115"
      },
      "supporting_quote": "Traditional management of atrial flutter (AFl) includes catheter ablation and pharmacological therapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:43:51"
    },
    {
      "id": 922,
      "intervention": {
        "name": "intrinsic antitachycardia pacing (iATP)",
        "canonical_name": "catheter ablation",
        "category": "device",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "atrial flutter (AFl)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.85
      },
      "study": {
        "type": "prospective, randomized crossover trial",
        "sample_size": 17,
        "duration": null,
        "population": "patients undergoing AFl ablation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Management of Atrial Flutter (AFL) Using Intrinsic Antitachycardia Pacing (iATP) Protocol.",
        "journal": "Journal of cardiovascular electrophysiology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039805",
        "doi": "10.1111/jce.70115"
      },
      "supporting_quote": "This study evaluates the efficacy of iATP in terminating AFl and compares it to traditional ramp pacing protocols",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:43:51"
    },
    {
      "id": 923,
      "intervention": {
        "name": "ramp pacing",
        "canonical_name": "catheter ablation",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "atrial flutter (AFl)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.85
      },
      "study": {
        "type": "prospective, randomized crossover trial",
        "sample_size": 17,
        "duration": null,
        "population": "patients undergoing AFl ablation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Management of Atrial Flutter (AFL) Using Intrinsic Antitachycardia Pacing (iATP) Protocol.",
        "journal": "Journal of cardiovascular electrophysiology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41039805",
        "doi": "10.1111/jce.70115"
      },
      "supporting_quote": "This study evaluates the efficacy of iATP in terminating AFl and compares it to traditional ramp pacing protocols",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:43:51"
    },
    {
      "id": 918,
      "intervention": {
        "name": "dry cupping therapy",
        "canonical_name": "dry cupping therapy",
        "category": "therapy",
        "details": "{\"duration\": \"15 minutes per session\", \"frequency\": \"2 times per week\", \"total_sessions\": 12, \"study_duration\": \"6 weeks\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "knee osteoarthritis (KOA)",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 62,
        "duration": "10 weeks",
        "population": "women aged 50-75 years with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dry cupping therapy has no effect on pain, function, or quality of life in women with knee osteoarthritis: Randomized placebo-controlled trial.",
        "journal": "Brazilian journal of physical therapy",
        "publication_date": "2025-10-02",
        "pubmed_id": "41043303",
        "doi": "10.1016/j.bjpt.2025.101259"
      },
      "supporting_quote": "Dry cupping therapy was not superior to sham cupping in improving pain, functional capacity, and quality of life, and in GPE in women with knee osteoarthritis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:42:26"
    },
    {
      "id": 919,
      "intervention": {
        "name": "sham cupping",
        "canonical_name": "dry cupping therapy",
        "category": "therapy",
        "details": "{\"duration\": \"15 minutes per session\", \"frequency\": \"2 times per week\", \"total_sessions\": 12, \"study_duration\": \"6 weeks\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "knee osteoarthritis (KOA)",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 62,
        "duration": "10 weeks",
        "population": "women aged 50-75 years with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dry cupping therapy has no effect on pain, function, or quality of life in women with knee osteoarthritis: Randomized placebo-controlled trial.",
        "journal": "Brazilian journal of physical therapy",
        "publication_date": "2025-10-02",
        "pubmed_id": "41043303",
        "doi": "10.1016/j.bjpt.2025.101259"
      },
      "supporting_quote": "Dry cupping therapy was not superior to sham cupping in improving pain, functional capacity, and quality of life, and in GPE in women with knee osteoarthritis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:42:26"
    },
    {
      "id": 911,
      "intervention": {
        "name": "salvage radiotherapy (SRT)",
        "canonical_name": "metastasis-directed RT",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "phase 2 randomized clinical trial",
        "sample_size": 128,
        "duration": "median follow-up of 37 months",
        "population": "patients with biochemical recurrence following radical prostatectomy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical Trial.",
        "journal": "JAMA oncology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037308",
        "doi": "10.1001/jamaoncol.2025.3746"
      },
      "supporting_quote": "PSMAiSRT improved FFS (hazard ratio [HR], 0.50; 95% CI, 0.27-0.94; P = .04)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:39:13"
    },
    {
      "id": 912,
      "intervention": {
        "name": "prostate-specific membrane antigen PET-guided intensification of salvage radiotherapy (PSMAiSRT)",
        "canonical_name": "metastasis-directed RT",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "phase 2 randomized clinical trial",
        "sample_size": 128,
        "duration": "median follow-up of 37 months",
        "population": "patients with biochemical recurrence following radical prostatectomy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical Trial.",
        "journal": "JAMA oncology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037308",
        "doi": "10.1001/jamaoncol.2025.3746"
      },
      "supporting_quote": "PSMAiSRT improved FFS (hazard ratio [HR], 0.50; 95% CI, 0.27-0.94; P = .04)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:39:13"
    },
    {
      "id": 913,
      "intervention": {
        "name": "pelvic RT",
        "canonical_name": "metastasis-directed RT",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "phase 2 randomized clinical trial",
        "sample_size": 128,
        "duration": "median follow-up of 37 months",
        "population": "patients with biochemical recurrence following radical prostatectomy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical Trial.",
        "journal": "JAMA oncology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037308",
        "doi": "10.1001/jamaoncol.2025.3746"
      },
      "supporting_quote": "In the PSMAiSRT group, 33 of 64 patients (52%) received intensified SRT; with addition of pelvic RT",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:39:13"
    },
    {
      "id": 914,
      "intervention": {
        "name": "metastasis-directed RT",
        "canonical_name": "metastasis-directed RT",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "phase 2 randomized clinical trial",
        "sample_size": 128,
        "duration": "median follow-up of 37 months",
        "population": "patients with biochemical recurrence following radical prostatectomy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical Trial.",
        "journal": "JAMA oncology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037308",
        "doi": "10.1001/jamaoncol.2025.3746"
      },
      "supporting_quote": "In the PSMAiSRT group, 33 of 64 patients (52%) received intensified SRT; with addition of metastasis-directed RT",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:39:13"
    },
    {
      "id": 915,
      "intervention": {
        "name": "lymph node boost",
        "canonical_name": "lymph node boost",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "phase 2 randomized clinical trial",
        "sample_size": 128,
        "duration": "median follow-up of 37 months",
        "population": "patients with biochemical recurrence following radical prostatectomy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical Trial.",
        "journal": "JAMA oncology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037308",
        "doi": "10.1001/jamaoncol.2025.3746"
      },
      "supporting_quote": "In the PSMAiSRT group, 33 of 64 patients (52%) received intensified SRT; with addition of lymph node boost",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:39:13"
    },
    {
      "id": 916,
      "intervention": {
        "name": "prostate bed boost",
        "canonical_name": "metastasis-directed RT",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "phase 2 randomized clinical trial",
        "sample_size": 128,
        "duration": "median follow-up of 37 months",
        "population": "patients with biochemical recurrence following radical prostatectomy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical Trial.",
        "journal": "JAMA oncology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037308",
        "doi": "10.1001/jamaoncol.2025.3746"
      },
      "supporting_quote": "In the PSMAiSRT group, 33 of 64 patients (52%) received intensified SRT; with addition of prostate bed boost",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:39:13"
    },
    {
      "id": 917,
      "intervention": {
        "name": "adjuvant hormone therapy",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "prostate cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "phase 2 randomized clinical trial",
        "sample_size": 128,
        "duration": "median follow-up of 37 months",
        "population": "patients with biochemical recurrence following radical prostatectomy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical Trial.",
        "journal": "JAMA oncology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41037308",
        "doi": "10.1001/jamaoncol.2025.3746"
      },
      "supporting_quote": "Adjuvant hormone therapy was equally prevalent in both arms (55 [86%] control vs 54 [84%] PSMAiSRT)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:39:13"
    },
    {
      "id": 908,
      "intervention": {
        "name": "high-intensity laser therapy (HILT)",
        "canonical_name": "high-intensity laser therapy (HILT)",
        "category": "therapy",
        "details": "{\"frequency\": \"5 sessions per week\", \"duration\": \"2 weeks\", \"combined_with\": \"exercise therapy\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.8,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "double-blind, prospective, randomized controlled trial",
        "sample_size": 45,
        "duration": "2 weeks",
        "population": "patients diagnosed with knee osteoarthritis according to the criteria of the American College of Rheumatology",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of the effects of high-intensity laser therapy and low-level laser therapy in knee osteoarthritis.",
        "journal": "Clinical rheumatology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042410",
        "doi": "10.1007/s10067-025-07657-9"
      },
      "supporting_quote": "Both HILT and LLLT, when combined with ET, were found to be effective in the treatment of knee osteoarthritis. However, HILT provided more pronounced improvements in pain, functionality, and flexion ROM.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:33:39"
    },
    {
      "id": 909,
      "intervention": {
        "name": "low-level laser therapy (LLLT)",
        "canonical_name": "high-intensity laser therapy (HILT)",
        "category": "therapy",
        "details": "{\"frequency\": \"5 sessions per week\", \"duration\": \"2 weeks\", \"combined_with\": \"exercise therapy\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.7,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "double-blind, prospective, randomized controlled trial",
        "sample_size": 45,
        "duration": "2 weeks",
        "population": "patients diagnosed with knee osteoarthritis according to the criteria of the American College of Rheumatology",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of the effects of high-intensity laser therapy and low-level laser therapy in knee osteoarthritis.",
        "journal": "Clinical rheumatology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042410",
        "doi": "10.1007/s10067-025-07657-9"
      },
      "supporting_quote": "Both HILT and LLLT, when combined with ET, were found to be effective in the treatment of knee osteoarthritis. However, HILT provided more pronounced improvements in pain, functionality, and flexion ROM.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:33:39"
    },
    {
      "id": 910,
      "intervention": {
        "name": "exercise therapy (ET)",
        "canonical_name": "exercise therapy (ET)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "double-blind, prospective, randomized controlled trial",
        "sample_size": 90,
        "duration": "2 weeks",
        "population": "patients diagnosed with knee osteoarthritis according to the criteria of the American College of Rheumatology",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of the effects of high-intensity laser therapy and low-level laser therapy in knee osteoarthritis.",
        "journal": "Clinical rheumatology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042410",
        "doi": "10.1007/s10067-025-07657-9"
      },
      "supporting_quote": "Both HILT and LLLT, when combined with ET, were found to be effective in the treatment of knee osteoarthritis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:33:39"
    },
    {
      "id": 905,
      "intervention": {
        "name": "high-intensity interval training",
        "canonical_name": "high-intensity interval training",
        "category": "exercise",
        "details": "{\"duration\": \"8-12 weeks\", \"frequency\": \"3 sessions per week\", \"time_per_session\": \"30--40 minutes\"}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "breast cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "breast cancer survivors",
        "adverse_effects": "no major exercise-related adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "A systematic review and meta-analysis of randomized controlled trials on the effects of high-intensity interval training in breast cancer survivors.",
        "journal": "Clinical rehabilitation",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042936",
        "doi": "10.1177/02692155251383151"
      },
      "supporting_quote": "High-intensity interval training is a safe and effective modality for breast cancer survivors, demonstrating superior improvements in cardiorespiratory fitness over various control interventions.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:32:03"
    },
    {
      "id": 906,
      "intervention": {
        "name": "moderate-intensity continuous training",
        "canonical_name": null,
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "breast cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "breast cancer survivors",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A systematic review and meta-analysis of randomized controlled trials on the effects of high-intensity interval training in breast cancer survivors.",
        "journal": "Clinical rehabilitation",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042936",
        "doi": "10.1177/02692155251383151"
      },
      "supporting_quote": "High-intensity interval training was also superior to moderate-intensity continuous training for reducing Interleukin-6.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:32:03"
    },
    {
      "id": 907,
      "intervention": {
        "name": "resistance training",
        "canonical_name": null,
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "breast cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "breast cancer survivors",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A systematic review and meta-analysis of randomized controlled trials on the effects of high-intensity interval training in breast cancer survivors.",
        "journal": "Clinical rehabilitation",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042936",
        "doi": "10.1177/02692155251383151"
      },
      "supporting_quote": "High-intensity interval training significantly improved cardiorespiratory fitness compared to usual care, moderate-intensity continuous training, and resistance training.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:32:03"
    },
    {
      "id": 903,
      "intervention": {
        "name": "complete revascularization",
        "canonical_name": "culprit-only revascularization",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "myocardial infarction with multivessel disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1445,
        "duration": "3 years",
        "population": "older patients with myocardial infarction and multivessel disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Complete Revascularization in Older Patients With Myocardial Infarction With or Without Complex Nonculprit Lesions.",
        "journal": "Circulation. Cardiovascular interventions",
        "publication_date": "2025-10-03",
        "pubmed_id": "41039960",
        "doi": "10.1161/CIRCINTERVENTIONS.125.015902"
      },
      "supporting_quote": "Complete revascularization reduced the primary outcome in both the complex (HR, 0.75 [95% CI, 0.56-0.99]) and noncomplex (HR, 0.71 [95% CI, 0.53-0.95]) subgroups",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:30:47"
    },
    {
      "id": 904,
      "intervention": {
        "name": "culprit-only revascularization",
        "canonical_name": "culprit-only revascularization",
        "category": "procedure",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "myocardial infarction with multivessel disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 1445,
        "duration": "3 years",
        "population": "older patients with myocardial infarction and multivessel disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Complete Revascularization in Older Patients With Myocardial Infarction With or Without Complex Nonculprit Lesions.",
        "journal": "Circulation. Cardiovascular interventions",
        "publication_date": "2025-10-03",
        "pubmed_id": "41039960",
        "doi": "10.1161/CIRCINTERVENTIONS.125.015902"
      },
      "supporting_quote": "Overall, 1445 patients were randomized to culprit-only or complete revascularization.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:30:47"
    },
    {
      "id": 900,
      "intervention": {
        "name": "blood flow restriction training (BFRT)",
        "canonical_name": "high-intensity interval training",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "parallel randomized controlled trial",
        "sample_size": 64,
        "duration": "8 weeks",
        "population": "university football players with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of blood flow restriction combined with electrical stimulation on muscle functions and performance in university football players with knee osteoarthritis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044340",
        "doi": "10.1038/s41598-025-18089-5"
      },
      "supporting_quote": "Participants were enrolled based on predefined eligibility criteria and randomly allocated to four groups: the control group (CTR, n = 16), BFRT-alone group (BFRT, n = 16)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:29:42"
    },
    {
      "id": 901,
      "intervention": {
        "name": "electrical muscle stimulation (EMS)",
        "canonical_name": "blood flow restriction training combined with electrical muscle stimulation",
        "category": "device",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "parallel randomized controlled trial",
        "sample_size": 64,
        "duration": "8 weeks",
        "population": "university football players with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of blood flow restriction combined with electrical stimulation on muscle functions and performance in university football players with knee osteoarthritis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044340",
        "doi": "10.1038/s41598-025-18089-5"
      },
      "supporting_quote": "Participants were enrolled based on predefined eligibility criteria and randomly allocated to four groups: the control group (CTR, n = 16), EMS-alone group (EMS, n = 16)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:29:42"
    },
    {
      "id": 902,
      "intervention": {
        "name": "blood flow restriction training combined with electrical muscle stimulation",
        "canonical_name": "blood flow restriction training combined with electrical muscle stimulation",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "parallel randomized controlled trial",
        "sample_size": 64,
        "duration": "8 weeks",
        "population": "university football players with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of blood flow restriction combined with electrical stimulation on muscle functions and performance in university football players with knee osteoarthritis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044340",
        "doi": "10.1038/s41598-025-18089-5"
      },
      "supporting_quote": "Participants were enrolled based on predefined eligibility criteria and randomly allocated to four groups: the control group (CTR, n = 16), BFRT combined with EMS group (CMB, n = 16)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:29:42"
    },
    {
      "id": 897,
      "intervention": {
        "name": "calorie restriction",
        "canonical_name": null,
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "people living with obesity (PwO)",
        "adverse_effects": "increased bone loss and fracture risk",
        "cost_category": null
      },
      "paper": {
        "title": "Effects of weight-loss interventions on bone health in people living with obesity.",
        "journal": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042228",
        "doi": "10.1093/jbmr/zjaf135"
      },
      "supporting_quote": "Strategies to reduce weight in people living with obesity (PwO) include calorie restriction, metabolic and bariatric surgery (MBS), and anti-obesity drugs including glucagon-like peptide-1 receptor agonists (GLP-1Ra)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:27:40"
    },
    {
      "id": 898,
      "intervention": {
        "name": "metabolic and bariatric surgery (MBS)",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "people living with obesity (PwO)",
        "adverse_effects": "substantial deterioration in bone microarchitecture and strength associated with an increased risk of fracture",
        "cost_category": null
      },
      "paper": {
        "title": "Effects of weight-loss interventions on bone health in people living with obesity.",
        "journal": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042228",
        "doi": "10.1093/jbmr/zjaf135"
      },
      "supporting_quote": "Strategies to reduce weight in people living with obesity (PwO) include calorie restriction, metabolic and bariatric surgery (MBS), and anti-obesity drugs including glucagon-like peptide-1 receptor agonists (GLP-1Ra)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:27:40"
    },
    {
      "id": 899,
      "intervention": {
        "name": "glucagon-like peptide-1 receptor agonists (GLP-1Ra)",
        "canonical_name": "glucagon-like peptide-1 receptor agonists (GLP-1Ra)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "people living with obesity (PwO)",
        "adverse_effects": "significant weight loss induced by GLP-1Ra may also result in accelerated bone turnover and bone loss, and semaglutide could lead to an increased risk of fractures in the at-risk population",
        "cost_category": null
      },
      "paper": {
        "title": "Effects of weight-loss interventions on bone health in people living with obesity.",
        "journal": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042228",
        "doi": "10.1093/jbmr/zjaf135"
      },
      "supporting_quote": "GLP-1Ra on bone health in PwO are still limited; however, significant weight loss induced by GLP-1Ra may also result in accelerated bone turnover and bone loss, and semaglutide could lead to an increased risk of fractures in the at-risk population",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:27:40"
    },
    {
      "id": 896,
      "intervention": {
        "name": "Vagus nerve stimulation (VNS)",
        "canonical_name": null,
        "category": "device",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "drug-resistant epilepsy (DRE)",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": null,
        "duration": null,
        "population": "patients with drug-resistant epilepsy (DRE) treated between 2000 and 2023",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Outcome and predictors of response to vagus nerve stimulation for drug-resistant epilepsy: a retrospective cohort study.",
        "journal": "Neurosurgical review",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042470",
        "doi": "10.1007/s10143-025-03839-w"
      },
      "supporting_quote": "Vagus nerve stimulation (VNS) has been used as an adjunctive therapy for patients with drug-resistant epilepsy (DRE) for decades.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:26:13"
    },
    {
      "id": 895,
      "intervention": {
        "name": "community orchestra intervention",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "Parkinson's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "non-randomized clinical trial",
        "sample_size": 22,
        "duration": null,
        "population": "individuals with Parkinson's disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "PARKinSOUND: Impact of participation in an orchestra in patients with Parkinson's disease.",
        "journal": "Journal of Parkinson's disease",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042999",
        "doi": "10.1177/1877718X251381089"
      },
      "supporting_quote": "PARKinSOUND, a non-randomized clinical trial, evaluated the feasibility of a community orchestra intervention for individuals with PD",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:25:43"
    },
    {
      "id": 893,
      "intervention": {
        "name": "transcatheter aortic valve replacement (TAVR)",
        "canonical_name": "transcatheter aortic valve replacement (TAVR)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "aortic valve stenosis",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "low, intermediate, high-risk patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Sutureless versus transcatheter valves for the treatment of aortic valve stenosis: a systematic review and meta-analysis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044191",
        "doi": "10.1038/s41598-025-17857-7"
      },
      "supporting_quote": "One large registry drove the outcome in low-risk patients, showing better early survival with TAVR",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:25:15"
    },
    {
      "id": 894,
      "intervention": {
        "name": "sutureless bioprosthetic valve (SU-AVR)",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "aortic valve stenosis",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "intermediate-risk patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Sutureless versus transcatheter valves for the treatment of aortic valve stenosis: a systematic review and meta-analysis.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044191",
        "doi": "10.1038/s41598-025-17857-7"
      },
      "supporting_quote": "Intermediate-risk patients showed improved early and medium-term survival with SU-AVR",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 08:25:15"
    },
    {
      "id": 892,
      "intervention": {
        "name": "transcranial direct current stimulation (tDCS)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{\"duration\": \"20 minutes\", \"frequency\": \"once per day\", \"intensity\": \"2 mA\"}",
        "delivery_method": "electrical stimulation"
      },
      "condition": {
        "name": "Parkinson's disease-related pain in the Off state",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled crossover trial",
        "sample_size": 15,
        "duration": null,
        "population": "patients aged 39-81, 5 male",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Transcranial Direct Current Stimulation in Parkinson's Disease Patients in the Off State: A Randomized Controlled Crossover Trial Examining the Effects on Pain With and Without the Influence of Dopaminergic Medication.",
        "journal": "Pain practice : the official journal of World Institute of Pain",
        "publication_date": "2025-11",
        "pubmed_id": "41039704",
        "doi": "10.1111/papr.70082"
      },
      "supporting_quote": "One session of tDCS over the M1 alleviates pain perception in PD patients in the Off state.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 07:57:41"
    },
    {
      "id": 890,
      "intervention": {
        "name": "Nutraceutical combination containing Monacolin K (MK) and Morus alba",
        "canonical_name": "Nutraceutical combination containing Monacolin K (MK) alone",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "cardiometabolic risk",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.85,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "prospective, randomized, active-treatment controlled trial",
        "sample_size": 359,
        "duration": "3 months",
        "population": "patients at cardiometabolic risk",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trial.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044582",
        "doi": "10.1186/s12933-025-02920-4"
      },
      "supporting_quote": "Participants in the two treatment arms (F1 vs. F2) were comparable in terms of sex, age, metabolic parameters, and BP. After 3 months, both groups experienced significant reductions in LDL-C, fasting plasma glucose, HbA1c, and HOMA index.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 07:51:56"
    },
    {
      "id": 891,
      "intervention": {
        "name": "Nutraceutical combination containing Monacolin K (MK) alone",
        "canonical_name": "Nutraceutical combination containing Monacolin K (MK) alone",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "cardiometabolic risk",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.85,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "prospective, randomized, active-treatment controlled trial",
        "sample_size": 359,
        "duration": "3 months",
        "population": "patients at cardiometabolic risk",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trial.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41044582",
        "doi": "10.1186/s12933-025-02920-4"
      },
      "supporting_quote": "Participants in the two treatment arms (F1 vs. F2) were comparable in terms of sex, age, metabolic parameters, and BP. After 3 months, both groups experienced significant reductions in LDL-C, fasting plasma glucose, HbA1c, and HOMA index.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 07:51:56"
    },
    {
      "id": 888,
      "intervention": {
        "name": "rituximab",
        "canonical_name": null,
        "category": "biologics",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "nephrotic syndrome",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.85
      },
      "study": {
        "type": null,
        "sample_size": 372,
        "duration": "4.9 years (median)",
        "population": "children and adults aged 1-40 years with steroid-sensitive nephrotic syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Steroid-sparing drugs in children and young adults with nephrotic syndrome: a target trial emulation.",
        "journal": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042242",
        "doi": "10.1093/ndt/gfaf207"
      },
      "supporting_quote": "Using real-world data, there was no difference in relapse rates after rituximab vs. calcineurin inhibitors among children and young adults with steroid-sensitive nephrotic syndrome.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 07:50:35"
    },
    {
      "id": 889,
      "intervention": {
        "name": "calcineurin inhibitors",
        "canonical_name": "potassium-competitive acid blockers (P-CABs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "nephrotic syndrome",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.85
      },
      "study": {
        "type": null,
        "sample_size": 372,
        "duration": "4.9 years (median)",
        "population": "children and adults aged 1-40 years with steroid-sensitive nephrotic syndrome",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Steroid-sparing drugs in children and young adults with nephrotic syndrome: a target trial emulation.",
        "journal": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042242",
        "doi": "10.1093/ndt/gfaf207"
      },
      "supporting_quote": "Using real-world data, there was no difference in relapse rates after rituximab vs. calcineurin inhibitors among children and young adults with steroid-sensitive nephrotic syndrome.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 07:50:35"
    },
    {
      "id": 887,
      "intervention": {
        "name": "liraglutide",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "obesity and pre-diabetes",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of a GLP-1 Receptor Polymorphism on Responses to Liraglutide.",
        "journal": "The Journal of endocrinology",
        "publication_date": "2025-10-03",
        "pubmed_id": "41042549",
        "doi": "10.1530/JOE-25-0174"
      },
      "supporting_quote": "Here we performed a pre-specified analysis of a randomized controlled trial in individuals with obesity and pre-diabetes comparing treatment with the GLP-1R agonist liraglutide",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 07:49:33"
    },
    {
      "id": 885,
      "intervention": {
        "name": "azithromycin therapy",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "chronic obstructive pulmonary disease (COPD) with Pseudomonas aeruginosa colonization",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 32753,
        "duration": null,
        "population": "patients with stable COPD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prevalence, Risk Factors, and Antibiotic Intervention of Lower Airway",
        "journal": "COPD",
        "publication_date": "2025-12",
        "pubmed_id": "41037326",
        "doi": "10.1080/15412555.2025.2564743"
      },
      "supporting_quote": "Exacerbations decreased within the next year after azithromycin treatment",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 07:47:53"
    },
    {
      "id": 886,
      "intervention": {
        "name": "inhaled antibiotics (IAs)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": "inhalation"
      },
      "condition": {
        "name": "chronic obstructive pulmonary disease (COPD) with Pseudomonas aeruginosa colonization",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 32753,
        "duration": null,
        "population": "patients with stable COPD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prevalence, Risk Factors, and Antibiotic Intervention of Lower Airway",
        "journal": "COPD",
        "publication_date": "2025-12",
        "pubmed_id": "41037326",
        "doi": "10.1080/15412555.2025.2564743"
      },
      "supporting_quote": "IAs reduced exacerbations in the following year",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 07:47:53"
    },
    {
      "id": 883,
      "intervention": {
        "name": "withholding angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs)",
        "canonical_name": "continuing angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "noncardiac surgery",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 4063,
        "duration": null,
        "population": "adult patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Withholding vs. continuing angiotensin-converting enzyme inhibitors or angiotensin receptor blockers before surgery: a systematic review and meta-analysis of randomized controlled trials.",
        "journal": "Annals of medicine",
        "publication_date": "2025-12",
        "pubmed_id": "41017370",
        "doi": "10.1080/07853890.2025.2566873"
      },
      "supporting_quote": "Withholding ACEIs/ARBs before noncardiac surgery was associated with a reduced incidence of intraoperative hypotension",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 07:46:40"
    },
    {
      "id": 884,
      "intervention": {
        "name": "continuing angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs)",
        "canonical_name": "continuing angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "noncardiac surgery",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": 4063,
        "duration": null,
        "population": "adult patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Withholding vs. continuing angiotensin-converting enzyme inhibitors or angiotensin receptor blockers before surgery: a systematic review and meta-analysis of randomized controlled trials.",
        "journal": "Annals of medicine",
        "publication_date": "2025-12",
        "pubmed_id": "41017370",
        "doi": "10.1080/07853890.2025.2566873"
      },
      "supporting_quote": "Withholding ACEIs/ARBs before noncardiac surgery was associated with a reduced incidence of intraoperative hypotension",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-04 07:46:40"
    },
    {
      "id": 879,
      "intervention": {
        "name": "lower body resistance training (RTL)",
        "canonical_name": "lower body resistance training (RTL)",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomised controlled feasibility trial",
        "sample_size": 36,
        "duration": null,
        "population": "people with knee OA (n = 36, 60 ± 11 years)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Training Modalities and Additional Pain Education on Exercise-Induced Hypoalgesia in People With Osteoarthritis of the Knee: A Randomised Controlled Feasibility Trial.",
        "journal": "European journal of pain (London, England)",
        "publication_date": "2025-11",
        "pubmed_id": "41041935",
        "doi": "10.1002/ejp.70141"
      },
      "supporting_quote": "Lower body resistance training may induce hypoalgesia in people with knee osteoarthritis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-03 21:49:27"
    },
    {
      "id": 880,
      "intervention": {
        "name": "upper body resistance training (RTU)",
        "canonical_name": "lower body resistance training (RTL)",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomised controlled feasibility trial",
        "sample_size": 36,
        "duration": null,
        "population": "people with knee OA (n = 36, 18-70 years)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Training Modalities and Additional Pain Education on Exercise-Induced Hypoalgesia in People With Osteoarthritis of the Knee: A Randomised Controlled Feasibility Trial.",
        "journal": "European journal of pain (London, England)",
        "publication_date": "2025-11",
        "pubmed_id": "41041935",
        "doi": "10.1002/ejp.70141"
      },
      "supporting_quote": "Upper body resistance training may induce hypoalgesia in people with knee osteoarthritis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-03 21:49:27"
    },
    {
      "id": 881,
      "intervention": {
        "name": "aerobic training (AET)",
        "canonical_name": "exercise therapy (ET)",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomised controlled feasibility trial",
        "sample_size": 36,
        "duration": null,
        "population": "people with knee OA (n = 36, 18-70 years)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Training Modalities and Additional Pain Education on Exercise-Induced Hypoalgesia in People With Osteoarthritis of the Knee: A Randomised Controlled Feasibility Trial.",
        "journal": "European journal of pain (London, England)",
        "publication_date": "2025-11",
        "pubmed_id": "41041935",
        "doi": "10.1002/ejp.70141"
      },
      "supporting_quote": "Aerobic training may induce hypoalgesia in people with knee osteoarthritis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-03 21:49:27"
    },
    {
      "id": 882,
      "intervention": {
        "name": "pain education",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": "randomised controlled feasibility trial",
        "sample_size": 36,
        "duration": null,
        "population": "people with knee OA (n = 36, 18-70 years)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Training Modalities and Additional Pain Education on Exercise-Induced Hypoalgesia in People With Osteoarthritis of the Knee: A Randomised Controlled Feasibility Trial.",
        "journal": "European journal of pain (London, England)",
        "publication_date": "2025-11",
        "pubmed_id": "41041935",
        "doi": "10.1002/ejp.70141"
      },
      "supporting_quote": "Pain education might have a useful supporting function.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-03 21:49:27"
    },
    {
      "id": 877,
      "intervention": {
        "name": "intra-articular steroid injection (IASI)",
        "canonical_name": "high-intensity laser therapy (HILT)",
        "category": "procedure",
        "details": "{\"dosage\": \"8 mg of intra-articular dexamethasone\", \"delivery_method\": \"injection\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 54,
        "duration": "12 weeks",
        "population": "patients with knee pain persisting for more than 3 months, stage II-III knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The effectiveness of intra-articular pulsed radiofrequency in patients with painful knee osteoarthritis: A randomized controlled trial.",
        "journal": "Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology",
        "publication_date": "2025-10",
        "pubmed_id": "41042043",
        "doi": "10.14744/agri.2025.90757"
      },
      "supporting_quote": "Pain intensity and participation in daily activities were evaluated using the Numerical Rating Scale and the Western Ontario and McMaster Universities Arthritis Index, respectively",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-03 21:47:44"
    },
    {
      "id": 878,
      "intervention": {
        "name": "intra-articular pulsed radiofrequency (IAPRF)",
        "canonical_name": "non-invasive pulsed radiofrequency (NipRF)",
        "category": "procedure",
        "details": "{\"duration\": \"360 s\", \"dosage\": null, \"delivery_method\": \"injection\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 54,
        "duration": "12 weeks",
        "population": "patients with knee pain persisting for more than 3 months, stage II-III knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The effectiveness of intra-articular pulsed radiofrequency in patients with painful knee osteoarthritis: A randomized controlled trial.",
        "journal": "Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology",
        "publication_date": "2025-10",
        "pubmed_id": "41042043",
        "doi": "10.14744/agri.2025.90757"
      },
      "supporting_quote": "Group 1 received 8 mg of intra-articular dexamethasone after IAPRF application for 360 s at 45 V, with the temperature not exceeding 42°C",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-03 21:47:44"
    },
    {
      "id": 866,
      "intervention": {
        "name": "Pegylated interferon alpha (Peg-IFNα)",
        "canonical_name": null,
        "category": "medication",
        "details": "{\"duration\": \"24 weeks\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "chronic hepatitis B (CHB)",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "retrospective study",
        "sample_size": 378,
        "duration": "24 weeks",
        "population": "CHB patients with HBsAg levels <50 IU/ml, including NUC-treated patients and inactive HBsAg carriers (IHCs)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Short-term pegylated interferon alpha in chronic HBV patients with ultra-low HBsAg: a retrospective study.",
        "journal": "Frontiers in cellular and infection microbiology",
        "publication_date": "2025",
        "pubmed_id": "40980017",
        "doi": "10.3389/fcimb.2025.1582997"
      },
      "supporting_quote": "Short-term Peg-IFNα therapy achieved high and comparable HBsAg clearance rates within 24 weeks in NUC-treated patients and IHCs with ultra-low HBsAg levels.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:57:35"
    },
    {
      "id": 864,
      "intervention": {
        "name": "arch bar splinting",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "dentoalveolar fractures",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of intraoperative and postoperative outcomes of arch bar splinting versus wire composite splinting in the management of patients with dentoalveolar fractures.",
        "journal": "National journal of maxillofacial surgery",
        "publication_date": "2025",
        "pubmed_id": "41019695",
        "doi": "10.4103/njms.njms_154_23"
      },
      "supporting_quote": "Group A- Patients in whom dentoalveolar fractures were managed by arch bar splinting.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:55:32"
    },
    {
      "id": 865,
      "intervention": {
        "name": "wire composite splinting",
        "canonical_name": "wire composite splinting",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "dentoalveolar fractures",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of intraoperative and postoperative outcomes of arch bar splinting versus wire composite splinting in the management of patients with dentoalveolar fractures.",
        "journal": "National journal of maxillofacial surgery",
        "publication_date": "2025",
        "pubmed_id": "41019695",
        "doi": "10.4103/njms.njms_154_23"
      },
      "supporting_quote": "Group B- Patients in whom dentoalveolar fractures were managed by wire composite splinting.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:55:32"
    },
    {
      "id": 863,
      "intervention": {
        "name": "pharmacotherapies",
        "canonical_name": "levothyroxine (LT4)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "stimulant use disorder and attention deficit hyperactivity disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "adults with comorbid StUD (cocaine, amphetamines, or methamphetamines) and ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacotherapies for stimulant use disorder and co-occurring attention deficit hyperactivity disorder: protocol for a systematic review and a meta-analysis.",
        "journal": "Frontiers in psychiatry",
        "publication_date": "2025",
        "pubmed_id": "40980048",
        "doi": "10.3389/fpsyt.2025.1667614"
      },
      "supporting_quote": "This review will synthesize existing evidence on the efficacy of pharmacotherapies (stimulants and non-stimulants) for individuals with co-occurring StUD and ADHD.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:54:42"
    },
    {
      "id": 861,
      "intervention": {
        "name": "IL-17 antagonists",
        "canonical_name": "IL-17 antagonists",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "lupus nephritis",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Enhancing the treatment potential of IL-17 antagonism in lupus nephritis: finding the right partner.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "40977724",
        "doi": "10.3389/fimmu.2025.1617451"
      },
      "supporting_quote": "IL-17 antagonists have been investigated for their potential in LN treatment, with mixed results from case reports and randomized controlled trials.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:54:09"
    },
    {
      "id": 862,
      "intervention": {
        "name": "combination biologic therapy (IL-17 antagonist + IL-36 antagonist)",
        "canonical_name": "IL-17 antagonists",
        "category": "emerging",
        "details": "{\"proposed_category\": \"biologics combination therapy\", \"category_rationale\": \"Combination of two cytokine antagonists for enhanced treatment potential\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "lupus nephritis",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Enhancing the treatment potential of IL-17 antagonism in lupus nephritis: finding the right partner.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "40977724",
        "doi": "10.3389/fimmu.2025.1617451"
      },
      "supporting_quote": "Given the limited success in clinical studies with IL-17 antagonism alone for LN, we discuss possible rational combination biologic therapies, with a focus on the potential combination with antagonism of IL-36",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:54:09"
    },
    {
      "id": 860,
      "intervention": {
        "name": "traditional Chinese medicine transdermal therapy",
        "canonical_name": "traditional Chinese medicine transdermal therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "chronic glomerulonephritis and uremic patients",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.85,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 50,
        "duration": "one month",
        "population": "hospitalized patients with chronic glomerulonephritis and uremia",
        "adverse_effects": "no severe adverse events observed",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of traditional Chinese medicine transdermal therapy in preventing lower limb deep vein thrombosis in chronic glomerulonephritis and uremic patients.",
        "journal": "Pakistan journal of pharmaceutical sciences",
        "publication_date": "2025",
        "pubmed_id": "40996201",
        "doi": "10.36721/PJPS.2025.38.5.REG.14686.1"
      },
      "supporting_quote": "The study group presented with significantly lower incidence of DVT, improved venous blood flow and reduced limb swelling and pain compared to the control group (P<0.05).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:53:09"
    },
    {
      "id": 858,
      "intervention": {
        "name": "aerobic exercise",
        "canonical_name": "aerobic exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "osteoporosis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "meta-analysis of randomized controlled trials",
        "sample_size": 1067,
        "duration": "varies (up to 24 studies)",
        "population": "postmenopausal women",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of exercise on bone metabolism in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.",
        "journal": "Frontiers in endocrinology",
        "publication_date": "2025",
        "pubmed_id": "41030850",
        "doi": "10.3389/fendo.2025.1597046"
      },
      "supporting_quote": "Aerobic exercise significantly reduced the levels of CTX",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:52:34"
    },
    {
      "id": 859,
      "intervention": {
        "name": "resistance exercise",
        "canonical_name": "cycling",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "osteoporosis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "meta-analysis of randomized controlled trials",
        "sample_size": 1067,
        "duration": "varies (up to 24 studies)",
        "population": "postmenopausal women",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of exercise on bone metabolism in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.",
        "journal": "Frontiers in endocrinology",
        "publication_date": "2025",
        "pubmed_id": "41030850",
        "doi": "10.3389/fendo.2025.1597046"
      },
      "supporting_quote": "Resistance exercise significantly increased OC levels",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:52:34"
    },
    {
      "id": 856,
      "intervention": {
        "name": "vonoprazan and amoxicillin dual therapy",
        "canonical_name": "vonoprazan and amoxicillin dual therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.85,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2039,
        "duration": null,
        "population": "adults >18 years of age",
        "adverse_effects": "lower incidence of adverse events than bismuth-based therapy",
        "cost_category": null
      },
      "paper": {
        "title": "Vonoprazan and amoxicillin dual therapy versus bismuth-based therapy for",
        "journal": "Proceedings (Baylor University. Medical Center)",
        "publication_date": "2025",
        "pubmed_id": "40821497",
        "doi": "10.1080/08998280.2025.2491964"
      },
      "supporting_quote": "The VA group had a lower incidence of total adverse events than the BBT group (OR: 0.32, 95% CI: 0.26-0.40; P = 0.0001)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:51:38"
    },
    {
      "id": 857,
      "intervention": {
        "name": "bismuth-based therapy (BBT)",
        "canonical_name": "vonoprazan and amoxicillin dual therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.15,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2039,
        "duration": null,
        "population": "adults >18 years of age",
        "adverse_effects": "higher incidence of adverse events than vonoprazan and amoxicillin dual therapy",
        "cost_category": null
      },
      "paper": {
        "title": "Vonoprazan and amoxicillin dual therapy versus bismuth-based therapy for",
        "journal": "Proceedings (Baylor University. Medical Center)",
        "publication_date": "2025",
        "pubmed_id": "40821497",
        "doi": "10.1080/08998280.2025.2491964"
      },
      "supporting_quote": "The VA group had a lower incidence of total adverse events than the BBT group (OR: 0.32, 95% CI: 0.26-0.40; P = 0.0001)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:51:38"
    },
    {
      "id": 854,
      "intervention": {
        "name": "omeprazole",
        "canonical_name": "omeprazole",
        "category": "medication",
        "details": "{\"dosage\": \"20 mg/day\", \"frequency\": \"daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "non-cardiac chest pain related to gastroesophageal reflux disease (GERD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.6,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "double-blind randomized controlled clinical trial",
        "sample_size": null,
        "duration": "8 weeks",
        "population": "adults with non-cardiac chest pain related to GERD",
        "adverse_effects": null,
        "cost_category": "medium"
      },
      "paper": {
        "title": "Comparison the effect of Asvard capsule and omeprazole in treatment and recurrence of non-cardiac chest pain related to gastroesophageal reflux disease in adults: A controlled double blind clinical trial.",
        "journal": "Avicenna journal of phytomedicine",
        "publication_date": "2025",
        "pubmed_id": "40969410",
        "doi": "10.22038/ajp.2025.25580"
      },
      "supporting_quote": "The average value of NCCP was reduced after the intervention compared to the study's baseline in all groups (Pv <0.001). However, two weeks after treatment (follow-up), participants recorded higher scores of NCCP in the omeprazole 20 mg group",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:50:25"
    },
    {
      "id": 855,
      "intervention": {
        "name": "Asvard capsule",
        "canonical_name": "combination of traditional Chinese and Western medicine",
        "category": "supplement",
        "details": "{\"frequency\": \"daily\", \"dosage\": \"['1200 mg/day', '1600 mg/day', '2000 mg/day']\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "non-cardiac chest pain related to gastroesophageal reflux disease (GERD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.8,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "double-blind randomized controlled clinical trial",
        "sample_size": null,
        "duration": "8 weeks",
        "population": "adults with non-cardiac chest pain related to GERD",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Comparison the effect of Asvard capsule and omeprazole in treatment and recurrence of non-cardiac chest pain related to gastroesophageal reflux disease in adults: A controlled double blind clinical trial.",
        "journal": "Avicenna journal of phytomedicine",
        "publication_date": "2025",
        "pubmed_id": "40969410",
        "doi": "10.22038/ajp.2025.25580"
      },
      "supporting_quote": "Our findings present that although omeprazole 20 mg decreased chest pain score, it has less lasting effect compared to the herbal medicine used in this study. It seems that Asvard can be effective for the treatment of NCCP related to gastroesophageal reflux disease (GERD)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:50:25"
    },
    {
      "id": 852,
      "intervention": {
        "name": "anticoagulant therapy",
        "canonical_name": "optimal medical therapy (OMT)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "ischemic stroke with active cancer",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": 135,
        "duration": "median follow-up time of 495 days (IQR, 57-1,029)",
        "population": "patients with acute ischemic stroke and active cancer hospitalized at a comprehensive stroke center from 2015 through 2020",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancer.",
        "journal": "Frontiers in neurology",
        "publication_date": "2025",
        "pubmed_id": "41036269",
        "doi": "10.3389/fneur.2025.1530775"
      },
      "supporting_quote": "Anticoagulant versus antiplatelet therapy was associated with similar risks of 1-year mortality and long-term recurrent AIS",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:49:07"
    },
    {
      "id": 853,
      "intervention": {
        "name": "antiplatelet therapy",
        "canonical_name": "antiplatelet therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "ischemic stroke with active cancer",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": 135,
        "duration": "median follow-up time of 495 days (IQR, 57-1,029)",
        "population": "patients with acute ischemic stroke and active cancer hospitalized at a comprehensive stroke center from 2015 through 2020",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancer.",
        "journal": "Frontiers in neurology",
        "publication_date": "2025",
        "pubmed_id": "41036269",
        "doi": "10.3389/fneur.2025.1530775"
      },
      "supporting_quote": "Anticoagulant versus antiplatelet therapy was associated with similar risks of 1-year mortality and long-term recurrent AIS",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:49:07"
    },
    {
      "id": 851,
      "intervention": {
        "name": "Persimmon leaf extract (PLE)",
        "canonical_name": "Persimmon leaf extract (PLE)",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "dyslipidemia",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 1572,
        "duration": null,
        "population": "adults with dyslipidemia, including those with comorbidities such as coronary artery disease, hypertension, ischemic cerebrovascular disease, and medication-induced dyslipidemia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Persimmon leaf extract in dyslipidemia: a systematic review and meta-analysis.",
        "journal": "Frontiers in pharmacology",
        "publication_date": "2025",
        "pubmed_id": "41031166",
        "doi": "10.3389/fphar.2025.1572678"
      },
      "supporting_quote": "Compared with the control group, the use of combined Persimmon leaf extract (PLE) significantly reduced total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) levels",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:47:59"
    },
    {
      "id": 850,
      "intervention": {
        "name": "Moringa oleifera (MO) supplementation",
        "canonical_name": "Moringa oleifera (MO) supplementation",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Human Immunodeficiency Virus (HIV)",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "HIV-infected adults",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of",
        "journal": "Frontiers in nutrition",
        "publication_date": "2025",
        "pubmed_id": "40989801",
        "doi": "10.3389/fnut.2025.1667158"
      },
      "supporting_quote": "MO supplementation significantly increased CD4+ T cell count, WBC (SMD = 0.22), and PLT count",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:47:20"
    },
    {
      "id": 849,
      "intervention": {
        "name": "egg ladder (EL)",
        "canonical_name": "auricular acupressure",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "IgE-mediated hen's egg allergy",
        "canonical_name": null,
        "category": "immunological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "open-label randomized controlled trial",
        "sample_size": 84,
        "duration": "18 weeks (for 4-EL) or 24 weeks (for 5-EL)",
        "population": "children with IgE-mediated hen's egg allergy",
        "adverse_effects": "anaphylaxis, exacerbation of atopic dermatitis",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of a 4-step versus a 5-step egg ladder in children with IgE-mediated hen's egg protein allergy: protocol for an open-label randomized controlled trial.",
        "journal": "Frontiers in allergy",
        "publication_date": "2025",
        "pubmed_id": "41031391",
        "doi": "10.3389/falgy.2025.1658186"
      },
      "supporting_quote": "This study aims to assess the efficacy and safety of the four-step EL (4-EL) compared with the five-step EL (5-EL) in children with IgE-mediated HEA.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:46:49"
    },
    {
      "id": 848,
      "intervention": {
        "name": "anti-inflammatory dietary program",
        "canonical_name": null,
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "cross-sectional study",
        "sample_size": 144,
        "duration": null,
        "population": "adults aged 45-85 years with symptomatic knee OA",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The inflammatory potential of diet in adults with knee osteoarthritis: sex-specific associations with quality of life, sleep, fatigue and mental health.",
        "journal": "Frontiers in nutrition",
        "publication_date": "2025",
        "pubmed_id": "41031358",
        "doi": "10.3389/fnut.2025.1624852"
      },
      "supporting_quote": "We evaluated the sex-specific relationship between the inflammatory potential of diet and health-related quality of life (HRQOL), sleep quality, energy and fatigue levels, and psychological distress in individuals with knee OA.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:45:37"
    },
    {
      "id": 842,
      "intervention": {
        "name": "vegan diet",
        "canonical_name": null,
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "rheumatoid arthritis (RA)",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nutrition and diet in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: a systematic review.",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "41030267",
        "doi": "10.3389/fmed.2025.1655165"
      },
      "supporting_quote": "In RA, vegan, anti-inflammatory, and Mediterranean diets improved disease activity, inflammation markers, and quality of life.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:45:02"
    },
    {
      "id": 843,
      "intervention": {
        "name": "anti-inflammatory diet",
        "canonical_name": "anti-inflammatory diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "rheumatoid arthritis (RA)",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nutrition and diet in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: a systematic review.",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "41030267",
        "doi": "10.3389/fmed.2025.1655165"
      },
      "supporting_quote": "In RA, vegan, anti-inflammatory, and Mediterranean diets improved disease activity, inflammation markers, and quality of life.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:45:02"
    },
    {
      "id": 844,
      "intervention": {
        "name": "Mediterranean diet",
        "canonical_name": "Mediterranean diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "rheumatoid arthritis (RA)",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nutrition and diet in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: a systematic review.",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "41030267",
        "doi": "10.3389/fmed.2025.1655165"
      },
      "supporting_quote": "In RA, vegan, anti-inflammatory, and Mediterranean diets improved disease activity, inflammation markers, and quality of life.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:45:02"
    },
    {
      "id": 845,
      "intervention": {
        "name": "polyunsaturated fatty acids (PUFAs)",
        "canonical_name": null,
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "axial spondyloarthritis (axSpA)",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nutrition and diet in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: a systematic review.",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "41030267",
        "doi": "10.3389/fmed.2025.1655165"
      },
      "supporting_quote": "For axSpA, evidence was limited, though supplementation with polyunsaturated fatty acids (PUFAs) showed potential benefits.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:45:02"
    },
    {
      "id": 846,
      "intervention": {
        "name": "hypocaloric diet",
        "canonical_name": "anti-inflammatory diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "psoriatic arthritis (PsA)",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nutrition and diet in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: a systematic review.",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "41030267",
        "doi": "10.3389/fmed.2025.1655165"
      },
      "supporting_quote": "In PsA, a hypocaloric diet supplemented with omega-3 fatty acids was associated with reduced disease activity.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:45:02"
    },
    {
      "id": 847,
      "intervention": {
        "name": "omega-3 fatty acids",
        "canonical_name": "omega-3 fatty acids",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "psoriatic arthritis (PsA)",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nutrition and diet in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: a systematic review.",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "41030267",
        "doi": "10.3389/fmed.2025.1655165"
      },
      "supporting_quote": "In PsA, a hypocaloric diet supplemented with omega-3 fatty acids was associated with reduced disease activity.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:45:02"
    },
    {
      "id": 839,
      "intervention": {
        "name": "Cetuximab-β",
        "canonical_name": "Cetuximab-β",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "RAS/BRAF wild-type metastatic colorectal cancer (mCRC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "Chinese patients with RAS/BRAF wild-type mCRC",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Network meta-analysis and cost-effectiveness analysis comparing Cetuximab-β and Cetuximab for Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer.",
        "journal": "Frontiers in pharmacology",
        "publication_date": "2025",
        "pubmed_id": "41031157",
        "doi": "10.3389/fphar.2025.1568385"
      },
      "supporting_quote": "Cetuximab-β, a newer version of Cetuximab, is approved for first-line RAS/BRAF wild-type mCRC",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:40:42"
    },
    {
      "id": 840,
      "intervention": {
        "name": "Cetuximab",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "RAS/BRAF wild-type metastatic colorectal cancer (mCRC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "Chinese patients with RAS/BRAF wild-type mCRC",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Network meta-analysis and cost-effectiveness analysis comparing Cetuximab-β and Cetuximab for Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer.",
        "journal": "Frontiers in pharmacology",
        "publication_date": "2025",
        "pubmed_id": "41031157",
        "doi": "10.3389/fphar.2025.1568385"
      },
      "supporting_quote": "This study evaluates the cost-effectiveness of Cetuximab-β with FOLFIRI for mCRC patients, comparing it to Cetuximab plus chemotherapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:40:42"
    },
    {
      "id": 841,
      "intervention": {
        "name": "FOLFIRI",
        "canonical_name": "Cetuximab-β",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "RAS/BRAF wild-type metastatic colorectal cancer (mCRC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "Chinese patients with RAS/BRAF wild-type mCRC",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Network meta-analysis and cost-effectiveness analysis comparing Cetuximab-β and Cetuximab for Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer.",
        "journal": "Frontiers in pharmacology",
        "publication_date": "2025",
        "pubmed_id": "41031157",
        "doi": "10.3389/fphar.2025.1568385"
      },
      "supporting_quote": "This study evaluates the cost-effectiveness of Cetuximab-β with FOLFIRI for mCRC patients, comparing it to Cetuximab plus chemotherapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:40:42"
    },
    {
      "id": 837,
      "intervention": {
        "name": "rhPTH(1-34)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "type 2 diabetic bone disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled clinical trial, animal study",
        "sample_size": null,
        "duration": "one year",
        "population": "postmenopausal patients with osteoporosis and type 2 diabetes (DOP), mice with T2DM",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of rhPTH(1-34) and alendronate on the treatment of type 2 diabetic bone disease.",
        "journal": "Frontiers in endocrinology",
        "publication_date": "2025",
        "pubmed_id": "41030855",
        "doi": "10.3389/fendo.2025.1657481"
      },
      "supporting_quote": "rhPTH(1-34) could reverse the low bone turnover observed in DM mice and had a better effect on improving BMD, bone volume per tissue volume (BV/TV), trabecular number in femoral trabecular bone, as well as BMD, BV/TV, and trabecular thickness in lumbar trabecular bone. For patients with DOP, rhPTH(1-34) had a better effect than ALN on BMD improvement at the lumbar spine.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:39:14"
    },
    {
      "id": 838,
      "intervention": {
        "name": "alendronate (ALN)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "type 2 diabetic bone disease",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled clinical trial, animal study",
        "sample_size": null,
        "duration": "one year",
        "population": "postmenopausal patients with osteoporosis and type 2 diabetes (DOP), mice with T2DM",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of rhPTH(1-34) and alendronate on the treatment of type 2 diabetic bone disease.",
        "journal": "Frontiers in endocrinology",
        "publication_date": "2025",
        "pubmed_id": "41030855",
        "doi": "10.3389/fendo.2025.1657481"
      },
      "supporting_quote": "Notably, the effect of ALN on lumbar spine improvement in patients with DOP was even smaller than that in patients with OP alone.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:39:14"
    },
    {
      "id": 836,
      "intervention": {
        "name": "digital therapeutics (DTx)",
        "canonical_name": "digital therapeutics (DTx)",
        "category": "emerging",
        "details": "{\"proposed_category\": \"digital intervention\", \"category_rationale\": \"The study focuses on a digital therapeutic app for obesity management, which is an emerging category.\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "overweight and obesity",
        "canonical_name": null,
        "category": "nutritional",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": 1.0,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "12 weeks",
        "population": "Adults with BMI ≥ 27 kg/m² and central obesity recruited from municipal Healthy Life Centers in Norway.",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Beyond weight loss: digital therapeutic for behavioral change and psychological well-being for individuals with overweight and obesity in a primary healthcare setting-A randomized controlled pilot study.",
        "journal": "Frontiers in digital health",
        "publication_date": "2025",
        "pubmed_id": "41035564",
        "doi": "10.3389/fdgth.2025.1671649"
      },
      "supporting_quote": "This study evaluated the effectiveness of the Lifeness DTx for obesity care and its effect on anthropometrics, reward-related eating behaviors and quality of life in individuals with overweight and obesity within a community-based healthcare setting.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:38:00"
    },
    {
      "id": 835,
      "intervention": {
        "name": "levothyroxine (LT4)",
        "canonical_name": "levothyroxine (LT4)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "thyroid dysfunction, subclinical hypothyroidism (SCH), thyroid peroxidase antibody (TPOAb) positivity",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.95,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "umbrella review of systematic reviews and meta-analyses",
        "sample_size": null,
        "duration": null,
        "population": "pregnant women with thyroid dysfunction, subclinical hypothyroidism (SCH), or positive TPOAb",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Levothyroxine supplementation and pregnancy outcomes in women with thyroid disorders: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials.",
        "journal": "Human reproduction open",
        "publication_date": "2025",
        "pubmed_id": "40978523",
        "doi": "10.1093/hropen/hoaf036"
      },
      "supporting_quote": "LT4 treatment significantly reduces the risks of pregnancy loss, preterm delivery, and gestational hypertension",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:37:19"
    },
    {
      "id": 832,
      "intervention": {
        "name": "diluted nitrous oxide inhalation",
        "canonical_name": "diluted nitrous oxide inhalation",
        "category": "medication",
        "details": "{\"dosage\": \"not specified\", \"frequency\": \"once daily for 4 weeks\", \"duration\": \"30 minutes\"}",
        "delivery_method": "inhalation"
      },
      "condition": {
        "name": "burn scar contracture pain",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 80,
        "duration": "4 weeks",
        "population": "patients ≥ 18 years of age who underwent rehabilitation 1 month after burn surgery with acute pain (VAS ≥ 4)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Analgesic effect of diluted nitrous oxide in rehabilitation training of patients with burn scar contracture: Study protocol for a randomized controlled trial.",
        "journal": "PloS one",
        "publication_date": "2025",
        "pubmed_id": "40997067",
        "doi": "10.1371/journal.pone.0333378"
      },
      "supporting_quote": "Group A will receive diluted nitrous oxide inhalation plus conventional therapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:36:36"
    },
    {
      "id": 833,
      "intervention": {
        "name": "oxygen",
        "canonical_name": "diluted nitrous oxide inhalation",
        "category": "medication",
        "details": "{\"dosage\": \"not specified\", \"frequency\": \"once daily for 4 weeks\", \"duration\": \"30 minutes\"}",
        "delivery_method": "inhalation"
      },
      "condition": {
        "name": "burn scar contracture pain",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 80,
        "duration": "4 weeks",
        "population": "patients ≥ 18 years of age who underwent rehabilitation 1 month after burn surgery with acute pain (VAS ≥ 4)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Analgesic effect of diluted nitrous oxide in rehabilitation training of patients with burn scar contracture: Study protocol for a randomized controlled trial.",
        "journal": "PloS one",
        "publication_date": "2025",
        "pubmed_id": "40997067",
        "doi": "10.1371/journal.pone.0333378"
      },
      "supporting_quote": "Group B will receive oxygen plus conventional therapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:36:36"
    },
    {
      "id": 834,
      "intervention": {
        "name": "rehabilitation training",
        "canonical_name": "rehabilitation training",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "burn scar contracture",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 80,
        "duration": "4 weeks",
        "population": "patients ≥ 18 years of age who underwent rehabilitation 1 month after burn surgery with acute pain (VAS ≥ 4)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Analgesic effect of diluted nitrous oxide in rehabilitation training of patients with burn scar contracture: Study protocol for a randomized controlled trial.",
        "journal": "PloS one",
        "publication_date": "2025",
        "pubmed_id": "40997067",
        "doi": "10.1371/journal.pone.0333378"
      },
      "supporting_quote": "Rehabilitation will be performed by a therapist",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:36:36"
    },
    {
      "id": 831,
      "intervention": {
        "name": "penalimab+tremelimumab+chemo",
        "canonical_name": "penalimab",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Penalimab+tremelimumab+chemo provided the best survival benefit [HR = 0.34, 95% CI: (0.24-0.48)].",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:06"
    },
    {
      "id": 761,
      "intervention": {
        "name": "immune checkpoint inhibitors (ICIs)",
        "canonical_name": "immune checkpoint inhibitors (ICIs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": 25,
        "duration": null,
        "population": "patients with advanced SqNSCLC",
        "adverse_effects": "ipilimumab+chemo had the highest incidence of adverse events (AEs)",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Immune-related therapy can provide significant benefit relative to chemotherapy alone in advanced SqNSCLC.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:05"
    },
    {
      "id": 762,
      "intervention": {
        "name": "chemotherapy",
        "canonical_name": "chemotherapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "negative",
        "strength": 0.1,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": 25,
        "duration": null,
        "population": "patients with advanced SqNSCLC",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Immune-related therapy can provide significant benefit relative to chemotherapy alone in advanced SqNSCLC.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:05"
    },
    {
      "id": 763,
      "intervention": {
        "name": "ipilimumab+chemo",
        "canonical_name": "atezolizumab+chemo",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "negative",
        "strength": 0.1,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "ipilimumab+chemo had the highest incidence of adverse events (AEs)",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Compared with chemotherapy, except for ipilimumab+chemo [HR = 0.92,95%CI: (0.59-1.40)], atezolizumab+chemo [HR = 0.88, 95%CI: (0.56-1.40)], and durvalumab+chemo [HR = 0.84, 95% CI: (0.52-1.40)], durvalumab+ tremelimumab+chemo [HR = 0. 88, 95% CI: (0.54-1.40)], which significantly improved overall survival(OS).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:05"
    },
    {
      "id": 764,
      "intervention": {
        "name": "atezolizumab+chemo",
        "canonical_name": "atezolizumab+chemo",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "negative",
        "strength": 0.1,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Compared with chemotherapy, except for ipilimumab+chemo [HR = 0.92,95%CI: (0.59-1.40)], atezolizumab+chemo [HR = 0.88, 95%CI: (0.56-1.40)], and durvalumab+chemo [HR = 0.84, 95% CI: (0.52-1.40)], durvalumab+ tremelimumab+chemo [HR = 0. 88, 95% CI: (0.54-1.40)], which significantly improved overall survival(OS).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:05"
    },
    {
      "id": 765,
      "intervention": {
        "name": "durvalumab+chemo",
        "canonical_name": "atezolizumab+chemo",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "negative",
        "strength": 0.1,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Compared with chemotherapy, except for ipilimumab+chemo [HR = 0.92,95%CI: (0.59-1.40)], atezolizumab+chemo [HR = 0.88, 95%CI: (0.56-1.40)], and durvalumab+chemo [HR = 0.84, 95% CI: (0.52-1.40)], durvalumab+ tremelimumab+chemo [HR = 0. 88, 95% CI: (0.54-1.40)], which significantly improved overall survival(OS).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:05"
    },
    {
      "id": 766,
      "intervention": {
        "name": "durvalumab+tremelimumab+chemo",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Compared with chemotherapy, except for ipilimumab+chemo [HR = 0.92,95%CI: (0.59-1.40)], atezolizumab+chemo [HR = 0.88, 95%CI: (0.56-1.40)], and durvalumab+chemo [HR = 0.84, 95% CI: (0.52-1.40)], durvalumab+ tremelimumab+chemo [HR = 0. 88, 95% CI: (0.54-1.40)], which significantly improved overall survival(OS).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:05"
    },
    {
      "id": 767,
      "intervention": {
        "name": "cemiplimab",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Cemiplimab [HR = 0.48, 95% CI: (0.34-0.67)] showed the best OS benefit.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:05"
    },
    {
      "id": 768,
      "intervention": {
        "name": "sugemalimab+chemo",
        "canonical_name": "atezolizumab+chemo",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Sugemalimab+chemo provided the best survival benefit [HR = 0.34, 95% CI: (0.24-0.48)].",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:05"
    },
    {
      "id": 769,
      "intervention": {
        "name": "penalimab",
        "canonical_name": "penalimab",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Penalimab [HR = 0.34, 95% CI: (0.24-0.48)] provided the best survival benefit.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:05"
    },
    {
      "id": 770,
      "intervention": {
        "name": "penalimab+chemo",
        "canonical_name": "penalimab",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "advanced squamous non-small cell lung cancer (SqNSCLC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035637",
        "doi": "10.3389/fimmu.2025.1635757"
      },
      "supporting_quote": "Penalimab+chemo provided the best survival benefit [HR = 0.34, 95% CI: (0.24-0.48)].",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 20:35:05"
    },
    {
      "id": 760,
      "intervention": {
        "name": "MCV (Measles-containing vaccine)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "SARS-CoV-2 infection, COVID-19",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.3,
        "extraction_confidence": 0.95,
        "study_confidence": 0.84
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 3411,
        "duration": "up to 150 days",
        "population": "adults aged 18 and older",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "No evidence of MMR induced trained immunity to prevent SARS COV2: results from a multi-centre RCT.",
        "journal": "Frontiers in immunology",
        "publication_date": "2025",
        "pubmed_id": "41035643",
        "doi": "10.3389/fimmu.2025.1588190"
      },
      "supporting_quote": "Administering MCVs to stimulate trained immunity did not prevent COVID-19 or SARS-CoV2 infection.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:56:27"
    },
    {
      "id": 759,
      "intervention": {
        "name": "mitiperstat",
        "canonical_name": null,
        "category": "medication",
        "details": "{\"dosage\": \"5 mg\", \"frequency\": \"once daily\", \"duration\": \"24 weeks\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "chronic obstructive pulmonary disease (COPD)",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "24 weeks",
        "population": "patients (40-80 years) with COPD at high risk of exacerbation",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Phase 2a, Randomized Trial of Mitiperstat Versus Placebo in Patients with COPD at High Risk of Exacerbation (CRESCENDO).",
        "journal": "International journal of chronic obstructive pulmonary disease",
        "publication_date": "2025",
        "pubmed_id": "41031389",
        "doi": "10.2147/COPD.S524775"
      },
      "supporting_quote": "We hypothesize that treatment with mitiperstat, a novel oral MPO inhibitor, may reduce lung oxidative stress, inflammation and exacerbations",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:55:51"
    },
    {
      "id": 756,
      "intervention": {
        "name": "tegoprazan-based therapies",
        "canonical_name": "tegoprazan-based therapies",
        "category": "medication",
        "details": "{\"dosage\": \"50 mg twice daily\", \"frequency\": \"twice daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.87,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 468,
        "duration": "14 days",
        "population": "adult patients with confirmed H. pylori infection",
        "adverse_effects": "comparable incidence of adverse events to BQT",
        "cost_category": null
      },
      "paper": {
        "title": "Tegoprazan dual and quadruple therapy for",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "40873796",
        "doi": "10.3389/fmed.2025.1629567"
      },
      "supporting_quote": "Tegoprazan-based therapies achieved acceptable H. pylori eradication rates exceeding 85%, outperforming the BQT.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:55:14"
    },
    {
      "id": 757,
      "intervention": {
        "name": "bismuth-containing quadruple therapy (BQT)",
        "canonical_name": "bismuth-containing quadruple therapy (BQT)",
        "category": "medication",
        "details": "{\"dosage\": \"rabeprazole 10 mg twice daily, compound bismuth aluminate granules 2.6 g thrice daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.78,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 468,
        "duration": "14 days",
        "population": "adult patients with confirmed H. pylori infection",
        "adverse_effects": "comparable incidence of adverse events to tegoprazan-based therapies",
        "cost_category": null
      },
      "paper": {
        "title": "Tegoprazan dual and quadruple therapy for",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "40873796",
        "doi": "10.3389/fmed.2025.1629567"
      },
      "supporting_quote": "The eradication rates for TBQT, TAD and BQT were 86.3, 85.5 and 77.2%, respectively.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:55:14"
    },
    {
      "id": 758,
      "intervention": {
        "name": "tegoprazan-amoxicillin dual therapy",
        "canonical_name": "tegoprazan-based therapies",
        "category": "medication",
        "details": "{\"dosage\": \"tegoprazan 50 mg twice daily, amoxicillin 1 g thrice daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "regions with high clarithromycin resistance",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Tegoprazan dual and quadruple therapy for",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "40873796",
        "doi": "10.3389/fmed.2025.1629567"
      },
      "supporting_quote": "tegoprazan-amoxicillin dual therapy may serve as an alternative H. pylori eradication regimen in regions with high clarithromycin resistance.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:55:14"
    },
    {
      "id": 755,
      "intervention": {
        "name": "gut-directed hypnotherapy",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "disorders of gut-brain interaction",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "uncontrolled within-group feasibility study",
        "sample_size": 32,
        "duration": "12 weeks",
        "population": "children and adolescents aged 8-17 with irritable bowel syndrome, functional abdominal pain, or functional dyspepsia",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Hypnotherapy self-exercises with audio files for children and adolescents with disorders of gut-brain interaction-a study of feasibility and preliminary effects in Sweden.",
        "journal": "Therapeutic advances in gastroenterology",
        "publication_date": "2025",
        "pubmed_id": "41030295",
        "doi": "10.1177/17562848251381141"
      },
      "supporting_quote": "Gut-directed hypnotherapy is effective for treating children with disorders of gut-brain interaction",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:53:28"
    },
    {
      "id": 754,
      "intervention": {
        "name": "positive psychological intervention based on PERMA model",
        "canonical_name": "positive psychological intervention based on PERMA model",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "inflammatory bowel disease (IBD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 47,
        "duration": "8 weeks",
        "population": "hospitalized patients experiencing fear of recurrence related to IBD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The impact of a PERMA model-based positive psychology intervention on fear of recurrence of inflammatory bowel disease: a randomized controlled trial.",
        "journal": "Frontiers in psychology",
        "publication_date": "2025",
        "pubmed_id": "41020125",
        "doi": "10.3389/fpsyg.2025.1611899"
      },
      "supporting_quote": "Positive psychological interventions based on the PERMA model significantly reduced fear of recurrence in IBD patients, and positively affected their subjective well-being, psychological resilience, and quality of life.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:52:54"
    },
    {
      "id": 751,
      "intervention": {
        "name": "ketogenic diet (KD)",
        "canonical_name": null,
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "drug-resistant epilepsy",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "children (≤18 years) with drug-resistant epilepsy",
        "adverse_effects": "constipation, anorexia, diarrhea",
        "cost_category": null
      },
      "paper": {
        "title": "Impact of a high-fat, low-carbohydrate ketogenic diet on seizure frequency in children with drug-resistant epilepsy: a systematic review and Meta-analysis.",
        "journal": "Frontiers in nutrition",
        "publication_date": "2025",
        "pubmed_id": "41001121",
        "doi": "10.3389/fnut.2025.1634041"
      },
      "supporting_quote": "The KD significantly improved seizure outcomes, with robust efficacy in reducing seizure frequency and a higher likelihood of achieving seizure freedom",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:52:19"
    },
    {
      "id": 752,
      "intervention": {
        "name": "modified Atkins diet (MAD)",
        "canonical_name": null,
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "drug-resistant epilepsy",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Impact of a high-fat, low-carbohydrate ketogenic diet on seizure frequency in children with drug-resistant epilepsy: a systematic review and Meta-analysis.",
        "journal": "Frontiers in nutrition",
        "publication_date": "2025",
        "pubmed_id": "41001121",
        "doi": "10.3389/fnut.2025.1634041"
      },
      "supporting_quote": "This meta-analysis aimed to systematically evaluate the impact of the KD on seizure frequency in pediatric patients with drug-resistant epilepsy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:52:19"
    },
    {
      "id": 753,
      "intervention": {
        "name": "low-glycemic-index treatment (LGIT)",
        "canonical_name": null,
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "drug-resistant epilepsy",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Impact of a high-fat, low-carbohydrate ketogenic diet on seizure frequency in children with drug-resistant epilepsy: a systematic review and Meta-analysis.",
        "journal": "Frontiers in nutrition",
        "publication_date": "2025",
        "pubmed_id": "41001121",
        "doi": "10.3389/fnut.2025.1634041"
      },
      "supporting_quote": "This meta-analysis aimed to systematically evaluate the impact of the KD on seizure frequency in pediatric patients with drug-resistant epilepsy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:52:19"
    },
    {
      "id": 749,
      "intervention": {
        "name": "traditional physiotherapy",
        "canonical_name": "biofeedback training with Biometrics device",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "stroke",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 120,
        "duration": "3 weeks",
        "population": "late stroke patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessment of the effects of rehabilitation of hand function using a biometrics device in people after stroke - a randomized controlled trial.",
        "journal": "Frontiers in neurology",
        "publication_date": "2025",
        "pubmed_id": "41036275",
        "doi": "10.3389/fneur.2025.1643336"
      },
      "supporting_quote": "While the control group received traditional physiotherapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:50:54"
    },
    {
      "id": 750,
      "intervention": {
        "name": "biofeedback training with Biometrics device",
        "canonical_name": "biofeedback training with Biometrics device",
        "category": "emerging",
        "details": "{\"proposed_category\": \"digital therapeutics\", \"category_rationale\": \"The use of a biometric device for biofeedback training is novel and falls under digital health interventions.\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "stroke",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 120,
        "duration": "3 weeks",
        "population": "late stroke patients",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessment of the effects of rehabilitation of hand function using a biometrics device in people after stroke - a randomized controlled trial.",
        "journal": "Frontiers in neurology",
        "publication_date": "2025",
        "pubmed_id": "41036275",
        "doi": "10.3389/fneur.2025.1643336"
      },
      "supporting_quote": "the test group additionally underwent biofeedback training",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:50:54"
    },
    {
      "id": 748,
      "intervention": {
        "name": "apixaban",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "atrial fibrillation (AF)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "observational, multicentric study",
        "sample_size": 257,
        "duration": "two consecutive years during the month of Ramadan",
        "population": "AF patients who were on apixaban and fasted at least 10 days",
        "adverse_effects": "minor bleeding events in only 4.7% of patients (no major bleeding event)",
        "cost_category": null
      },
      "paper": {
        "title": "Safety and effectiveness of apixaban use for stroke prevention during Ramadan fasting (the API-RAM study).",
        "journal": "Frontiers in pharmacology",
        "publication_date": "2025",
        "pubmed_id": "41031153",
        "doi": "10.3389/fphar.2025.1565094"
      },
      "supporting_quote": "Apixaban seems to be safe and effective for the prevention of the thromboembolic episode in AF patients during Ramadan fasting",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:49:59"
    },
    {
      "id": 747,
      "intervention": {
        "name": "optimal medical therapy (OMT)",
        "canonical_name": "optimal medical therapy (OMT)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "stable coronary artery disease involving ≥50% stenosis in the left main coronary artery",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Left Main Disease: The Last Frontier for Medical Therapy in Stable Coronary Artery Disease?",
        "journal": "European cardiology",
        "publication_date": "2025",
        "pubmed_id": "41036022",
        "doi": "10.15420/ecr.2025.28"
      },
      "supporting_quote": "Current clinical practice guidelines still base their recommendations on small subsets of RCTs conducted in the 1970s and early 1980s.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:49:23"
    },
    {
      "id": 746,
      "intervention": {
        "name": "oat β-glucan",
        "canonical_name": "Persimmon leaf extract (PLE)",
        "category": "diet",
        "details": "{\"frequency\": \"daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "hypertension",
        "canonical_name": null,
        "category": "cardiac",
        "severity": "mild"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized cross-over pilot trial",
        "sample_size": 21,
        "duration": "4 weeks",
        "population": "middle age and older adults with mild hypertension",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Effect of oat β-glucan in managing blood pressure: a randomized cross-over pilot trial.",
        "journal": "Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme",
        "publication_date": "2025-01-01",
        "pubmed_id": "41031804",
        "doi": "10.1139/apnm-2024-0317"
      },
      "supporting_quote": "Consumption of oat β-glucan breakfast cookies for 4 weeks did not reduce systolic or diastolic blood pressure compared to a wheat-based control in middle age and older adults with mild hypertension.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:48:52"
    },
    {
      "id": 744,
      "intervention": {
        "name": "thyroidectomy",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "thyroid disorders",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "prospective, randomized, interventional study",
        "sample_size": 32,
        "duration": "18 months",
        "population": "patients aged 18-50 years undergoing conventional thyroidectomy",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Autologous Platelet-Rich Plasma on Thyroidectomy Scars: A Prospective Interventional Study in a Tertiary Care Hospital in India.",
        "journal": "Cureus",
        "publication_date": "2025-06",
        "pubmed_id": "40621269",
        "doi": "10.7759/cureus.85404"
      },
      "supporting_quote": "thyroidectomy is a frequently performed surgical procedure to manage these conditions",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:48:16"
    },
    {
      "id": 745,
      "intervention": {
        "name": "autologous platelet-rich plasma (PRP)",
        "canonical_name": null,
        "category": "emerging",
        "details": "{\"proposed_category\": \"surgery\", \"category_rationale\": \"PRP is used in conjunction with thyroidectomy to improve scar quality\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "thyroidectomy scars",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "prospective, randomized, interventional study",
        "sample_size": 32,
        "duration": "18 months",
        "population": "patients aged 18-50 years undergoing conventional thyroidectomy",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Effect of Autologous Platelet-Rich Plasma on Thyroidectomy Scars: A Prospective Interventional Study in a Tertiary Care Hospital in India.",
        "journal": "Cureus",
        "publication_date": "2025-06",
        "pubmed_id": "40621269",
        "doi": "10.7759/cureus.85404"
      },
      "supporting_quote": "Intraoperative application of autologous PRP significantly enhances scar quality following thyroidectomy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:48:16"
    },
    {
      "id": 743,
      "intervention": {
        "name": "Nordic hamstring exercise (NHE)",
        "canonical_name": null,
        "category": "exercise",
        "details": "{\"duration\": \"6 weeks\", \"frequency\": \"weekly increasing volume from 6 to 18 repetitions\"}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "anterior cruciate ligament injury risk",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 35,
        "duration": "6 weeks",
        "population": "youth female athletes aged 12-15 years old",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Effects of Nordic Hamstring Exercise Set Configuration on Eccentric Hamstring Strength Changes in Youth Female Athletes.",
        "journal": "Journal of strength and conditioning research",
        "publication_date": "2025-06-10",
        "pubmed_id": "40489412",
        "doi": "10.1519/JSC.0000000000005139"
      },
      "supporting_quote": "Both TS and RR significantly increased NordBord EHS ( g = 0.34-0.98)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:47:12"
    },
    {
      "id": 741,
      "intervention": {
        "name": "collateral puncture therapy",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "erythematotelangiectatic rosacea (ETR)",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 60,
        "duration": "ongoing until December 2025",
        "population": "patients diagnosed with ETR",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Treatment of Erythematotelangiectatic Rosacea With Collateral Puncture Therapy: Protocol for a Randomized Controlled Trial.",
        "journal": "JMIR research protocols",
        "publication_date": "2025-06-17",
        "pubmed_id": "40527501",
        "doi": "10.2196/59682"
      },
      "supporting_quote": "Collateral puncture therapy for ETR offers advantages such as rapid onset of effect, a simple procedure, and low cost.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:46:36"
    },
    {
      "id": 742,
      "intervention": {
        "name": "IPL therapy",
        "canonical_name": "intense pulsed light combined with 3% tranexamic acid",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "erythematotelangiectatic rosacea (ETR)",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 60,
        "duration": "ongoing until December 2025",
        "population": "patients diagnosed with ETR",
        "adverse_effects": "prolonged treatment course and high costs",
        "cost_category": "high"
      },
      "paper": {
        "title": "Treatment of Erythematotelangiectatic Rosacea With Collateral Puncture Therapy: Protocol for a Randomized Controlled Trial.",
        "journal": "JMIR research protocols",
        "publication_date": "2025-06-17",
        "pubmed_id": "40527501",
        "doi": "10.2196/59682"
      },
      "supporting_quote": "Intense pulsed light (IPL) therapy demonstrates notable improvement in persistent erythema and telangiectasia; however, it is associated with issues such as a prolonged treatment course and high costs.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:46:36"
    },
    {
      "id": 739,
      "intervention": {
        "name": "arthroscopic rotator cuff repair (RCR)",
        "canonical_name": "arthroscopic rotator cuff repair (RCR)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "rotator cuff tear (RCT)",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "meta-analysis of comparative studies",
        "sample_size": 415,
        "duration": "variable follow-up period",
        "population": "patients with rotator cuff tears",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Combined arthroscopic rotator cuff repair with mesenchymal stem cell augmentation shows similar functional outcomes but a higher structural integrity rate compared with isolated repair: a meta-analysis of comparative studies.",
        "journal": "JSES international",
        "publication_date": "2025-07",
        "pubmed_id": "40959003",
        "doi": "10.1016/j.jseint.2025.03.017"
      },
      "supporting_quote": "Arthroscopic surgical repair combined with MSC augmentation reported better structural outcomes compared to isolated surgical repair for RCT.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:45:30"
    },
    {
      "id": 740,
      "intervention": {
        "name": "mesenchymal stem cell (MSC) augmentation",
        "canonical_name": "mesenchymal stem cell (MSC) augmentation",
        "category": "emerging",
        "details": "{\"proposed_category\": \"stem cell therapy\", \"category_rationale\": \"Mesenchymal stem cells are used to enhance tendon-bone healing.\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "rotator cuff tear (RCT)",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.9
      },
      "study": {
        "type": "meta-analysis of comparative studies",
        "sample_size": 415,
        "duration": "variable follow-up period",
        "population": "patients with rotator cuff tears",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Combined arthroscopic rotator cuff repair with mesenchymal stem cell augmentation shows similar functional outcomes but a higher structural integrity rate compared with isolated repair: a meta-analysis of comparative studies.",
        "journal": "JSES international",
        "publication_date": "2025-07",
        "pubmed_id": "40959003",
        "doi": "10.1016/j.jseint.2025.03.017"
      },
      "supporting_quote": "MSC augmentation has been proposed as a therapy associated with surgical repair, potentially enhancing the overall surgical outcomes for patients with RCTs.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:45:30"
    },
    {
      "id": 738,
      "intervention": {
        "name": "increased water intake",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "polycystic kidney disease (ADPKD)",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "loss of control particularly at social events, somatic and emotional state undermining motivation",
        "cost_category": "low"
      },
      "paper": {
        "title": "Participant Perceptions of Increasing Water Intake in Polycystic Kidney Disease.",
        "journal": "Kidney international reports",
        "publication_date": "2025-07",
        "pubmed_id": "40677362",
        "doi": "10.1016/j.ekir.2025.04.041"
      },
      "supporting_quote": "Participants were motivated to adhere to the increased water intake at the start of the trial, but it became more difficult over time.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:44:27"
    },
    {
      "id": 737,
      "intervention": {
        "name": "mental fatigue induction through Stroop task",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "non-contact anterior cruciate ligament injury risk",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.9,
        "study_confidence": 0.85
      },
      "study": {
        "type": "self-controlled trial",
        "sample_size": 38,
        "duration": null,
        "population": "basketball players",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Impact of mental fatigue on lower limb biomechanics and non-contact anterior cruciate ligament injury risk in basketball players during the stop-jump task: a self-controlled trial.",
        "journal": "Journal of orthopaedic surgery and research",
        "publication_date": "2025-07-17",
        "pubmed_id": "40676617",
        "doi": "10.1186/s13018-025-05905-x"
      },
      "supporting_quote": "MF was induced through a 45-minute Stroop task, with fatigue levels assessed via the visual analogue scale (VAS)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:43:57"
    },
    {
      "id": 736,
      "intervention": {
        "name": "30% supramolecular salicylic acid (SSA)",
        "canonical_name": null,
        "category": "medication",
        "details": "{\"dosage\": \"30%\", \"frequency\": \"biweekly\", \"duration\": \"six weeks\"}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "papulopustular rosacea",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 1.0,
        "extraction_confidence": 1.0,
        "study_confidence": 1.0
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 480,
        "duration": "eight weeks",
        "population": "patients aged 18 to 60 years with papulopustular rosacea",
        "adverse_effects": "no significant difference in adverse event rates compared to placebo",
        "cost_category": null
      },
      "paper": {
        "title": "Study on the efficacy and safety of supramolecular salicylic acid in the treatment of papulopustular rosacea: results from a multicenter randomized double-blind placebo-controlled superiority study.",
        "journal": "Clinical and experimental dermatology",
        "publication_date": "2025-07-24",
        "pubmed_id": "40701547",
        "doi": "10.1093/ced/llaf316"
      },
      "supporting_quote": "The SSA group showed a significant improvement in the primary efficacy endpoint at week 8, with efficacy rates of 51.25% (full-analysis set, FAS) and 59.90% (per-protocol set, PPS), compared to 18.33% (FAS) and 20.50% (PPS) in the placebo group",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:43:15"
    },
    {
      "id": 727,
      "intervention": {
        "name": "tacrolimus",
        "canonical_name": "tacrolimus",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "vitiligo",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": "In vitiligo, microneedling with tacrolimus or 5-fluorouracil (5-FU) achieved repigmentation rates of 40-76.6% compared with 16.9-39.9% for monotherapy.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:42:28"
    },
    {
      "id": 728,
      "intervention": {
        "name": "5-fluorouracil (5-FU)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "vitiligo",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": "In vitiligo, microneedling with tacrolimus or 5-fluorouracil (5-FU) achieved repigmentation rates of 40-76.6% compared with 16.9-39.9% for monotherapy.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:42:28"
    },
    {
      "id": 729,
      "intervention": {
        "name": "fractional microneedle radiofrequency (FMR)",
        "canonical_name": "fractional microneedle radiofrequency (FMR)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "hyperhidrosis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": "In hyperhidrosis, fractional microneedle radiofrequency (FMR) reduced sweat production",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:42:28"
    },
    {
      "id": 730,
      "intervention": {
        "name": "botulinum toxin A",
        "canonical_name": "traditional Chinese medicine transdermal therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "hyperhidrosis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": "botulinum toxin A yielded longer-lasting results and greater patient satisfaction",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:42:28"
    },
    {
      "id": 731,
      "intervention": {
        "name": "tranexamic acid",
        "canonical_name": "tranexamic acid",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "melasma",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": "For melasma, combinations with tranexamic acid or cysteamine produced notable modified melasma area and severity index (mMASI) score reductions",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:42:28"
    },
    {
      "id": 732,
      "intervention": {
        "name": "cysteamine",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "melasma",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": "For melasma, combinations with tranexamic acid or cysteamine produced notable modified melasma area and severity index (mMASI) score reductions",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:42:28"
    },
    {
      "id": 733,
      "intervention": {
        "name": "microneedle radiofrequency (MRF)",
        "canonical_name": "fractional microneedle radiofrequency (FMR)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": "In acne vulgaris, microneedle radiofrequency (MRF) outperformed photodynamic therapy (PDT), achieving an 81% reduction in inflammatory lesions versus 73%, with fewer adverse events",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:42:28"
    },
    {
      "id": 734,
      "intervention": {
        "name": "photodynamic therapy (PDT)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": "In acne vulgaris, microneedle radiofrequency (MRF) outperformed photodynamic therapy (PDT), achieving an 81% reduction in inflammatory lesions versus 73%, with fewer adverse events",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:42:28"
    },
    {
      "id": 735,
      "intervention": {
        "name": "microneedling-assisted PDT",
        "canonical_name": "fractional microneedle radiofrequency (FMR)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "actinic keratoses",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "transient erythema and mild pain",
        "cost_category": null
      },
      "paper": {
        "title": "Microneedling for Non-cosmetic Dermatologic Conditions: A Systematic Review of Efficacy and Safety.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40995236",
        "doi": "10.7759/cureus.90857"
      },
      "supporting_quote": "Microneedling-assisted PDT also improved actinic keratoses clearance rates by 18% (76% vs 58%).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:42:28"
    },
    {
      "id": 726,
      "intervention": {
        "name": "Extracorporeal shock wave lithotripsy (ESWL)",
        "canonical_name": "Extracorporeal shock wave lithotripsy (ESWL)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "urinary stones",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "systematic review",
        "sample_size": 412,
        "duration": null,
        "population": "adults undergoing ESWL",
        "adverse_effects": "risk of causing renal injury",
        "cost_category": null
      },
      "paper": {
        "title": "Urinary Biomarkers for Early Detection of Kidney Injury Following Extracorporeal Shock Wave Lithotripsy: A Systematic Review.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40978830",
        "doi": "10.7759/cureus.90688"
      },
      "supporting_quote": "Extracorporeal shock wave lithotripsy (ESWL) is a commonly used, non-invasive intervention used for the treatment of urinary stones",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:38:30"
    },
    {
      "id": 725,
      "intervention": {
        "name": "seed cycling",
        "canonical_name": null,
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "premenstrual syndrome (PMS)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.6,
        "extraction_confidence": 1.0,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": 635,
        "duration": null,
        "population": "reproductive-aged women aged 15-49 years with PMS or PCOS",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Efficacy of Seed Cycling as an Integrative Therapy for Premenstrual Syndrome and Polycystic Ovary Syndrome in Reproductive-Aged Women: A Systematic Review.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41018334",
        "doi": "10.7759/cureus.90997"
      },
      "supporting_quote": "seed cycling, particularly flax and sesame seeds, was associated with improved menstrual regularity, reduced PMS symptom severity",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:37:56"
    },
    {
      "id": 723,
      "intervention": {
        "name": "povidone-iodine (PI)",
        "canonical_name": "povidone-iodine (PI)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "ventilator-associated pneumonia prevention",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 20,
        "duration": "6 hours",
        "population": "ICU patients undergoing mechanical ventilation",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Effect of Topical Application of Povidone-Iodine on the Number of Bacteria Entering the Lower Respiratory Tract of Intubated Patients: A Randomized Controlled Trial.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030697",
        "doi": "10.7759/cureus.91274"
      },
      "supporting_quote": "PI oral care effectively reduces viable bacterial load in the lower respiratory tract",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:37:12"
    },
    {
      "id": 724,
      "intervention": {
        "name": "toothbrushing",
        "canonical_name": "povidone-iodine (PI)",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "ventilator-associated pneumonia prevention",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 20,
        "duration": "6 hours",
        "population": "ICU patients undergoing mechanical ventilation",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Effect of Topical Application of Povidone-Iodine on the Number of Bacteria Entering the Lower Respiratory Tract of Intubated Patients: A Randomized Controlled Trial.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030697",
        "doi": "10.7759/cureus.91274"
      },
      "supporting_quote": "The toothbrushing group did not show significant changes",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:37:12"
    },
    {
      "id": 716,
      "intervention": {
        "name": "Janus kinase inhibitors (JAKi)",
        "canonical_name": "Baricitinib",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Large vessel vasculitis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "infections",
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": "Most studies and case reports demonstrated the effectiveness of JAKi in the outcomes measured, namely, clinical activity, symptoms or signs, imaging findings, inflammatory marker levels, disease relapse, and corticosteroid requirement. JAKi are also generally safe, with infections being the most common adverse effect.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:35:08"
    },
    {
      "id": 717,
      "intervention": {
        "name": "Upadacitinib",
        "canonical_name": "Leflunomide",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Giant Cell Arteritis (GCA)",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "double-blind randomized controlled trial (RCT)",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": "The only RCT was done with GCA patients using upadacitinib 15mg daily vs 7.5mg daily vs placebo.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:35:08"
    },
    {
      "id": 718,
      "intervention": {
        "name": "Tofacitinib",
        "canonical_name": "Leflunomide",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Large vessel vasculitis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": "Upadacitinib, tofacitinib, baricitinib, and ruxolitinib were the JAKi studied.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:35:08"
    },
    {
      "id": 719,
      "intervention": {
        "name": "Baricitinib",
        "canonical_name": "Baricitinib",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Large vessel vasculitis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": "Upadacitinib, tofacitinib, baricitinib, and ruxolitinib were the JAKi studied.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:35:08"
    },
    {
      "id": 720,
      "intervention": {
        "name": "Ruxolitinib",
        "canonical_name": "Leflunomide",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Large vessel vasculitis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": "Upadacitinib, tofacitinib, baricitinib, and ruxolitinib were the JAKi studied.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:35:08"
    },
    {
      "id": 721,
      "intervention": {
        "name": "Methotrexate",
        "canonical_name": "Leflunomide",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Large vessel vasculitis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": "Two included a comparison group with traditional immunosuppressants, namely, methotrexate and leflunomide",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:35:08"
    },
    {
      "id": 722,
      "intervention": {
        "name": "Leflunomide",
        "canonical_name": "Leflunomide",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "Large vessel vasculitis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "41030746",
        "doi": "10.7759/cureus.91235"
      },
      "supporting_quote": "Two included a comparison group with traditional immunosuppressants, namely, methotrexate and leflunomide",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:35:08"
    },
    {
      "id": 714,
      "intervention": {
        "name": "warfarin",
        "canonical_name": "DOACs (direct oral anticoagulants)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "thrombogenic nature of mechanical heart valves",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "adults with mechanical heart valves",
        "adverse_effects": "frequent monitoring requirements, drug-drug interactions",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40932963",
        "doi": "10.7759/cureus.89736"
      },
      "supporting_quote": "Warfarin has been the mainstay of therapy, but its drug-drug interactions and frequent monitoring requirements have diverted attention toward DOACs",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:30:28"
    },
    {
      "id": 715,
      "intervention": {
        "name": "DOACs (direct oral anticoagulants)",
        "canonical_name": "DOACs (direct oral anticoagulants)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "thrombogenic nature of mechanical heart valves",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": "adults with mechanical heart valves",
        "adverse_effects": "negative outcomes in earlier trials",
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review.",
        "journal": "Cureus",
        "publication_date": "2025-08",
        "pubmed_id": "40932963",
        "doi": "10.7759/cureus.89736"
      },
      "supporting_quote": "However, the use of DOACs in this group of patients remains controversial, particularly after negative outcomes in earlier trials",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:30:28"
    },
    {
      "id": 713,
      "intervention": {
        "name": "systemic thrombolysis",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "high-risk pulmonary embolism (PE)",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": "adults with confirmed acute PE, high risk for mortality, and CDT available and technically feasible",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Thrombectomy in high-risk pulmonary embolism - device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial.",
        "journal": "Thrombosis research",
        "publication_date": "2025-08-07",
        "pubmed_id": "41027123",
        "doi": "10.1016/j.thromres.2025.109420"
      },
      "supporting_quote": "Randomized trials evaluating the safety and efficacy of CDT in high-risk patients are currently unavailable.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:29:29"
    },
    {
      "id": 712,
      "intervention": {
        "name": "colchicine",
        "canonical_name": "colchicine",
        "category": "medication",
        "details": "{\"dosage\": \"0.5 mg daily\", \"duration\": \"6 months\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "gout",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized double-blind placebo-controlled trial",
        "sample_size": 200,
        "duration": "6 months and further 6-month follow-up",
        "population": "Participants with gout fulfilling the American College of Rheumatology recommendations for starting urate-lowering therapy and with serum urate ≥0.36 mmol/L (6mg/dL)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-effectiveness of low dose colchicine prophylaxis when starting allopurinol using the \"start-low go-slow\" approach for gout: evidence from a non-inferiority randomised double-blind placebo-controlled trial.",
        "journal": "Arthritis care & research",
        "publication_date": "2025-08-18",
        "pubmed_id": "40827007",
        "doi": "10.1002/acr.25631"
      },
      "supporting_quote": "Participants were randomly allocated to either colchicine (0.5 mg daily) or placebo for six months with a further six-month follow-up.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:28:28"
    },
    {
      "id": 710,
      "intervention": {
        "name": "Nintendo Switch-based therapy",
        "canonical_name": "Nintendo Switch-based therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "ADHD",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 17,
        "duration": "8 weeks",
        "population": "children and adolescents aged 6-17 years with ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preliminary Research: Effectiveness of an Intervention Program Based on New Technologies for the Improvement of Cognitive and Motor Processes in Children and Adolescents with ADHD: A Randomized Controlled Trial.",
        "journal": "European journal of investigation in health, psychology and education",
        "publication_date": "2025-08-22",
        "pubmed_id": "41002748",
        "doi": "10.3390/ejihpe15090167"
      },
      "supporting_quote": "The experimental group received Nintendo Switch-based therapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:27:15"
    },
    {
      "id": 711,
      "intervention": {
        "name": "traditional board game therapy",
        "canonical_name": "Nintendo Switch-based therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "ADHD",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 16,
        "duration": "8 weeks",
        "population": "children and adolescents aged 6-17 years with ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Preliminary Research: Effectiveness of an Intervention Program Based on New Technologies for the Improvement of Cognitive and Motor Processes in Children and Adolescents with ADHD: A Randomized Controlled Trial.",
        "journal": "European journal of investigation in health, psychology and education",
        "publication_date": "2025-08-22",
        "pubmed_id": "41002748",
        "doi": "10.3390/ejihpe15090167"
      },
      "supporting_quote": "The control group received traditional board game therapy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:27:15"
    },
    {
      "id": 709,
      "intervention": {
        "name": "metformin",
        "canonical_name": "metformin",
        "category": "medication",
        "details": "{\"dosage\": \"up to 2000 mg per day\", \"frequency\": \"daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "autosomal dominant polycystic kidney disease (ADPKD)",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "phase III, multi-centre, randomized, placebo-controlled trial",
        "sample_size": 1174,
        "duration": "2 years",
        "population": "adults with ADPKD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.",
        "journal": "Trials",
        "publication_date": "2025-08-25",
        "pubmed_id": "40855441",
        "doi": "10.1186/s13063-025-09010-6"
      },
      "supporting_quote": "IMPEDE-PKD is a prospective, multicentre, international, double-blind, randomized controlled trial of metformin versus placebo in adults with ADPKD.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:26:23"
    },
    {
      "id": 707,
      "intervention": {
        "name": "resveratrol",
        "canonical_name": "resveratrol",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "metabolic syndrome",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "New Perspectives on the Use of Resveratrol in the Treatment of Metabolic and Estrogen-Dependent Conditions Through Hormonal Modulation and Anti-Inflammatory Effects.",
        "journal": "Current issues in molecular biology",
        "publication_date": "2025-08-27",
        "pubmed_id": "41020814",
        "doi": "10.3390/cimb47090692"
      },
      "supporting_quote": "Resveratrol has been studied in the treatment of inflammatory diseases like obesity, metabolic syndrome, and endometriosis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:25:45"
    },
    {
      "id": 708,
      "intervention": {
        "name": "resveratrol",
        "canonical_name": "resveratrol",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "endometriosis",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "New Perspectives on the Use of Resveratrol in the Treatment of Metabolic and Estrogen-Dependent Conditions Through Hormonal Modulation and Anti-Inflammatory Effects.",
        "journal": "Current issues in molecular biology",
        "publication_date": "2025-08-27",
        "pubmed_id": "41020814",
        "doi": "10.3390/cimb47090692"
      },
      "supporting_quote": "Resveratrol has been studied in the treatment of inflammatory diseases like obesity, metabolic syndrome, and endometriosis.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:25:45"
    },
    {
      "id": 706,
      "intervention": {
        "name": "SGLT2 inhibitors (SGLT2is)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "chronic kidney disease (CKD)",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nephroprotective Mechanisms of SGLT2i: Beyond the Glucose-Lowering Effect.",
        "journal": "Biomedicines",
        "publication_date": "2025-08-30",
        "pubmed_id": "41007686",
        "doi": "10.3390/biomedicines13092123"
      },
      "supporting_quote": "SGLT2is are drugs able to address both of these deleterious effects, preventing kidney damage from progressing.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:24:56"
    },
    {
      "id": 705,
      "intervention": {
        "name": "IKAP theory-based digital health management",
        "canonical_name": "IKAP theory-based digital health management",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "postmastectomy breast cancer survivors",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.95,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 200,
        "duration": "12 weeks",
        "population": "postmastectomy patients at Nantong University Affiliated Hospital from July to December 2024",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Digital Health Management via IKAP Theory Improves Upper Limb Function and Psychological Adaptation in Postmastectomy Patients: A Randomized Controlled Trial.",
        "journal": "Clinical breast cancer",
        "publication_date": "2025-08-31",
        "pubmed_id": "41033915",
        "doi": "10.1016/j.clbc.2025.08.017"
      },
      "supporting_quote": "IKAP theory-based digital health management significantly enhanced breast cancer survivors' functional recovery and psychological adaptation",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:24:27"
    },
    {
      "id": 704,
      "intervention": {
        "name": "biologics",
        "canonical_name": "biologics",
        "category": "medication",
        "details": "{}",
        "delivery_method": "inhalation"
      },
      "condition": {
        "name": "asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": "patients with severe asthma",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Current data on biologics: Evaluating clinical remission in asthma.",
        "journal": "The Journal of allergy and clinical immunology",
        "publication_date": "2025-09",
        "pubmed_id": "41033735",
        "doi": "10.1016/j.jaci.2025.05.034"
      },
      "supporting_quote": "Rates of clinical asthma remission in patients treated with a biologic have ranged from 19% to 43% in retrospective real-world studies and 13% to 35% in post hoc analyses of randomized controlled studies of biologics.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:23:11"
    },
    {
      "id": 703,
      "intervention": {
        "name": "zinc therapy",
        "canonical_name": "zinc therapy",
        "category": "supplement",
        "details": "{\"duration\": \"24 weeks\", \"dosage\": \"135 mg/day for 12 weeks, then 65 mg/day\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "mild cognitive impairment due to Alzheimer's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 48,
        "duration": "24 weeks",
        "population": "individuals with mild cognitive impairment due to Alzheimer's disease",
        "adverse_effects": "mild gastrointestinal symptoms in eight participants, two serious adverse events in placebo group",
        "cost_category": null
      },
      "paper": {
        "title": "Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial.",
        "journal": "Biomolecules",
        "publication_date": "2025-09-01",
        "pubmed_id": "41008575",
        "doi": "10.3390/biom15091268"
      },
      "supporting_quote": "Zinc therapy stabilized cognition in a pharmacodynamically defined MCI subgroup.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:22:39"
    },
    {
      "id": 702,
      "intervention": {
        "name": "Surgical left atrial appendage occlusion (SLAAO)",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "valvular heart disease without atrial fibrillation, CHA₂DS₂-VASc ≥2",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "multicentre, open-label, randomized, superiority trial",
        "sample_size": 2118,
        "duration": "3 years (April 2021 - June 2024)",
        "population": "non-AF patients with CHA₂DS₂-VASc ≥2 and indication for valve repair or replacement due to mitral or aortic valve lesions",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial.",
        "journal": "European heart journal",
        "publication_date": "2025-09-01",
        "pubmed_id": "40888584",
        "doi": "10.1093/eurheartj/ehaf674"
      },
      "supporting_quote": "The aim of this study was to evaluate whether prophylactic SLAAO reduces post-operative thrombo-embolic events in valvular surgery patients.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:22:01"
    },
    {
      "id": 701,
      "intervention": {
        "name": "electroacupuncture",
        "canonical_name": null,
        "category": "therapy",
        "details": "{\"frequency\": \"3 times per week\"}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "urinary incontinence after radical prostatectomy",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.82
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 110,
        "duration": "6 weeks",
        "population": "men with localized prostate cancer who underwent robot-assisted RP and experienced UI (defined as use of ≥2 pads per day) 4 to 6 weeks postoperatively",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Electroacupuncture in Patients With Early Urinary Incontinence After Radical Prostatectomy: A Randomized Clinical Trial.",
        "journal": "JAMA network open",
        "publication_date": "2025-09-02",
        "pubmed_id": "41026492",
        "doi": "10.1001/jamanetworkopen.2025.34491"
      },
      "supporting_quote": "The findings of this randomized clinical trial show that electroacupuncture significantly accelerated postprostatectomy UC recovery and may serve as a safe adjunct to standard care.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:21:18"
    },
    {
      "id": 699,
      "intervention": {
        "name": "physical intervention",
        "canonical_name": "exercise intervention",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "heart valve disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.85,
        "study_confidence": null
      },
      "study": {
        "type": "quasi-experimental study",
        "sample_size": null,
        "duration": null,
        "population": "adults diagnosed with heart valve disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nurse-led cardiac rehabilitation programme on physical capacity and mental health for heart valve patients: study protocol of a quasi-experimental study.",
        "journal": "BMJ open",
        "publication_date": "2025-09-02",
        "pubmed_id": "40897479",
        "doi": "10.1136/bmjopen-2024-096823"
      },
      "supporting_quote": "The recovery for valvular heart disease intervention, based on the broaden-and-build theory, will be guided one-on-one by a multidisciplinary team and will consist of two main components: physical intervention and psychological intervention.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:19:56"
    },
    {
      "id": 700,
      "intervention": {
        "name": "psychological intervention",
        "canonical_name": "Digital health (DH)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "heart valve disease",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.85,
        "study_confidence": null
      },
      "study": {
        "type": "quasi-experimental study",
        "sample_size": null,
        "duration": null,
        "population": "adults diagnosed with heart valve disease",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Nurse-led cardiac rehabilitation programme on physical capacity and mental health for heart valve patients: study protocol of a quasi-experimental study.",
        "journal": "BMJ open",
        "publication_date": "2025-09-02",
        "pubmed_id": "40897479",
        "doi": "10.1136/bmjopen-2024-096823"
      },
      "supporting_quote": "The recovery for valvular heart disease intervention, based on the broaden-and-build theory, will be guided one-on-one by a multidisciplinary team and will consist of two main components: physical intervention and psychological intervention.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:19:56"
    },
    {
      "id": 694,
      "intervention": {
        "name": "aerobic exercise",
        "canonical_name": "aerobic exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": "Early pulmonary rehabilitation-including aerobic and resistance exercise, inspiratory muscle training, and psychological support-demonstrated improvements in functional capacity, dyspnea, and quality of life",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:17:58"
    },
    {
      "id": 695,
      "intervention": {
        "name": "resistance training",
        "canonical_name": null,
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": "Early pulmonary rehabilitation-including aerobic and resistance exercise, inspiratory muscle training, and psychological support-demonstrated improvements in functional capacity, dyspnea, and quality of life",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:17:58"
    },
    {
      "id": 696,
      "intervention": {
        "name": "omega-3 fatty acids",
        "canonical_name": "omega-3 fatty acids",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": "Supplementation with omega-3 fatty acids and vitamin D may further mitigate thromboembolic risk via anti-inflammatory pathways",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:17:58"
    },
    {
      "id": 697,
      "intervention": {
        "name": "vitamin D",
        "canonical_name": "vitamin D",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": "Supplementation with omega-3 fatty acids and vitamin D may further mitigate thromboembolic risk via anti-inflammatory pathways",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:17:58"
    },
    {
      "id": 698,
      "intervention": {
        "name": "psychological support",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "pulmonary embolism",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Role of Early Rehabilitation in Treatment of Acute Pulmonary Embolism-A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-03",
        "pubmed_id": "40943985",
        "doi": "10.3390/jcm14176230"
      },
      "supporting_quote": "Early pulmonary rehabilitation-including aerobic and resistance exercise, inspiratory muscle training, and psychological support-demonstrated improvements in functional capacity, dyspnea, and quality of life",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:17:58"
    },
    {
      "id": 693,
      "intervention": {
        "name": "music therapy",
        "canonical_name": "music therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "neurological conditions",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.75
      },
      "study": {
        "type": "systematic review",
        "sample_size": 469,
        "duration": null,
        "population": "individuals with Parkinson's disease, Traumatic Brain Injury, stroke, Huntington's disease, and multiple sclerosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The Effect of Music Therapy on Psychological Outcomes for Neurological Conditions: A Systematic Review.",
        "journal": "Medicina (Kaunas, Lithuania)",
        "publication_date": "2025-09-05",
        "pubmed_id": "41011002",
        "doi": "10.3390/medicina61091611"
      },
      "supporting_quote": "MT was found to improve cognitive function in individuals with Parkinson's disease (PD) and Traumatic Brain Injury (TBI), but not in those with stroke or Huntington's disease (HD). In HD, improvements in cognitive function were noted in the comparator group. MT led to significant improvements in emotional well-being in stroke survivors, though not in mood.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:15:07"
    },
    {
      "id": 691,
      "intervention": {
        "name": "botulinum neurotoxin of type A (BoNT-A)",
        "canonical_name": "botulinum neurotoxin of type A (BoNT-A)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "Major Depressive Disorder (MDD)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.7
      },
      "study": {
        "type": "randomized controlled trials, observational studies, animal models, and mechanistic investigations",
        "sample_size": null,
        "duration": null,
        "population": "patients with MDD and Treatment-Resistant Depression (TRD)",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Botulinum Toxin: An Unconventional Tool for the Treatment of Depression?",
        "journal": "Brain sciences",
        "publication_date": "2025-09-10",
        "pubmed_id": "41008331",
        "doi": "10.3390/brainsci15090971"
      },
      "supporting_quote": "Some randomized and observational studies would indicate that glabellar BoNT-A injections might lead to significant reductions in depressive symptoms in patients with MDD and TRD.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:13:44"
    },
    {
      "id": 692,
      "intervention": {
        "name": "SSRIs (Selective Serotonin Reuptake Inhibitors)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Major Depressive Disorder (MDD)",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.85,
        "study_confidence": 0.6
      },
      "study": {
        "type": "comparative studies",
        "sample_size": null,
        "duration": null,
        "population": "patients with MDD and TRD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Botulinum Toxin: An Unconventional Tool for the Treatment of Depression?",
        "journal": "Brain sciences",
        "publication_date": "2025-09-10",
        "pubmed_id": "41008331",
        "doi": "10.3390/brainsci15090971"
      },
      "supporting_quote": "The few comparative studies suggest therapeutic efficacy comparable to that of SSRIs, with a more rapid onset.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:13:44"
    },
    {
      "id": 687,
      "intervention": {
        "name": "anti-TNF agents",
        "canonical_name": "monoclonal antibodies against Tumor Necrosis Factor-alpha (TNF-α)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "inflammatory bowel disease (IBD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and pharmacovigilance data analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with IBD",
        "adverse_effects": "increased reporting of heart failure (HF) and arrhythmias, particularly in patients with pre-existing cardiac disease",
        "cost_category": null
      },
      "paper": {
        "title": "The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-14",
        "pubmed_id": "41010679",
        "doi": "10.3390/jcm14186476"
      },
      "supporting_quote": "Anti-TNF agents, particularly infliximab, have been associated with increased reporting of HF and arrhythmias, particularly in patients with pre-existing cardiac disease.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:11:17"
    },
    {
      "id": 688,
      "intervention": {
        "name": "ustekinumab",
        "canonical_name": "monoclonal antibodies against Tumor Necrosis Factor-alpha (TNF-α)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "inflammatory bowel disease (IBD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and pharmacovigilance data analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with IBD",
        "adverse_effects": "consistently favorable CV safety profiles across trials and real-world studies",
        "cost_category": null
      },
      "paper": {
        "title": "The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-14",
        "pubmed_id": "41010679",
        "doi": "10.3390/jcm14186476"
      },
      "supporting_quote": "Ustekinumab and vedolizumab show consistently favorable CV safety profiles across trials and real-world studies.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:11:17"
    },
    {
      "id": 689,
      "intervention": {
        "name": "vedolizumab",
        "canonical_name": "monoclonal antibodies against Tumor Necrosis Factor-alpha (TNF-α)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "inflammatory bowel disease (IBD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and pharmacovigilance data analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with IBD",
        "adverse_effects": "consistently favorable CV safety profiles across trials and real-world studies",
        "cost_category": null
      },
      "paper": {
        "title": "The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-14",
        "pubmed_id": "41010679",
        "doi": "10.3390/jcm14186476"
      },
      "supporting_quote": "Ustekinumab and vedolizumab show consistently favorable CV safety profiles across trials and real-world studies.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:11:17"
    },
    {
      "id": 690,
      "intervention": {
        "name": "IL-23p19 inhibitors",
        "canonical_name": "GLP-1 receptor agonists (GLP-1 RAs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "inflammatory bowel disease (IBD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and pharmacovigilance data analysis",
        "sample_size": null,
        "duration": null,
        "population": "patients with IBD",
        "adverse_effects": "low CV event rates overall, although signals for atrial fibrillation have emerged with risankizumab",
        "cost_category": null
      },
      "paper": {
        "title": "The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-14",
        "pubmed_id": "41010679",
        "doi": "10.3390/jcm14186476"
      },
      "supporting_quote": "IL-23p19 inhibitors demonstrate low CV event rates overall, although signals for atrial fibrillation have emerged with risankizumab.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:11:17"
    },
    {
      "id": 683,
      "intervention": {
        "name": "Conventional surgery",
        "canonical_name": "Conventional surgery",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "non-melanoma skin cancer (NMSCs)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010389",
        "doi": "10.3390/life15091447"
      },
      "supporting_quote": "Conventional surgery is the most employed technique for the removal of non-melanoma skin cancer (NMSCs).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:07:38"
    },
    {
      "id": 684,
      "intervention": {
        "name": "Mohs Micrographic Surgery (MMS)",
        "canonical_name": "Conventional surgery",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "non-melanoma skin cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010389",
        "doi": "10.3390/life15091447"
      },
      "supporting_quote": "Mohs Micrographic Surgery (MMS) is the most precise surgical method for the treatment of non-melanoma skin cancer, allowing for 100% margin evaluation, being the gold-standard method for surgical treatment of non-melanoma skin cancer.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:07:38"
    },
    {
      "id": 685,
      "intervention": {
        "name": "Imiquimod",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "superficial basal cell carcinoma (sBCC)",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010389",
        "doi": "10.3390/life15091447"
      },
      "supporting_quote": "Imiquimod, a synthetic imidazoquinolinone amine, is a topical immune response modifier approved by the U.S. Food and Drug Administration (FDA) for the treatment of external anogenital warts, actinic keratosis (AK), and superficial basal cell carcinoma (sBCC).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:07:38"
    },
    {
      "id": 686,
      "intervention": {
        "name": "Cemiplimab",
        "canonical_name": null,
        "category": "emerging",
        "details": "{\"proposed_category\": \"immunotherapy\", \"category_rationale\": \"Cemiplimab is a human programmed cell death 1 (PD-1)-blocking antibody that triggers an immune response to cancer cells.\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "locally advanced and metastatic cutaneous squamous cell carcinoma (SCC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial (RCT)",
        "sample_size": null,
        "duration": null,
        "population": "patients with locally advanced and metastatic SCC",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010389",
        "doi": "10.3390/life15091447"
      },
      "supporting_quote": "Cemiplimab is a human programmed cell death 1 (PD-1)-blocking antibody that triggers a response to over 50% of patients with locally advanced and metastatic SCC.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:07:38"
    },
    {
      "id": 680,
      "intervention": {
        "name": "'Living with the Sun' (LWS) educational programme",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "sun protection behaviours",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 1.0
      },
      "study": {
        "type": "cluster randomized controlled trial",
        "sample_size": 1452,
        "duration": "6 months",
        "population": "pupils aged 7-11 in primary schools on the island of Réunion",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of sun risk prevention programmes in primary schools in a tropical region: The PRESOLRE trial.",
        "journal": "Journal of the European Academy of Dermatology and Venereology : JEADV",
        "publication_date": "2025-09-17",
        "pubmed_id": "40960198",
        "doi": "10.1111/jdv.70049"
      },
      "supporting_quote": "The main analysis, based on a linear mixed model with random intercept, involved a comparison of the percentage of correct answers to the knowledge questionnaire administered at the end of the school year (at 6 months from baseline), after adjustment for the average level of knowledge in the class at the start of the school year.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:03:59"
    },
    {
      "id": 681,
      "intervention": {
        "name": "Peer Intervention (PI)",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "sun protection behaviours",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 1.0
      },
      "study": {
        "type": "cluster randomized controlled trial",
        "sample_size": 1452,
        "duration": "6 months",
        "population": "pupils aged 7-11 in primary schools on the island of Réunion",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of sun risk prevention programmes in primary schools in a tropical region: The PRESOLRE trial.",
        "journal": "Journal of the European Academy of Dermatology and Venereology : JEADV",
        "publication_date": "2025-09-17",
        "pubmed_id": "40960198",
        "doi": "10.1111/jdv.70049"
      },
      "supporting_quote": "The main analysis, based on a linear mixed model with random intercept, involved a comparison of the percentage of correct answers to the knowledge questionnaire administered at the end of the school year (at 6 months from baseline), after adjustment for the average level of knowledge in the class at the start of the school year.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:03:59"
    },
    {
      "id": 682,
      "intervention": {
        "name": "photoprotection equipment delivery",
        "canonical_name": null,
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "sun protection behaviours",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 1.0
      },
      "study": {
        "type": "cluster randomized controlled trial",
        "sample_size": 1452,
        "duration": "6 months",
        "population": "pupils aged 7-11 in primary schools on the island of Réunion",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effectiveness of sun risk prevention programmes in primary schools in a tropical region: The PRESOLRE trial.",
        "journal": "Journal of the European Academy of Dermatology and Venereology : JEADV",
        "publication_date": "2025-09-17",
        "pubmed_id": "40960198",
        "doi": "10.1111/jdv.70049"
      },
      "supporting_quote": "The main analysis, based on a linear mixed model with random intercept, involved a comparison of the percentage of correct answers to the knowledge questionnaire administered at the end of the school year (at 6 months from baseline), after adjustment for the average level of knowledge in the class at the start of the school year.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 19:03:59"
    },
    {
      "id": 678,
      "intervention": {
        "name": "Eggshell membrane (ESM)",
        "canonical_name": "Eggshell membrane (ESM)",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "inflammatory bowel disease (IBD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.8,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "double-blind, randomized controlled trial",
        "sample_size": null,
        "duration": "2 months",
        "population": "mice and healthy human subjects",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Pharmacokinetic Profiling Using",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-18",
        "pubmed_id": "41009682",
        "doi": "10.3390/ijms26189102"
      },
      "supporting_quote": "Oral ESM significantly alleviated body weight loss, diarrhea, and hematochezia in a DSS-induced murine model of IBD",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:59:28"
    },
    {
      "id": 679,
      "intervention": {
        "name": "dextran sulfate sodium (DSS)-induced diet",
        "canonical_name": "dextran sulfate sodium (DSS)-induced diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "inflammatory bowel disease (IBD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.8,
        "extraction_confidence": 1.0,
        "study_confidence": 0.95
      },
      "study": {
        "type": "double-blind, randomized controlled trial",
        "sample_size": null,
        "duration": "2 months",
        "population": "mice and healthy human subjects",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Pharmacokinetic Profiling Using",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-18",
        "pubmed_id": "41009682",
        "doi": "10.3390/ijms26189102"
      },
      "supporting_quote": "The therapeutic potential of ESM was further examined in a 2.0% dextran sulfate sodium (DSS)-induced murine model of IBD",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:59:28"
    },
    {
      "id": 677,
      "intervention": {
        "name": "auricular acupressure",
        "canonical_name": "auricular acupressure",
        "category": "therapy",
        "details": "{\"duration\": \"six weeks\", \"frequency\": \"three times daily\"}",
        "delivery_method": "topical"
      },
      "condition": {
        "name": "diabetic peripheral neuropathy",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.95,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "double-blind randomized clinical trial",
        "sample_size": 41,
        "duration": "six weeks",
        "population": "patients with type 2 diabetes",
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Effect of auricular acupressure on neuropathy symptoms and quality of life in patients with type 2 diabetes: A double-blind, randomized clinical trial.",
        "journal": "Explore (New York, N.Y.)",
        "publication_date": "2025-09-19",
        "pubmed_id": "41033250",
        "doi": "10.1016/j.explore.2025.103264"
      },
      "supporting_quote": "Auriculotherapy appears to be a cost-effective, non-invasive, and practical approach for reducing neuropathic symptoms and improving QoL in individuals with type 2 diabetes.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:57:31"
    },
    {
      "id": 676,
      "intervention": {
        "name": "vasopressor and/or inotropic support",
        "canonical_name": "vasopressor and/or inotropic support",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "sepsis, septic shock",
        "canonical_name": null,
        "category": "toxicological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "prospective randomized controlled trial",
        "sample_size": 200,
        "duration": null,
        "population": "patients with sepsis and septic shock",
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Peripheral Perfusion vs Standard Management in Sepsis/Septic Shock: A Prospective Randomized ED Study.",
        "journal": "The American journal of emergency medicine",
        "publication_date": "2025-09-20",
        "pubmed_id": "41033063",
        "doi": "10.1016/j.ajem.2025.09.024"
      },
      "supporting_quote": "If adequate perfusion was not achieved with fluid resuscitation, vasopressor and/or inotropic support was used without regard to the MAP target.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:56:25"
    },
    {
      "id": 675,
      "intervention": {
        "name": "Sincrolab Adults program",
        "canonical_name": null,
        "category": "emerging",
        "details": "{\"proposed_category\": \"digital cognitive stimulation\", \"category_rationale\": \"The intervention is an AI-based cognitive stimulation program, which does not fit into existing categories.\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "ADHD",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 104,
        "duration": "12 weeks",
        "population": "adults diagnosed with ADHD",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Randomized Controlled Trial of an Intelligent Cognitive Stimulation Program for Adults with ADHD: Study Protocol.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-20",
        "pubmed_id": "41010833",
        "doi": "10.3390/jcm14186629"
      },
      "supporting_quote": "This study describes the protocol for a randomized controlled trial (RCT) evaluating Sincrolab Adults, an AI-based cognitive stimulation program for adults with ADHD.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:55:21"
    },
    {
      "id": 674,
      "intervention": {
        "name": "physical activity intervention",
        "canonical_name": "aerobic exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "HIV",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 302,
        "duration": "up to 12 months post-intervention",
        "population": "African American men living with HIV, aged 40 years or older",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Assessing Mediation and Moderation of an Efficacious Physical Activity Intervention for African American Men Living with HIV: The Influence of Self-Efficacy in Behavior Change.",
        "journal": "AIDS and behavior",
        "publication_date": "2025-09-22",
        "pubmed_id": "40976796",
        "doi": "10.1007/s10461-025-04871-z"
      },
      "supporting_quote": "This research evaluates the mediation and moderation of an efficacious physical activity (PA) intervention designed for African American men living with human immunodeficiency virus (HIV)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:54:13"
    },
    {
      "id": 672,
      "intervention": {
        "name": "rituximab",
        "canonical_name": "complement inhibitors",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "recurrent glomerular disease (GN)",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-22",
        "pubmed_id": "41010890",
        "doi": "10.3390/jcm14186686"
      },
      "supporting_quote": "Treatment strategies are evolving towards targeted therapies, such as rituximab for antibody-mediated GN",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:53:12"
    },
    {
      "id": 673,
      "intervention": {
        "name": "complement inhibitors",
        "canonical_name": "GLP-1 receptor agonists (GLP-1 RAs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "C3 glomerulopathy (C3G)",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-09-22",
        "pubmed_id": "41010890",
        "doi": "10.3390/jcm14186686"
      },
      "supporting_quote": "Treatment strategies are evolving towards targeted therapies, such as complement inhibitors for C3G",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:53:12"
    },
    {
      "id": 670,
      "intervention": {
        "name": "Retrograde Intrarenal Ureteral Lithotripsy (RIRS)",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "residual fragments after retrograde intrarenal surgery",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "prospective study",
        "sample_size": 136,
        "duration": "20 days",
        "population": "patients with residual fragments determined by X-ray or CT after RIRS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Clinical study of the postural drainage lithotripsy system for the treatment of residual fragments after retrograde intrarenal surgery.",
        "journal": "World journal of urology",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999120",
        "doi": "10.1007/s00345-025-05956-z"
      },
      "supporting_quote": "This prospective study was carried out from 2022-02-16 to 2025-02-16 and included patients attending our hospital to collect clinical data, with surgery performed by the same attending surgeon.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:42:17"
    },
    {
      "id": 671,
      "intervention": {
        "name": "Posterior Drainage Lithotripsy System (PDLS)",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "residual fragments after retrograde intrarenal surgery",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.8
      },
      "study": {
        "type": "prospective study",
        "sample_size": 136,
        "duration": "20 days",
        "population": "patients with residual fragments determined by X-ray or CT after RIRS",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Clinical study of the postural drainage lithotripsy system for the treatment of residual fragments after retrograde intrarenal surgery.",
        "journal": "World journal of urology",
        "publication_date": "2025-09-25",
        "pubmed_id": "40999120",
        "doi": "10.1007/s00345-025-05956-z"
      },
      "supporting_quote": "Patients in the treatment group were treated with preoperative water to hold urine and PDLS for 10 min, adverse effects and stone expulsion were recorded",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:42:17"
    },
    {
      "id": 667,
      "intervention": {
        "name": "cognitive-behavioral therapy (CBT)",
        "canonical_name": "music therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "depression and anxiety",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 720,
        "duration": "3 months",
        "population": "UK university students aged over 16 with elevated symptoms of depression and/or anxiety",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomized controlled trial of Internet-delivered guided and unguided cognitive behaviour therapy for treating depression and anxiety in UK university students: study protocol for the Nurture-U Internet CBT trial.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013730",
        "doi": "10.1186/s13063-025-09023-1"
      },
      "supporting_quote": "Internet-delivered cognitive-behavioural therapy (iCBT) is increasingly offered to UK university students in guided or unguided formats.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:40:01"
    },
    {
      "id": 668,
      "intervention": {
        "name": "guided transdiagnostic iCBT",
        "canonical_name": "music therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "depression and anxiety",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 720,
        "duration": "3 months",
        "population": "UK university students aged over 16 with elevated symptoms of depression and/or anxiety",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomized controlled trial of Internet-delivered guided and unguided cognitive behaviour therapy for treating depression and anxiety in UK university students: study protocol for the Nurture-U Internet CBT trial.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013730",
        "doi": "10.1186/s13063-025-09023-1"
      },
      "supporting_quote": "Eligible participants will be randomized to guided transdiagnostic iCBT supported by a psychological wellbeing practitioner or to the same transdiagnostic iCBT content as unguided self-help.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:40:01"
    },
    {
      "id": 669,
      "intervention": {
        "name": "unguided transdiagnostic iCBT",
        "canonical_name": "music therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "depression and anxiety",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 720,
        "duration": "3 months",
        "population": "UK university students aged over 16 with elevated symptoms of depression and/or anxiety",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomized controlled trial of Internet-delivered guided and unguided cognitive behaviour therapy for treating depression and anxiety in UK university students: study protocol for the Nurture-U Internet CBT trial.",
        "journal": "Trials",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013730",
        "doi": "10.1186/s13063-025-09023-1"
      },
      "supporting_quote": "Eligible participants will be randomized to guided transdiagnostic iCBT supported by a psychological wellbeing practitioner or to the same transdiagnostic iCBT content as unguided self-help.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:40:01"
    },
    {
      "id": 666,
      "intervention": {
        "name": "indole-3-acetic acid (IAA)",
        "canonical_name": "resveratrol",
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "pneumonia",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe"
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "translational analyses in a large general-population cohort",
        "sample_size": 13464,
        "duration": null,
        "population": "general population",
        "adverse_effects": "aggravates pulmonary damage, increases mortality risk",
        "cost_category": null
      },
      "paper": {
        "title": "Effect of the gut microbiota-derived tryptophan metabolite indole-3-acetic acid in pneumonia.",
        "journal": "Nature communications",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022731",
        "doi": "10.1038/s41467-025-63611-y"
      },
      "supporting_quote": "In the population-based cohort, baseline IAA is associated with a higher risk of future hospital admission for pneumonia. In patients with severe CAP higher levels of IAA are associated with increased mortality.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:26:36"
    },
    {
      "id": 664,
      "intervention": {
        "name": "slow movement training with tonic force generation",
        "canonical_name": "slow movement training with tonic force generation",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "lung cancer",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "prospective, single-center study",
        "sample_size": 17,
        "duration": "4 weeks",
        "population": "patients with suspected advanced lung cancer",
        "adverse_effects": "no adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "Combined effects of slow movement training with tonic force generation and aerobic exercise prior to cancer therapy in patients with lung cancer (START-lung): a pilot feasibility trial.",
        "journal": "BMC cancer",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023950",
        "doi": "10.1186/s12885-025-14728-2"
      },
      "supporting_quote": "This study aimed to evaluate the feasibility of a structured exercise program during this period.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:25:30"
    },
    {
      "id": 665,
      "intervention": {
        "name": "aerobic exercise",
        "canonical_name": "aerobic exercise",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "lung cancer",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "prospective, single-center study",
        "sample_size": 17,
        "duration": "4 weeks",
        "population": "patients with suspected advanced lung cancer",
        "adverse_effects": "no adverse events reported",
        "cost_category": null
      },
      "paper": {
        "title": "Combined effects of slow movement training with tonic force generation and aerobic exercise prior to cancer therapy in patients with lung cancer (START-lung): a pilot feasibility trial.",
        "journal": "BMC cancer",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023950",
        "doi": "10.1186/s12885-025-14728-2"
      },
      "supporting_quote": "This study aimed to evaluate the feasibility of a structured exercise program during this period.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:25:30"
    },
    {
      "id": 663,
      "intervention": {
        "name": "progressive muscle relaxation exercises",
        "canonical_name": "progressive muscle relaxation exercises",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "anxiety before ECT",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.75,
        "extraction_confidence": 1.0,
        "study_confidence": 0.8
      },
      "study": {
        "type": "quasi-experimental study",
        "sample_size": 30,
        "duration": "May 29 - October 29, 2020",
        "population": "in-patients with bipolar disorder and depression",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Progressive muscle relaxation to reduce anxiety before electroconvulsive therapy (ECT).",
        "journal": "BMC nursing",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023665",
        "doi": "10.1186/s12912-025-03874-4"
      },
      "supporting_quote": "The mean VAS-A score decreased from 4.93 ± 1.88 before PMR to 2.83 ± 1.76 after PMR",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:22:51"
    },
    {
      "id": 661,
      "intervention": {
        "name": "suprapatellar intramedullary nailing",
        "canonical_name": "infrapatellar intramedullary nailing",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "extra-articular tibial fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with extra-articular tibial fractures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of suprapatellar and infrapatellar intramedullary nailing for tibial fractures: a systematic review and meta-analysis of randomized controlled trials.",
        "journal": "BMC musculoskeletal disorders",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034881",
        "doi": "10.1186/s12891-025-09162-1"
      },
      "supporting_quote": "The SP nailing approach is a safe and effective alternative to the traditional IP approach",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:19:19"
    },
    {
      "id": 662,
      "intervention": {
        "name": "infrapatellar intramedullary nailing",
        "canonical_name": "infrapatellar intramedullary nailing",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "extra-articular tibial fractures",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": 0.95,
        "study_confidence": 0.85
      },
      "study": {
        "type": "systematic review and meta-analysis of randomized controlled trials",
        "sample_size": null,
        "duration": null,
        "population": "patients with extra-articular tibial fractures",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of suprapatellar and infrapatellar intramedullary nailing for tibial fractures: a systematic review and meta-analysis of randomized controlled trials.",
        "journal": "BMC musculoskeletal disorders",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034881",
        "doi": "10.1186/s12891-025-09162-1"
      },
      "supporting_quote": "The SP nailing approach is a safe and effective alternative to the traditional IP approach",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:19:19"
    },
    {
      "id": 659,
      "intervention": {
        "name": "minodronate",
        "canonical_name": "alendronate",
        "category": "medication",
        "details": "{\"dosage\": \"50 mg/tablet once every four weeks\", \"frequency\": \"monthly\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "osteoporosis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 330,
        "duration": "48 weeks",
        "population": "Chinese postmenopausal women with osteoporosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A phase III clinical trial of monthly minodronate in the treatment of Chinese postmenopausal women with osteoporosis.",
        "journal": "Acta pharmacologica Sinica",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034401",
        "doi": "10.1038/s41401-025-01661-0"
      },
      "supporting_quote": "The monthly minodronate did not cause new safety risks compared with alendronate.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:11:22"
    },
    {
      "id": 660,
      "intervention": {
        "name": "alendronate",
        "canonical_name": "alendronate",
        "category": "medication",
        "details": "{\"dosage\": \"70 mg/tablet once weekly\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "osteoporosis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.9,
        "extraction_confidence": 1.0,
        "study_confidence": 0.85
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 330,
        "duration": "48 weeks",
        "population": "Chinese postmenopausal women with osteoporosis",
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A phase III clinical trial of monthly minodronate in the treatment of Chinese postmenopausal women with osteoporosis.",
        "journal": "Acta pharmacologica Sinica",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034401",
        "doi": "10.1038/s41401-025-01661-0"
      },
      "supporting_quote": "The bone mineral density (BMD) of the lumbar spine, femoral neck and total hip were measured using dual-energy X-ray absorptiometry (DXA)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 18:11:22"
    },
    {
      "id": 657,
      "intervention": {
        "name": "medication reminders",
        "canonical_name": "antiretroviral regimens",
        "category": "lifestyle",
        "details": "{\"duration\": \"6 months\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "drug-resistant epilepsy",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 100,
        "duration": "6 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Enhancing medication adherence in drug-resistant epilepsy using \"Epilepto\": A pilot randomized controlled trial (EMPOWER-E).",
        "journal": "Epileptic disorders : international epilepsy journal with videotape",
        "publication_date": "2025-09-23",
        "pubmed_id": "40985745",
        "doi": "10.1002/epd2.70103"
      },
      "supporting_quote": "The use of medication reminders appeared to be a feasible intervention for children with drug-resistant epilepsy to improve medication adherence.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:53:36"
    },
    {
      "id": 656,
      "intervention": {
        "name": "antiretroviral regimens",
        "canonical_name": "Rifampin-based regimen (4 months daily)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "HIV-1 infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Emergent Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.",
        "journal": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
        "publication_date": "2025-09-23",
        "pubmed_id": "40985680",
        "doi": "10.1093/cid/ciaf471"
      },
      "supporting_quote": "The occurrence of virological failure in a subset of individuals is an inevitable aspect of antiretroviral treatment",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:52:54"
    },
    {
      "id": 655,
      "intervention": {
        "name": "liver fibrosis blood tests",
        "canonical_name": null,
        "category": "test",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "cirrhosis, hepatocellular carcinoma surveillance",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 2470,
        "duration": "1 year",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The IC3 trial: protocol for a multicentre individually randomised controlled trial to compare a cirrhosis detection and hepatocellular carcinoma surveillance pathway vs usual care in Australian general practice for 45-75 years old with risk factors for chronic liver disease.",
        "journal": "Trials",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993832",
        "doi": "10.1186/s13063-025-09037-9"
      },
      "supporting_quote": "The cirrhosis detection intervention consists of liver fibrosis blood tests (comprising the Fibrosis-4 Index and Hepascore) and a liver stiffness measurement conducted by FibroScan in those with elevated liver fibrosis blood markers.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:51:29"
    },
    {
      "id": 653,
      "intervention": {
        "name": "rotator cuff repair surgery",
        "canonical_name": "bone marrow aspirate concentrate (BMAC) injection",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "chronic rat rotator cuff tear",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Optimal timing of bone marrow aspiration concentrate injection for tendon-bone healing in a chronic rat rotator cuff tear model.",
        "journal": "Journal of orthopaedic surgery and research",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993702",
        "doi": "10.1186/s13018-025-06253-6"
      },
      "supporting_quote": "Supraspinatus tendon tears were induced at the greater tuberosity in 152 Wistar rats. Three weeks after the tear induction, the rats following RC repair surgery were then randomly divided into four groups based on the timing of BMAC injection",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:50:41"
    },
    {
      "id": 654,
      "intervention": {
        "name": "bone marrow aspirate concentrate (BMAC) injection",
        "canonical_name": "bone marrow aspirate concentrate (BMAC) injection",
        "category": "emerging",
        "details": "{\"proposed_category\": \"surgery\", \"category_rationale\": \"It is a surgical intervention used to enhance healing.\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "chronic rat rotator cuff tear",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Optimal timing of bone marrow aspiration concentrate injection for tendon-bone healing in a chronic rat rotator cuff tear model.",
        "journal": "Journal of orthopaedic surgery and research",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993702",
        "doi": "10.1186/s13018-025-06253-6"
      },
      "supporting_quote": "The Bone marrow aspirate concentrate (BMAC) injection is a beneficial therapy for bone-tendon interface (BTI) regeneration following rotator cuff (RC) repair.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:50:41"
    },
    {
      "id": 650,
      "intervention": {
        "name": "online Pilates classes",
        "canonical_name": null,
        "category": "exercise",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "lupus",
        "canonical_name": null,
        "category": "immunological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 124,
        "duration": "8-12 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trial.",
        "journal": "Rheumatology international",
        "publication_date": "2025-09-24",
        "pubmed_id": "40991063",
        "doi": "10.1007/s00296-025-05959-4"
      },
      "supporting_quote": "Lupus patients (N = 124) were randomised to a control arm or one of three interventions delivered remotely over 8-12 weeks: (1) listening support (The Wren project), (2) online Pilates classes, and (3) a text message and video support programme.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:48:35"
    },
    {
      "id": 651,
      "intervention": {
        "name": "listening support (The Wren project)",
        "canonical_name": "listening support (The Wren project)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "lupus",
        "canonical_name": null,
        "category": "immunological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 124,
        "duration": "8-12 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trial.",
        "journal": "Rheumatology international",
        "publication_date": "2025-09-24",
        "pubmed_id": "40991063",
        "doi": "10.1007/s00296-025-05959-4"
      },
      "supporting_quote": "Lupus patients (N = 124) were randomised to a control arm or one of three interventions delivered remotely over 8-12 weeks: (1) listening support (The Wren project), (2) online Pilates classes, and (3) a text message and video support programme.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:48:35"
    },
    {
      "id": 652,
      "intervention": {
        "name": "text message and video support programme",
        "canonical_name": "listening support (The Wren project)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "lupus",
        "canonical_name": null,
        "category": "immunological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 124,
        "duration": "8-12 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trial.",
        "journal": "Rheumatology international",
        "publication_date": "2025-09-24",
        "pubmed_id": "40991063",
        "doi": "10.1007/s00296-025-05959-4"
      },
      "supporting_quote": "Lupus patients (N = 124) were randomised to a control arm or one of three interventions delivered remotely over 8-12 weeks: (1) listening support (The Wren project), (2) online Pilates classes, and (3) a text message and video support programme.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:48:35"
    },
    {
      "id": 649,
      "intervention": {
        "name": "self-compassion based writing",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "systemic lupus erythematosus",
        "canonical_name": null,
        "category": "immunological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 86,
        "duration": "2022-2023",
        "population": null,
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Effect of writing based on self-compassion on body image and psychological distress among women with systemic lupus erythematosus: a randomized clinical trial.",
        "journal": "BMC rheumatology",
        "publication_date": "2025-09-24",
        "pubmed_id": "40993830",
        "doi": "10.1186/s41927-025-00565-0"
      },
      "supporting_quote": "Participants in the IG were instructed to engage in SC-based writing that emphasized the concepts of common humanity, mindfulness, and self-kindness.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:46:34"
    },
    {
      "id": 645,
      "intervention": {
        "name": "all-trans retinoic acid (ATRA)",
        "canonical_name": "all-trans retinoic acid (ATRA)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "acute promyelocytic leukemia (APL)",
        "canonical_name": null,
        "category": "hematological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Curative strategies for high-risk acute promyelocytic leukemia.",
        "journal": "Current opinion in oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41029961",
        "doi": "10.1097/CCO.0000000000001171"
      },
      "supporting_quote": "Patients with acute promyelocytic leukemia (APL) who present with leukocytosis are considered high-risk due to lower relapse-free survival when treated with all-trans retinoic acid (ATRA)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:43:27"
    },
    {
      "id": 646,
      "intervention": {
        "name": "arsenic trioxide (ATO)",
        "canonical_name": "all-trans retinoic acid (ATRA)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "acute promyelocytic leukemia (APL)",
        "canonical_name": null,
        "category": "hematological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Curative strategies for high-risk acute promyelocytic leukemia.",
        "journal": "Current opinion in oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41029961",
        "doi": "10.1097/CCO.0000000000001171"
      },
      "supporting_quote": "The discovery and incorporation of arsenic trioxide (ATO) in therapeutic regimens for high-risk patients have led to improved survival",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:43:27"
    },
    {
      "id": 647,
      "intervention": {
        "name": "idarubicin (IDA)",
        "canonical_name": "all-trans retinoic acid (ATRA)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "acute promyelocytic leukemia (APL)",
        "canonical_name": null,
        "category": "hematological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Curative strategies for high-risk acute promyelocytic leukemia.",
        "journal": "Current opinion in oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41029961",
        "doi": "10.1097/CCO.0000000000001171"
      },
      "supporting_quote": "ATRA-ATO combined with idarubicin (IDA) or gemtuzumab ozogamicin are highly effective compared to ATRA-IDA-based chemotherapy in clinical trials and real-world studies",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:43:27"
    },
    {
      "id": 648,
      "intervention": {
        "name": "gemtuzumab ozogamicin",
        "canonical_name": "all-trans retinoic acid (ATRA)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "acute promyelocytic leukemia (APL)",
        "canonical_name": null,
        "category": "hematological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Curative strategies for high-risk acute promyelocytic leukemia.",
        "journal": "Current opinion in oncology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41029961",
        "doi": "10.1097/CCO.0000000000001171"
      },
      "supporting_quote": "ATRA-ATO combined with idarubicin (IDA) or gemtuzumab ozogamicin are highly effective compared to ATRA-IDA-based chemotherapy in clinical trials and real-world studies",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:43:27"
    },
    {
      "id": 642,
      "intervention": {
        "name": "percutaneous nephrolithotomy (PCNL)",
        "canonical_name": "human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "urolithiasis in chronic kidney disease patients",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review",
        "sample_size": 6,
        "duration": null,
        "population": null,
        "adverse_effects": "bleeding, infection, acute kidney injury",
        "cost_category": null
      },
      "paper": {
        "title": "Safety, feasibility, and efficacy of surgical intervention for Urolithiasis in patients with chronic kidney disease: A systematic review.",
        "journal": "World journal of nephrology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41024960",
        "doi": "10.5527/wjn.v14.i3.105288"
      },
      "supporting_quote": "Perioperative and postoperative complications varied across studies, with bleeding, infection, and acute kidney injury being the most common.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:39:24"
    },
    {
      "id": 643,
      "intervention": {
        "name": "ureteroscopy (URS)",
        "canonical_name": "coronary artery bypass grafting (CABG)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "urolithiasis in chronic kidney disease patients",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review",
        "sample_size": 6,
        "duration": null,
        "population": null,
        "adverse_effects": "bleeding, infection, acute kidney injury",
        "cost_category": null
      },
      "paper": {
        "title": "Safety, feasibility, and efficacy of surgical intervention for Urolithiasis in patients with chronic kidney disease: A systematic review.",
        "journal": "World journal of nephrology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41024960",
        "doi": "10.5527/wjn.v14.i3.105288"
      },
      "supporting_quote": "Perioperative and postoperative complications varied across studies, with bleeding, infection, and acute kidney injury being the most common.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:39:24"
    },
    {
      "id": 644,
      "intervention": {
        "name": "extracorporeal shock wave lithotripsy (ESWL)",
        "canonical_name": "Extracorporeal shock wave lithotripsy (ESWL)",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "urolithiasis in chronic kidney disease patients",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review",
        "sample_size": 6,
        "duration": null,
        "population": null,
        "adverse_effects": "bleeding, infection, acute kidney injury",
        "cost_category": null
      },
      "paper": {
        "title": "Safety, feasibility, and efficacy of surgical intervention for Urolithiasis in patients with chronic kidney disease: A systematic review.",
        "journal": "World journal of nephrology",
        "publication_date": "2025-09-25",
        "pubmed_id": "41024960",
        "doi": "10.5527/wjn.v14.i3.105288"
      },
      "supporting_quote": "Perioperative and postoperative complications varied across studies, with bleeding, infection, and acute kidney injury being the most common.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:39:24"
    },
    {
      "id": 639,
      "intervention": {
        "name": "mask use",
        "canonical_name": "mask use",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "tuberculosis transmission",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "pilot cluster-randomized controlled trial",
        "sample_size": 329,
        "duration": "between October 2021 and December 2023",
        "population": null,
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial.",
        "journal": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
        "publication_date": "2025-09-26",
        "pubmed_id": "41003685",
        "doi": "10.1093/cid/ciaf526"
      },
      "supporting_quote": "The intervention included education, mask use, household ventilation, and nightly separation of tuberculosis patients",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:37:37"
    },
    {
      "id": 640,
      "intervention": {
        "name": "household ventilation",
        "canonical_name": "household ventilation",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "tuberculosis transmission",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "pilot cluster-randomized controlled trial",
        "sample_size": 329,
        "duration": "between October 2021 and December 2023",
        "population": null,
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial.",
        "journal": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
        "publication_date": "2025-09-26",
        "pubmed_id": "41003685",
        "doi": "10.1093/cid/ciaf526"
      },
      "supporting_quote": "The intervention included education, mask use, household ventilation, and nightly separation of tuberculosis patients",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:37:37"
    },
    {
      "id": 641,
      "intervention": {
        "name": "nightly separation of tuberculosis patients",
        "canonical_name": "nightly separation of tuberculosis patients",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "tuberculosis transmission",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "pilot cluster-randomized controlled trial",
        "sample_size": 329,
        "duration": "between October 2021 and December 2023",
        "population": null,
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial.",
        "journal": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
        "publication_date": "2025-09-26",
        "pubmed_id": "41003685",
        "doi": "10.1093/cid/ciaf526"
      },
      "supporting_quote": "The intervention included education, mask use, household ventilation, and nightly separation of tuberculosis patients",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:37:37"
    },
    {
      "id": 638,
      "intervention": {
        "name": "gut microbiota-targeted therapy (GMTT)",
        "canonical_name": null,
        "category": "supplement",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "psoriasis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.52,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 409,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of gut microbiota-targeted therapy in patients with psoriasis: a systematic review and meta-analysis of randomized controlled trials.",
        "journal": "BMC immunology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41013260",
        "doi": "10.1186/s12865-025-00747-y"
      },
      "supporting_quote": "GMTT was associated with a modest reduction in PASI scores",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:35:52"
    },
    {
      "id": 637,
      "intervention": {
        "name": "prucalopride",
        "canonical_name": "prucalopride",
        "category": "medication",
        "details": "{\"dosage\": \"2 mg\", \"frequency\": \"once daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "chronic constipation in Parkinson's disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.85,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 57,
        "duration": "8 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Role of Prucalopride in the Treatment of Chronic Constipation in Parkinson's Disease: A Randomized Controlled Trial.",
        "journal": "The American journal of gastroenterology",
        "publication_date": "2025-09-26",
        "pubmed_id": "41002195",
        "doi": "10.14309/ajg.0000000000003771"
      },
      "supporting_quote": "Prucalopride was safe, well-tolerated, and more effective than placebo in increasing bowel movement frequency in PD patients with chronic constipation",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:35:10"
    },
    {
      "id": 636,
      "intervention": {
        "name": "hypoxic conditioning",
        "canonical_name": "intermittent theta burst stimulation (iTBS)",
        "category": "emerging",
        "details": "{\"proposed_category\": \"hypoxia protocols\", \"category_rationale\": \"Hypoxic conditioning is a novel intervention not fitting existing categories\"}",
        "delivery_method": "inhalation"
      },
      "condition": {
        "name": "Parkinson's disease",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled multiple N-of-1 trials",
        "sample_size": 20,
        "duration": "varied (multiple sessions)",
        "population": null,
        "adverse_effects": "95 adverse events occurred, including one moderate and three serious events. Adverse events were not dose-dependent.",
        "cost_category": null
      },
      "paper": {
        "title": "Hypoxic conditioning in Parkinson's disease: randomized controlled multiple N-of-1 trials.",
        "journal": "Nature communications",
        "publication_date": "2025-09-26",
        "pubmed_id": "41006236",
        "doi": "10.1038/s41467-025-63324-2"
      },
      "supporting_quote": "This study (NCT05214287) investigated the safety, feasibility, short-term symptomatic and downstream effects of hypoxic conditioning in individuals with PD.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:33:42"
    },
    {
      "id": 634,
      "intervention": {
        "name": "whole blood transfusion",
        "canonical_name": "whole blood transfusion",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "traumatic injuries",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "meta-analysis",
        "sample_size": 59213,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Evaluating the safety outcomes of whole blood versus component transfusion in trauma: A meta-analysis of 59,213 patients.",
        "journal": "Thrombosis research",
        "publication_date": "2025-09-27",
        "pubmed_id": "41027124",
        "doi": "10.1016/j.thromres.2025.109495"
      },
      "supporting_quote": "A random-effects meta-analysis of 14 studies showed a significant reduction in 24-h all-cause mortality with whole blood transfusion compared to component therapy (OR: 0.67, 95 % CI [0.50, 0.88]; p = 0.005)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:32:51"
    },
    {
      "id": 635,
      "intervention": {
        "name": "component therapy",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "traumatic injuries",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "meta-analysis",
        "sample_size": 59213,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Evaluating the safety outcomes of whole blood versus component transfusion in trauma: A meta-analysis of 59,213 patients.",
        "journal": "Thrombosis research",
        "publication_date": "2025-09-27",
        "pubmed_id": "41027124",
        "doi": "10.1016/j.thromres.2025.109495"
      },
      "supporting_quote": "A random-effects meta-analysis of 14 studies showed a significant reduction in 24-h all-cause mortality with whole blood transfusion compared to component therapy (OR: 0.67, 95 % CI [0.50, 0.88]; p = 0.005)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:32:51"
    },
    {
      "id": 632,
      "intervention": {
        "name": "uniportal video-assisted thoracoscopic surgery (VATS)",
        "canonical_name": "continuous intertransverse process block",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "lung cancer diagnosis and resection",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "protocol for a double-blind, prospective, randomised controlled trial",
        "sample_size": 96,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of ultrasound-guided continuous intertransverse process block and continuous erector spinae plane block for postoperative analgesia after uniportal video-assisted thoracoscopic surgery: protocol for a double-blind, prospective, randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-09-28",
        "pubmed_id": "41022450",
        "doi": "10.1136/bmjopen-2025-099082"
      },
      "supporting_quote": "Video-assisted thoracoscopic surgery (VATS) has become the predominant method for lung cancer diagnosis and resection",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:29:34"
    },
    {
      "id": 633,
      "intervention": {
        "name": "continuous intertransverse process block",
        "canonical_name": "continuous intertransverse process block",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "postoperative analgesia after uniportal video-assisted thoracoscopic surgery",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "protocol for a double-blind, prospective, randomised controlled trial",
        "sample_size": 96,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Comparison of ultrasound-guided continuous intertransverse process block and continuous erector spinae plane block for postoperative analgesia after uniportal video-assisted thoracoscopic surgery: protocol for a double-blind, prospective, randomised controlled trial.",
        "journal": "BMJ open",
        "publication_date": "2025-09-28",
        "pubmed_id": "41022450",
        "doi": "10.1136/bmjopen-2025-099082"
      },
      "supporting_quote": "This study aims to address these gaps by comparing the analgesic effects and recovery quality of continuous ESPB and ITPB in patients undergoing single-port VATS",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:29:34"
    },
    {
      "id": 630,
      "intervention": {
        "name": "budesonide-formoterol",
        "canonical_name": "budesonide-formoterol",
        "category": "medication",
        "details": "{\"dosage\": \"50 \\u03bcg budesonide and 3 \\u03bcg formoterol, two actuations as needed\"}",
        "delivery_method": "inhalation"
      },
      "condition": {
        "name": "asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "mild"
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 360,
        "duration": "52 weeks",
        "population": null,
        "adverse_effects": "91% of participants had at least one adverse event",
        "cost_category": null
      },
      "paper": {
        "title": "Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.",
        "journal": "Lancet (London, England)",
        "publication_date": "2025-09-28",
        "pubmed_id": "41033330",
        "doi": "10.1016/S0140-6736(25)00861-X"
      },
      "supporting_quote": "The annualised rate of asthma attacks was lower in the budesonide-formoterol group than in the salbutamol group-cluster-adjusted rates 0·23 versus 0·41 per participant per year",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:27:40"
    },
    {
      "id": 631,
      "intervention": {
        "name": "salbutamol",
        "canonical_name": "budesonide-formoterol",
        "category": "medication",
        "details": "{\"dosage\": \"100 \\u03bcg, two actuations as needed\"}",
        "delivery_method": "inhalation"
      },
      "condition": {
        "name": "asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "mild"
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 360,
        "duration": "52 weeks",
        "population": null,
        "adverse_effects": "92% of participants had at least one adverse event",
        "cost_category": null
      },
      "paper": {
        "title": "Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.",
        "journal": "Lancet (London, England)",
        "publication_date": "2025-09-28",
        "pubmed_id": "41033330",
        "doi": "10.1016/S0140-6736(25)00861-X"
      },
      "supporting_quote": "The annualised rate of asthma attacks was lower in the budesonide-formoterol group than in the salbutamol group-cluster-adjusted rates 0·23 versus 0·41 per participant per year",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:27:40"
    },
    {
      "id": 628,
      "intervention": {
        "name": "acetaminophen",
        "canonical_name": "acetaminophen",
        "category": "medication",
        "details": "{\"dosage\": \"1 g paracetamol\", \"frequency\": \"single oral treatment\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "endotoxemia",
        "canonical_name": null,
        "category": "toxicological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 40,
        "duration": null,
        "population": null,
        "adverse_effects": "headache",
        "cost_category": "low"
      },
      "paper": {
        "title": "A randomized placebo-controlled trial in healthy volunteers examining the effects of acetaminophen and NO-acetaminophen NCX 701 in human endotoxemia.",
        "journal": "Scientific reports",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023080",
        "doi": "10.1038/s41598-025-19046-y"
      },
      "supporting_quote": "Both acetaminophen and NCX 701 effectively reduced the proportion of subjects experiencing headache.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:25:22"
    },
    {
      "id": 629,
      "intervention": {
        "name": "NCX 701",
        "canonical_name": "acetaminophen",
        "category": "medication",
        "details": "{\"dosage\": \"1-2 g\", \"frequency\": \"single oral treatment\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "endotoxemia",
        "canonical_name": null,
        "category": "toxicological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.5,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized placebo-controlled trial",
        "sample_size": 40,
        "duration": null,
        "population": null,
        "adverse_effects": "headache",
        "cost_category": "low"
      },
      "paper": {
        "title": "A randomized placebo-controlled trial in healthy volunteers examining the effects of acetaminophen and NO-acetaminophen NCX 701 in human endotoxemia.",
        "journal": "Scientific reports",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023080",
        "doi": "10.1038/s41598-025-19046-y"
      },
      "supporting_quote": "Both acetaminophen and NCX 701 effectively reduced the proportion of subjects experiencing headache.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:25:22"
    },
    {
      "id": 625,
      "intervention": {
        "name": "cognitive rehabilitation nursing (CRN)",
        "canonical_name": "progressive muscle relaxation exercises",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "schizophrenia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.35,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Cognitive Rehabilitation Nursing on Cognitive Impairment in Patients With Schizophrenia: A Comprehensive Systematic Review and Meta-Analysis.",
        "journal": "Journal of cognitive psychotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022617",
        "doi": "10.1891/JCP-2025-0012"
      },
      "supporting_quote": "Cognitive rehabilitation yielded a small but favorable effect across cognitive domains (SMD = .35, p = .084)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:24:09"
    },
    {
      "id": 626,
      "intervention": {
        "name": "computerized interventions",
        "canonical_name": "positive psychological intervention based on PERMA model",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "schizophrenia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.63,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Cognitive Rehabilitation Nursing on Cognitive Impairment in Patients With Schizophrenia: A Comprehensive Systematic Review and Meta-Analysis.",
        "journal": "Journal of cognitive psychotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022617",
        "doi": "10.1891/JCP-2025-0012"
      },
      "supporting_quote": "particularly in studies employing computerized, individualized, or virtual reality-based interventions",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:24:09"
    },
    {
      "id": 627,
      "intervention": {
        "name": "game-based interventions",
        "canonical_name": "positive psychological intervention based on PERMA model",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "schizophrenia",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effect of Cognitive Rehabilitation Nursing on Cognitive Impairment in Patients With Schizophrenia: A Comprehensive Systematic Review and Meta-Analysis.",
        "journal": "Journal of cognitive psychotherapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41022617",
        "doi": "10.1891/JCP-2025-0012"
      },
      "supporting_quote": "Pharmacological and game-based interventions showed inconsistent efficacy",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:24:09"
    },
    {
      "id": 620,
      "intervention": {
        "name": "exercise programme",
        "canonical_name": "slow movement training with tonic force generation",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024272",
        "doi": "10.1186/s13063-025-09063-7"
      },
      "supporting_quote": "The 20-week multi-modal intervention incorporates structured resilience training conducted by a clinical health psychologist (CHP), followed by an exercise physiologist (EP)-led exercise programme",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:22:33"
    },
    {
      "id": 621,
      "intervention": {
        "name": "Mediterranean diet",
        "canonical_name": "Mediterranean diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024272",
        "doi": "10.1186/s13063-025-09063-7"
      },
      "supporting_quote": "RA-HEAL tests whether a tailored intervention including formal resilience training with a clinical psychologist followed by Mediterranean diet, exercise, smoking cessation and behaviour change support has a greater effect on health-related QoL at 6 months than written advice given in current best-practice settings",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:22:33"
    },
    {
      "id": 622,
      "intervention": {
        "name": "smoking cessation programme",
        "canonical_name": "smoking cessation programme",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024272",
        "doi": "10.1186/s13063-025-09063-7"
      },
      "supporting_quote": "The 20-week multi-modal intervention incorporates structured resilience training conducted by a clinical health psychologist (CHP), followed by an exercise physiologist (EP)-led exercise programme, dietary education conducted by a dietitian nutritionist (DN), a smoking cessation programme (where applicable)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:22:33"
    },
    {
      "id": 623,
      "intervention": {
        "name": "resilience training",
        "canonical_name": "smoking cessation programme",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024272",
        "doi": "10.1186/s13063-025-09063-7"
      },
      "supporting_quote": "The 20-week multi-modal intervention incorporates structured resilience training conducted by a clinical health psychologist (CHP)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:22:33"
    },
    {
      "id": 624,
      "intervention": {
        "name": "psychologist-led behaviour-change support",
        "canonical_name": "rheumatology clinician training",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "rheumatoid arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024272",
        "doi": "10.1186/s13063-025-09063-7"
      },
      "supporting_quote": "The 20-week multi-modal intervention incorporates structured resilience training conducted by a clinical health psychologist (CHP), followed by an exercise physiologist (EP)-led exercise programme, dietary education conducted by a dietitian nutritionist (DN), a smoking cessation programme (where applicable) and psychologist-led behaviour-change support",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:22:33"
    },
    {
      "id": 619,
      "intervention": {
        "name": "colonoscopic auxiliary devices",
        "canonical_name": "wire composite splinting",
        "category": "test",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "polyp detection",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 264,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Application of colonoscopic auxiliary devices in reducing the polyp miss rate: a prospective randomized controlled study.",
        "journal": "BMC gastroenterology",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023652",
        "doi": "10.1186/s12876-025-04313-z"
      },
      "supporting_quote": "The use of auxiliary devices in colonoscopy significantly improves the PDR, espicially no-adnoma or smaller polyp",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:19:38"
    },
    {
      "id": 618,
      "intervention": {
        "name": "rivaroxaban",
        "canonical_name": "antiplatelet therapy",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "acute myocardial infarction and new-onset atrial fibrillation",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": 2477,
        "duration": "median follow-up of 922 days",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Association between rivaroxaban and the prognosis of patients with acute myocardial infarction and new-onset atrial fibrillation.",
        "journal": "Postgraduate medical journal",
        "publication_date": "2025-09-29",
        "pubmed_id": "41020767",
        "doi": "10.1093/postmj/qgaf163"
      },
      "supporting_quote": "Among patients with AMI and new-onset AF receiving dual antiplatelet therapy, no significant differences were observed between rivaroxaban users and non-oral anticoagulant users in terms of the risks of stroke, ischemic stroke, hemorrhagic stroke, all-cause mortality, cardiovascular mortality, bleeding, or major bleeding.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:18:21"
    },
    {
      "id": 616,
      "intervention": {
        "name": "smart pillbox",
        "canonical_name": "medication labels",
        "category": "emerging",
        "details": "{\"proposed_category\": \"digital adherence technology\", \"category_rationale\": \"The intervention uses a smart pillbox with audio-visual reminders and real-time dose logging.\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "drug-sensitive tuberculosis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "pragmatic cluster-randomised controlled trial",
        "sample_size": 3858,
        "duration": "12 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Digital adherence technology interventions to reduce poor end-of-treatment outcomes and recurrence among adults with drug-sensitive tuberculosis in Ethiopia: a three-arm, pragmatic, cluster-randomised, controlled trial.",
        "journal": "The Lancet. Digital health",
        "publication_date": "2025-09-29",
        "pubmed_id": "41027822",
        "doi": "10.1016/j.landig.2025.100895"
      },
      "supporting_quote": "Participants in the smart pillbox group received a pillbox with customisable audio-visual reminders",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:17:26"
    },
    {
      "id": 617,
      "intervention": {
        "name": "medication labels",
        "canonical_name": "medication labels",
        "category": "emerging",
        "details": "{\"proposed_category\": \"digital adherence technology\", \"category_rationale\": \"The intervention uses medication labels with weekly unique code labels for real-time dose logging.\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "drug-sensitive tuberculosis",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "pragmatic cluster-randomised controlled trial",
        "sample_size": 3858,
        "duration": "12 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Digital adherence technology interventions to reduce poor end-of-treatment outcomes and recurrence among adults with drug-sensitive tuberculosis in Ethiopia: a three-arm, pragmatic, cluster-randomised, controlled trial.",
        "journal": "The Lancet. Digital health",
        "publication_date": "2025-09-29",
        "pubmed_id": "41027822",
        "doi": "10.1016/j.landig.2025.100895"
      },
      "supporting_quote": "Participants in the medications label group received their tuberculosis medication with a weekly unique code label",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:17:26"
    },
    {
      "id": 614,
      "intervention": {
        "name": "nemolizumab",
        "canonical_name": "immune checkpoint inhibitor therapy",
        "category": "medication",
        "details": "{\"dosage\": \"variable based on PK model\", \"frequency\": \"every 2 weeks\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "prurigo nodularis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "population pharmacokinetics and model-based meta-analysis",
        "sample_size": null,
        "duration": "up to 24 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Quantitative Evaluation of Nemolizumab Pharmacokinetics and Efficacy in Prurigo Nodularis: A Population Pharmacokinetics and Model-Based Meta-analysis Approach.",
        "journal": "Dermatology and therapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023527",
        "doi": "10.1007/s13555-025-01554-4"
      },
      "supporting_quote": "The PopPK and PopPD models well described the PK and PD profiles of nemolizumab in patients with PN.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:16:08"
    },
    {
      "id": 615,
      "intervention": {
        "name": "dupilumab",
        "canonical_name": "immune checkpoint inhibitor therapy",
        "category": "medication",
        "details": "{\"dosage\": \"variable based on literature review\", \"frequency\": \"every 2 weeks\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "prurigo nodularis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "model-based meta-analysis",
        "sample_size": null,
        "duration": "up to 24 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Quantitative Evaluation of Nemolizumab Pharmacokinetics and Efficacy in Prurigo Nodularis: A Population Pharmacokinetics and Model-Based Meta-analysis Approach.",
        "journal": "Dermatology and therapy",
        "publication_date": "2025-09-29",
        "pubmed_id": "41023527",
        "doi": "10.1007/s13555-025-01554-4"
      },
      "supporting_quote": "Model simulations indicated that the success rates for PP-NRS and IGA were consistently higher for nemolizumab compared with dupilumab, up to 24 weeks.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:16:08"
    },
    {
      "id": 613,
      "intervention": {
        "name": "message-based intervention",
        "canonical_name": "positive psychological intervention based on PERMA model",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "serious mental illness",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 39,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Demographic, clinical, and linguistic features associated with engagement in message-based interventions for serious mental illness.",
        "journal": "Psychiatric rehabilitation journal",
        "publication_date": "2025-09-29",
        "pubmed_id": "41021485",
        "doi": "10.1037/prj0000667"
      },
      "supporting_quote": "Engagement was operationalized as total texts sent per day and total number of disengaged days.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:14:47"
    },
    {
      "id": 612,
      "intervention": {
        "name": "PARPi",
        "canonical_name": "suraxavir marboxil (GP681)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "solid tumors (prostate, breast, ovarian, pancreatic, glioblastoma, small-cell lung cancer, non-small-cell lung cancer)",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "meta-analysis of randomized controlled phase II and III clinical trials",
        "sample_size": 15008,
        "duration": null,
        "population": null,
        "adverse_effects": "venous thromboembolic events (VTEs)",
        "cost_category": null
      },
      "paper": {
        "title": "Venous thromboembolic event risk with PARP inhibitors in solid tumors: a systematic review and meta-analysis.",
        "journal": "ESMO open",
        "publication_date": "2025-09-29",
        "pubmed_id": "41027069",
        "doi": "10.1016/j.esmoop.2025.105811"
      },
      "supporting_quote": "The incidence of any-grade VTEs with PARPi was observed to be 2.4%, compared with 1.6% in controls, suggesting a possible increase in risk",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:13:30"
    },
    {
      "id": 611,
      "intervention": {
        "name": "standard preoperative diet",
        "canonical_name": "Mediterranean diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "colorectal cancer surgery",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy of preoperative immunonutrition in malnourished patients undergoing colorectal cancer surgery: a study protocol for a multicenter randomized clinical trial.",
        "journal": "Trials",
        "publication_date": "2025-09-29",
        "pubmed_id": "41024239",
        "doi": "10.1186/s13063-025-09082-4"
      },
      "supporting_quote": "Patients will be randomly assigned (1:1) to receive either preoperative immunonutrition with oral nutritional supplements (400 mL/day) containing arginine and ω-3 fatty acids for 7 days before surgery (intervention group) or a standard preoperative diet alone (control group)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:12:42"
    },
    {
      "id": 610,
      "intervention": {
        "name": "ureteral access sheath (UAS)",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "renal stones",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "retrospective, multicenter cohort study",
        "sample_size": 1177,
        "duration": "24 months (January 2017 to December 2018)",
        "population": null,
        "adverse_effects": "increased perioperative morbidity",
        "cost_category": null
      },
      "paper": {
        "title": "Does the use of a ureteral access sheath improve perioperative outcomes in ureteroscopy? A real-world multi-institutional study.",
        "journal": "Urolithiasis",
        "publication_date": "2025-09-29",
        "pubmed_id": "41021049",
        "doi": "10.1007/s00240-025-01865-3"
      },
      "supporting_quote": "In this large multicenter retrospective study, UAS use during RIRS was associated with a similar stone-free rate but increased perioperative morbidity.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:11:24"
    },
    {
      "id": 608,
      "intervention": {
        "name": "SRS (stereotactic radiosurgery)",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "brain metastases from non-small cell lung cancer",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study.",
        "journal": "International journal of radiation oncology, biology, physics",
        "publication_date": "2025-09-29",
        "pubmed_id": "41033612",
        "doi": "10.1016/j.ijrobp.2025.08.066"
      },
      "supporting_quote": "In the phase 3 METIS trial (NCT02831959) adults with 1-10 newly-diagnosed NSCLC BM suitable for SRS receiving optimal therapy for extracranial disease were randomized 1:1 to SRS followed by TTFields (150 kHz) or SRS alone.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:10:07"
    },
    {
      "id": 609,
      "intervention": {
        "name": "TTFields (Tumor Treating Fields)",
        "canonical_name": null,
        "category": "emerging",
        "details": "{\"proposed_category\": \"electromagnetic therapy\", \"category_rationale\": \"TTFields is a novel intervention that uses electric fields to disrupt cancer cell division, which does not fit into existing categories.\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "brain metastases from non-small cell lung cancer",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 298,
        "duration": "median of 8.6 months (range: 0.07-85.2 months)",
        "population": null,
        "adverse_effects": "Device-related AEs were mainly grade ≤2 skin events.",
        "cost_category": null
      },
      "paper": {
        "title": "Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study.",
        "journal": "International journal of radiation oncology, biology, physics",
        "publication_date": "2025-09-29",
        "pubmed_id": "41033612",
        "doi": "10.1016/j.ijrobp.2025.08.066"
      },
      "supporting_quote": "TTFields significantly delayed TTIP (HR 0.72 [95% CI 0.53-0.98]; Fine-Gray P=0.044).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:10:07"
    },
    {
      "id": 606,
      "intervention": {
        "name": "mepolizumab",
        "canonical_name": "mepolizumab",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "severe therapy resistant asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Bayesian framework to evaluate non-inferiority in randomised controlled trials of uncommon conditions.",
        "journal": "Journal of clinical epidemiology",
        "publication_date": "2025-09-29",
        "pubmed_id": "41033406",
        "doi": "10.1016/j.jclinepi.2025.112002"
      },
      "supporting_quote": "We illustrate the framework in an NIHR funded NI trial of mepolizumab compared to omalizumab in children with severe therapy resistant asthma.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:08:34"
    },
    {
      "id": 607,
      "intervention": {
        "name": "omalizumab",
        "canonical_name": "mepolizumab",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "severe therapy resistant asthma",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A Bayesian framework to evaluate non-inferiority in randomised controlled trials of uncommon conditions.",
        "journal": "Journal of clinical epidemiology",
        "publication_date": "2025-09-29",
        "pubmed_id": "41033406",
        "doi": "10.1016/j.jclinepi.2025.112002"
      },
      "supporting_quote": "We illustrate the framework in an NIHR funded NI trial of mepolizumab compared to omalizumab in children with severe therapy resistant asthma.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:08:34"
    },
    {
      "id": 605,
      "intervention": {
        "name": "robot-assisted total knee arthroplasty (TKA)",
        "canonical_name": null,
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "end-stage osteoarthritis of the knee",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "prospective non-randomized study",
        "sample_size": 40,
        "duration": "18 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "A prospective study to compare clinical and radiological outcomes of functionally versus mechanically aligned knees following robotic total knee arthroplasty.",
        "journal": "The journal of knee surgery",
        "publication_date": "2025-09-30",
        "pubmed_id": "41027465",
        "doi": "10.1055/a-2712-4085"
      },
      "supporting_quote": "FA with robot-assisted TKA was associated with improvement in clinical outcomes and reduced pain",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:07:27"
    },
    {
      "id": 604,
      "intervention": {
        "name": "home-based support",
        "canonical_name": "physical therapy",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "chronic obstructive pulmonary disease (COPD)",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "qualitative study",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Patients' and healthcare personnel's experiences of a health-literacy intervention in chronic obstructive pulmonary disease - a qualitative study.",
        "journal": "BMC health services research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029694",
        "doi": "10.1186/s12913-025-13299-z"
      },
      "supporting_quote": "Patients described how home-based support from competent nurses may have contributed to a better understanding of post-discharge care and fostered a sense of preparedness.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:06:48"
    },
    {
      "id": 603,
      "intervention": {
        "name": "suraxavir marboxil (GP681)",
        "canonical_name": "suraxavir marboxil (GP681)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "influenza virus replication prevention",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "phase I study",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "well tolerated with all adverse events recovering without treatment after discontinuation of suraxavir marboxil",
        "cost_category": null
      },
      "paper": {
        "title": "A first-in-human phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel anti-influenza agent suraxavir marboxil in healthy Chinese subjects.",
        "journal": "Antimicrobial agents and chemotherapy",
        "publication_date": "2025-09-30",
        "pubmed_id": "41025645",
        "doi": "10.1128/aac.00685-25"
      },
      "supporting_quote": "Suraxavir marboxil was well tolerated in healthy Chinese subjects.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:05:43"
    },
    {
      "id": 602,
      "intervention": {
        "name": "rusfertide",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": "subcutaneous injection"
      },
      "condition": {
        "name": "polycythemia vera",
        "canonical_name": null,
        "category": "hematological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 60,
        "duration": "not specified",
        "population": null,
        "adverse_effects": "mild TEAEs (headache, nausea, injection site erythema, injection site pain, influenza-like illness)",
        "cost_category": null
      },
      "paper": {
        "title": "Evaluation of Rusfertide, a Hepcidin Mimetic, on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled Crossover Thorough QT Study in Healthy Participants.",
        "journal": "Clinical therapeutics",
        "publication_date": "2025-09-30",
        "pubmed_id": "41033871",
        "doi": "10.1016/j.clinthera.2025.09.002"
      },
      "supporting_quote": "Rusfertide had no clinically relevant effect on HR, cardiac conduction, or QTc. Rusfertide was well tolerated.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:05:03"
    },
    {
      "id": 601,
      "intervention": {
        "name": "corticosteroids",
        "canonical_name": "corticosteroids",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "sepsis",
        "canonical_name": null,
        "category": "infectious",
        "severity": "severe"
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 176,
        "duration": null,
        "population": null,
        "adverse_effects": "harmful signal in CTS2-assigned patients",
        "cost_category": null
      },
      "paper": {
        "title": "A consensus blood transcriptomic framework for sepsis.",
        "journal": "Nature medicine",
        "publication_date": "2025-09-30",
        "pubmed_id": "41028542",
        "doi": "10.1038/s41591-025-03964-5"
      },
      "supporting_quote": "post hoc analysis of a pseudo-randomized cohort, along with a reanalysis of the VANISH trial data, unmasked a harmful signal in CTS2-assigned patients treated with corticosteroids",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:03:43"
    },
    {
      "id": 600,
      "intervention": {
        "name": "risankizumab",
        "canonical_name": "risankizumab",
        "category": "medication",
        "details": "{\"dosage\": \"150 mg subcutaneous injection\", \"frequency\": \"every 12 weeks\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "psoriatic arthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 1038,
        "duration": "196 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials.",
        "journal": "Rheumatology and therapy",
        "publication_date": "2025-09-30",
        "pubmed_id": "41028616",
        "doi": "10.1007/s40744-025-00793-3"
      },
      "supporting_quote": "Risankizumab demonstrated durable efficacy and safety at week 196 in KS1 and KS2.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:03:00"
    },
    {
      "id": 598,
      "intervention": {
        "name": "deucravacitinib",
        "canonical_name": "risankizumab",
        "category": "medication",
        "details": "{\"dosage\": \"6 mg once daily\", \"frequency\": \"daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "moderate-to-severe plaque psoriasis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-effectiveness of deucravacitinib versus apremilast of moderate-to-severe plaque psoriasis in China.",
        "journal": "BMC health services research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029430",
        "doi": "10.1186/s12913-025-13403-3"
      },
      "supporting_quote": "The study aimed to assess the cost-effectiveness of deucravacitinib versus apremilast for treating moderate-to-severe plaque psoriasis",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:02:17"
    },
    {
      "id": 599,
      "intervention": {
        "name": "apremilast",
        "canonical_name": "risankizumab",
        "category": "medication",
        "details": "{\"dosage\": \"30 mg twice daily\", \"frequency\": \"twice daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "moderate-to-severe plaque psoriasis",
        "canonical_name": null,
        "category": "dermatological",
        "severity": "moderate"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cost-effectiveness of deucravacitinib versus apremilast of moderate-to-severe plaque psoriasis in China.",
        "journal": "BMC health services research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029430",
        "doi": "10.1186/s12913-025-13403-3"
      },
      "supporting_quote": "The study aimed to assess the cost-effectiveness of deucravacitinib versus apremilast for treating moderate-to-severe plaque psoriasis",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:02:17"
    },
    {
      "id": 597,
      "intervention": {
        "name": "empowerment program",
        "canonical_name": "Stress First Aid (SFA)",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "quasi-experimental study",
        "sample_size": 98,
        "duration": "6 weeks postoperatively",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "The effect of an empowerment program on pain control and self-efficacy in patients undergoing total knee arthroplasty in Iran: a quasi-experimental study.",
        "journal": "BMC musculoskeletal disorders",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029288",
        "doi": "10.1186/s12891-025-09150-5"
      },
      "supporting_quote": "The empowerment program proved effective as an interactive, applicable, and non-invasive approach for enhancing pain management and self-efficacy in total knee arthroplasty patients.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:01:03"
    },
    {
      "id": 596,
      "intervention": {
        "name": "physical therapy",
        "canonical_name": "physical therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Collaborative model of care between orthopaedics and allied health professionals in knee osteoarthritis (CONNACT): process evaluation of an effectiveness-implementation hybrid randomized control trial.",
        "journal": "BMC musculoskeletal disorders",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029682",
        "doi": "10.1186/s12891-025-08925-0"
      },
      "supporting_quote": "CONNACT intervention is not superior to control hospital-based usual care in terms of pain, function, and quality of life",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 16:00:14"
    },
    {
      "id": 593,
      "intervention": {
        "name": "fracture fixation",
        "canonical_name": "fracture fixation",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "periprosthetic fractures around elbow prosthesis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 85,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Classification-based treatment of periprosthetic fractures around total elbow arthroplasty: a systematic review and meta-analysis.",
        "journal": "Patient safety in surgery",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029869",
        "doi": "10.1186/s13037-025-00447-x"
      },
      "supporting_quote": "type 2 and 3 fractures without stem loosening with fracture fixation",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:59:37"
    },
    {
      "id": 594,
      "intervention": {
        "name": "revision arthroplasty",
        "canonical_name": "fracture fixation",
        "category": "surgery",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "periprosthetic fractures around elbow prosthesis",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 85,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Classification-based treatment of periprosthetic fractures around total elbow arthroplasty: a systematic review and meta-analysis.",
        "journal": "Patient safety in surgery",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029869",
        "doi": "10.1186/s13037-025-00447-x"
      },
      "supporting_quote": "type 2 fractures with stem loosening with revision arthroplasty",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:59:37"
    },
    {
      "id": 595,
      "intervention": {
        "name": "non-operative treatment",
        "canonical_name": "fracture fixation",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "periprosthetic fractures around elbow prosthesis without stem loosening (type 1)",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 85,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Classification-based treatment of periprosthetic fractures around total elbow arthroplasty: a systematic review and meta-analysis.",
        "journal": "Patient safety in surgery",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029869",
        "doi": "10.1186/s13037-025-00447-x"
      },
      "supporting_quote": "type 1 fractures without stem loosening were treated non-operatively",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:59:37"
    },
    {
      "id": 590,
      "intervention": {
        "name": "cabazitaxel",
        "canonical_name": "cabazitaxel",
        "category": "medication",
        "details": "{\"dosage\": \"25 mg/m2 every 3 weeks\", \"frequency\": \"every 3 weeks\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "poor-prognosis metastatic castration-resistant prostate cancer (mCRPC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "phase 2b trial",
        "sample_size": 106,
        "duration": "median follow-up of 30.9 months",
        "population": null,
        "adverse_effects": "Adverse events of grade ≥3 were more frequent with cabazitaxel (65.4% vs 30.2%)",
        "cost_category": "high"
      },
      "paper": {
        "title": "Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.",
        "journal": "European urology oncology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41033927",
        "doi": "10.1016/j.euo.2025.07.006"
      },
      "supporting_quote": "A multicenter, open-label, phase 2b trial randomized poor-prognosis mCRPC patients to an ARPI or cabazitaxel",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:58:01"
    },
    {
      "id": 591,
      "intervention": {
        "name": "abiraterone plus prednisone",
        "canonical_name": "cabazitaxel",
        "category": "medication",
        "details": "{\"dosage\": \"1000 mg abiraterone plus prednisone daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "poor-prognosis metastatic castration-resistant prostate cancer (mCRPC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "phase 2b trial",
        "sample_size": 106,
        "duration": "median follow-up of 30.9 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.",
        "journal": "European urology oncology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41033927",
        "doi": "10.1016/j.euo.2025.07.006"
      },
      "supporting_quote": "A multicenter, open-label, phase 2b trial randomized poor-prognosis mCRPC patients to an ARPI or cabazitaxel",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:58:01"
    },
    {
      "id": 592,
      "intervention": {
        "name": "enzalutamide",
        "canonical_name": "cabazitaxel",
        "category": "medication",
        "details": "{\"dosage\": \"160 mg enzalutamide daily\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "poor-prognosis metastatic castration-resistant prostate cancer (mCRPC)",
        "canonical_name": null,
        "category": "oncological",
        "severity": "severe"
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "phase 2b trial",
        "sample_size": 106,
        "duration": "median follow-up of 30.9 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.",
        "journal": "European urology oncology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41033927",
        "doi": "10.1016/j.euo.2025.07.006"
      },
      "supporting_quote": "A multicenter, open-label, phase 2b trial randomized poor-prognosis mCRPC patients to an ARPI or cabazitaxel",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:58:01"
    },
    {
      "id": 588,
      "intervention": {
        "name": "oral liposomal iron",
        "canonical_name": "intravenous iron dextran",
        "category": "supplement",
        "details": "{\"duration\": \"3 months\", \"dosage\": \"30 mg/day\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "pediatric CKD anemia",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 1.0,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 30,
        "duration": "3 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Liposomal iron dramatic effect on chronic kidney disease pediatric anemia: a randomized clinical trial.",
        "journal": "Pediatric research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41028503",
        "doi": "10.1038/s41390-025-04418-x"
      },
      "supporting_quote": "Oral liposomal iron has higher efficacy than IV dextran, which is the traditional CKD anemia treatment in pediatric with no reported side effects.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:55:43"
    },
    {
      "id": 589,
      "intervention": {
        "name": "intravenous iron dextran",
        "canonical_name": "intravenous iron dextran",
        "category": "supplement",
        "details": "{\"duration\": \"3 months\", \"dosage\": \"50 mg three times/week\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "pediatric CKD anemia",
        "canonical_name": null,
        "category": "renal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.7,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 30,
        "duration": "3 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Liposomal iron dramatic effect on chronic kidney disease pediatric anemia: a randomized clinical trial.",
        "journal": "Pediatric research",
        "publication_date": "2025-09-30",
        "pubmed_id": "41028503",
        "doi": "10.1038/s41390-025-04418-x"
      },
      "supporting_quote": "Oral liposomal iron has higher efficacy than IV dextran, which is the traditional CKD anemia treatment in pediatric with no reported side effects.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:55:43"
    },
    {
      "id": 586,
      "intervention": {
        "name": "glucagon-like peptide-1 receptor agonists (GLP-1RA)",
        "canonical_name": "glucagon-like peptide-1 receptor agonists (GLP-1Ra)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "cardiovascular and renal outcomes in type 2 diabetes",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029853",
        "doi": "10.1186/s12933-025-02900-8"
      },
      "supporting_quote": "This study aimed to quantify the cardiorenal benefits of combination regimens with GLP-1RAs, SGLT2i, and/or finerenone versus corresponding monotherapies.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:54:27"
    },
    {
      "id": 587,
      "intervention": {
        "name": "sodium-glucose transport protein 2 inhibitors (SGLT2i)",
        "canonical_name": "glucagon-like peptide-1 receptor agonists (GLP-1Ra)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "cardiovascular and renal outcomes in type 2 diabetes",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis.",
        "journal": "Cardiovascular diabetology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41029853",
        "doi": "10.1186/s12933-025-02900-8"
      },
      "supporting_quote": "This study aimed to quantify the cardiorenal benefits of combination regimens with GLP-1RAs, SGLT2i, and/or finerenone versus corresponding monotherapies.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:54:27"
    },
    {
      "id": 582,
      "intervention": {
        "name": "Acetyl-L-Carnitine",
        "canonical_name": "Acetyl-L-Carnitine",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Polycystic ovary syndrome (PCOS)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "24 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy Of Combined Nutritional And Pharmacological Interventions In PCOS: A Six Month Randomized Controlled Trial.",
        "journal": "Naunyn-Schmiedeberg's archives of pharmacology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026176",
        "doi": "10.1007/s00210-025-04626-6"
      },
      "supporting_quote": "The syndrome primarily is associated with hyperandrogenism, hyperinsulinemia, menstrual irregularity, infertility, hormonal dysregulation and obesity. Here, we examined the effects of Acetyl-L-Carnitine...",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:52:34"
    },
    {
      "id": 583,
      "intervention": {
        "name": "L-Arginine",
        "canonical_name": "Acetyl-L-Carnitine",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Polycystic ovary syndrome (PCOS)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "24 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy Of Combined Nutritional And Pharmacological Interventions In PCOS: A Six Month Randomized Controlled Trial.",
        "journal": "Naunyn-Schmiedeberg's archives of pharmacology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026176",
        "doi": "10.1007/s00210-025-04626-6"
      },
      "supporting_quote": "...examined the effects of Acetyl-L-Carnitine, L-Arginine, CoQ10, (Carnitine + Arginine + CoQ10) and Metformin...",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:52:34"
    },
    {
      "id": 584,
      "intervention": {
        "name": "CoQ10",
        "canonical_name": "Acetyl-L-Carnitine",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Polycystic ovary syndrome (PCOS)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "24 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy Of Combined Nutritional And Pharmacological Interventions In PCOS: A Six Month Randomized Controlled Trial.",
        "journal": "Naunyn-Schmiedeberg's archives of pharmacology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026176",
        "doi": "10.1007/s00210-025-04626-6"
      },
      "supporting_quote": "...examined the effects of Acetyl-L-Carnitine, L-Arginine, CoQ10, (Carnitine + Arginine + CoQ10) and Metformin...",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:52:34"
    },
    {
      "id": 585,
      "intervention": {
        "name": "Metformin",
        "canonical_name": "metformin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Polycystic ovary syndrome (PCOS)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 63,
        "duration": "24 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy Of Combined Nutritional And Pharmacological Interventions In PCOS: A Six Month Randomized Controlled Trial.",
        "journal": "Naunyn-Schmiedeberg's archives of pharmacology",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026176",
        "doi": "10.1007/s00210-025-04626-6"
      },
      "supporting_quote": "...examined the effects of Acetyl-L-Carnitine, L-Arginine, CoQ10, (Carnitine + Arginine + CoQ10) and Metformin...",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:52:34"
    },
    {
      "id": 580,
      "intervention": {
        "name": "proton pump inhibitors",
        "canonical_name": "corticosteroids",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "gastroesophageal reflux disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Uncovering the Mechanisms of Failure of Proton Pump Inhibitors in GERD: The Role of Esophageal Acid Sensitivity.",
        "journal": "Digestive diseases and sciences",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026367",
        "doi": "10.1007/s10620-025-09450-9"
      },
      "supporting_quote": "Our primary objective was to examine esophageal acid in subjects who experienced heartburn following a standard meal that failed to respond to a proton pump inhibitor.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:50:00"
    },
    {
      "id": 581,
      "intervention": {
        "name": "omeprazole",
        "canonical_name": "omeprazole",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "gastroesophageal reflux disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Uncovering the Mechanisms of Failure of Proton Pump Inhibitors in GERD: The Role of Esophageal Acid Sensitivity.",
        "journal": "Digestive diseases and sciences",
        "publication_date": "2025-09-30",
        "pubmed_id": "41026367",
        "doi": "10.1007/s10620-025-09450-9"
      },
      "supporting_quote": "We analyzed data from a previous randomized crossover trial of proton pump inhibitors in 27 subjects with gastroesophageal reflux disease and baseline esophageal pH < 4 for more than 10% of a 24-h recording. Esophageal pH and heartburn severity were measured over 3 h following a standard meal at baseline and after omeprazole.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:50:00"
    },
    {
      "id": 579,
      "intervention": {
        "name": "antihypertensive medication",
        "canonical_name": "corticosteroids",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "hypertension",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 8,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Improvement in nocturnal blood pressure with bedtime antihypertensive administration in older adults aged 65 and above: a systematic review and meta-analysis.",
        "journal": "Clinical autonomic research : official journal of the Clinical Autonomic Research Society",
        "publication_date": "2025-09-30",
        "pubmed_id": "41028404",
        "doi": "10.1007/s10286-025-01159-z"
      },
      "supporting_quote": "Bedtime administration resulted in significantly greater reductions in nocturnal systolic BP and diastolic BP",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:48:45"
    },
    {
      "id": 578,
      "intervention": {
        "name": "trimetazidine",
        "canonical_name": "stress testing modalities",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "ischemic heart disease and atrial fibrillation",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.55,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "retrospective cohort study",
        "sample_size": 12527,
        "duration": "mean follow-up period of 1133 days (interquartile range, 442-2454)",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation.",
        "journal": "Journal of the American Heart Association",
        "publication_date": "2025-09-30",
        "pubmed_id": "41025486",
        "doi": "10.1161/JAHA.125.041629"
      },
      "supporting_quote": "Trimetazidine use was independently associated with a lower risk of new-onset ischemic stroke (hazard ratio [HR], 0.55 [95% CI, 0.44-0.68]; P<0.001)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:48:05"
    },
    {
      "id": 577,
      "intervention": {
        "name": "Yangxiao Fukang granule (YXFKG)",
        "canonical_name": "capecitabine plus oxaliplatin (XELOX)",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "stage III hepatitis B related liver cancer",
        "canonical_name": null,
        "category": "digestive",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 216,
        "duration": "six months treatment followed by six-month follow-up period",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and safety of Yangxiao Fukang granule in the treatment of stage Ⅲ hepatitis B related liver cancer: study protocol for a randomized controlled trial.",
        "journal": "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan",
        "publication_date": "2025-10",
        "pubmed_id": "41015811",
        "doi": "10.19852/j.cnki.jtcm.2025.05.018"
      },
      "supporting_quote": "Our purpose is to explore the efficacy and safety of Yangxiao Fukang granule (YXFKG) in the treatment of stage III hepatitis B related PLC.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:46:33"
    },
    {
      "id": 575,
      "intervention": {
        "name": "antitubercular therapy (ATT)",
        "canonical_name": "antitubercular therapy (ATT)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "uveitis of undetermined cause with positive interferon-gamma release assay",
        "canonical_name": null,
        "category": "immunological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.95,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 76,
        "duration": "from August 16, 2021 to February 5, 2024",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Antitubercular therapy for uveitis of undetermined cause with positive interferon-gamma release assay: a single-blind, single-centre, phase 2 randomised controlled trial.",
        "journal": "EClinicalMedicine",
        "publication_date": "2025-10",
        "pubmed_id": "41018498",
        "doi": "10.1016/j.eclinm.2025.103511"
      },
      "supporting_quote": "We aimed to assess the efficacy and safety of treatment involving ATT compared to treatment without ATT in these patients",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:45:18"
    },
    {
      "id": 576,
      "intervention": {
        "name": "systemic corticosteroids",
        "canonical_name": "antitubercular therapy (ATT)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "uveitis of undetermined cause with positive interferon-gamma release assay",
        "canonical_name": null,
        "category": "immunological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 76,
        "duration": "from August 16, 2021 to February 5, 2024",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Antitubercular therapy for uveitis of undetermined cause with positive interferon-gamma release assay: a single-blind, single-centre, phase 2 randomised controlled trial.",
        "journal": "EClinicalMedicine",
        "publication_date": "2025-10",
        "pubmed_id": "41018498",
        "doi": "10.1016/j.eclinm.2025.103511"
      },
      "supporting_quote": "Participants in the ATT group received an additional full course of ATT in addition to systemic corticosteroids. The control group received systemic corticosteroids without ATT.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:45:18"
    },
    {
      "id": 573,
      "intervention": {
        "name": "firsekibart",
        "canonical_name": null,
        "category": "medication",
        "details": "{\"dosage\": \"200 mg\", \"frequency\": \"single subcutaneous injection\"}",
        "delivery_method": "injection"
      },
      "condition": {
        "name": "gout flares",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "moderate"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.95,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 61,
        "duration": "8 days",
        "population": null,
        "adverse_effects": "hypertriglyceridemia",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Safety of Firsekibart Compared to Etoricoxib for Gout Flares: A Phase 2, Multicenter, Open-label, Active-controlled, Randomized Non-inferiority Trial.",
        "journal": "Rheumatology and therapy",
        "publication_date": "2025-10",
        "pubmed_id": "40833487",
        "doi": "10.1007/s40744-025-00790-6"
      },
      "supporting_quote": "Firsekibart was non-inferior and superior to etoricoxib in change from baseline in target joint pain VAS scores at 72 h post-treatment",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:44:00"
    },
    {
      "id": 574,
      "intervention": {
        "name": "etoricoxib",
        "canonical_name": "colchicine",
        "category": "medication",
        "details": "{\"dosage\": \"120 mg\", \"frequency\": \"once-daily oral\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "gout flares",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": "moderate"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.85,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 62,
        "duration": "8 days",
        "population": null,
        "adverse_effects": "hypertriglyceridemia",
        "cost_category": null
      },
      "paper": {
        "title": "Efficacy and Safety of Firsekibart Compared to Etoricoxib for Gout Flares: A Phase 2, Multicenter, Open-label, Active-controlled, Randomized Non-inferiority Trial.",
        "journal": "Rheumatology and therapy",
        "publication_date": "2025-10",
        "pubmed_id": "40833487",
        "doi": "10.1007/s40744-025-00790-6"
      },
      "supporting_quote": "Firsekibart was non-inferior and superior to etoricoxib in change from baseline in target joint pain VAS scores at 72 h post-treatment",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:44:00"
    },
    {
      "id": 572,
      "intervention": {
        "name": "tadalafil",
        "canonical_name": null,
        "category": "medication",
        "details": "{\"dosage\": \"40 mg/day\", \"duration\": \"6 months\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "COPD-PH",
        "canonical_name": null,
        "category": "pulmonary",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "prospective, randomized, double-blind, multi-center clinical trial",
        "sample_size": null,
        "duration": "6 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Study Design and Rationale for The Breathe Easier With Tadalafil Therapy for Exercise-Related Dyspnea in COPD-PH (BETTER COPD-PH).",
        "journal": "Pulmonary circulation",
        "publication_date": "2025-10",
        "pubmed_id": "41036079",
        "doi": "10.1002/pul2.70167"
      },
      "supporting_quote": "we will conduct a prospective, randomized, double-blind, multi-center clinical trial to evaluate the effects of 6 months of maximally tolerated therapy with tadalafil (target dose 40 mg/day) versus placebo on dyspnea",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:42:33"
    },
    {
      "id": 570,
      "intervention": {
        "name": "omeprazole",
        "canonical_name": "omeprazole",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "nonerosive gastroesophageal reflux disease (NERD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized, double-blinded study",
        "sample_size": 72,
        "duration": "8 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": "medium"
      },
      "paper": {
        "title": "Hewei Jiangni recipe improved the quality of life in patients with cold-heat mixed nonerosive reflux disease: a randomized, double-blinded study.",
        "journal": "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan",
        "publication_date": "2025-10",
        "pubmed_id": "41015809",
        "doi": "10.19852/j.cnki.jtcm.20250107.001"
      },
      "supporting_quote": "Compared with omeprazole, the TCM group significantly improved quality of life and alleviated symptoms such as loss of appetite, fatigue, bowel sounds, and coldness in the hands and feet",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:41:49"
    },
    {
      "id": 571,
      "intervention": {
        "name": "Hewei Jiangni recipe (HWJNR)",
        "canonical_name": "Yiqi Chupi powder",
        "category": "supplement",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "nonerosive gastroesophageal reflux disease (NERD) with cold-heat complex syndrome",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized, double-blinded study",
        "sample_size": 72,
        "duration": "8 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": "medium"
      },
      "paper": {
        "title": "Hewei Jiangni recipe improved the quality of life in patients with cold-heat mixed nonerosive reflux disease: a randomized, double-blinded study.",
        "journal": "Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan",
        "publication_date": "2025-10",
        "pubmed_id": "41015809",
        "doi": "10.19852/j.cnki.jtcm.20250107.001"
      },
      "supporting_quote": "HWJNR was clinically as effective as omeprazole and demonstrated advantages in improving quality of life",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:41:49"
    },
    {
      "id": 569,
      "intervention": {
        "name": "tele-genetic counseling (GC)",
        "canonical_name": null,
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "Alzheimer's disease risk",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 93,
        "duration": "6 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Tele-Genetic Versus Onsite Counseling for APOE Disclosure: A 6-Month Study of Empowerment, Psychological Distress, and Behavioral Outcomes in Cognitively Diverse Individuals.",
        "journal": "The journal of gene medicine",
        "publication_date": "2025-10",
        "pubmed_id": "41035143",
        "doi": "10.1002/jgm.70041"
      },
      "supporting_quote": "Tele-GC can serve as an effective intervention for APOE disclosure for healthy relatives of PwAD and people with MCI",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:40:36"
    },
    {
      "id": 568,
      "intervention": {
        "name": "opioid use",
        "canonical_name": "vasopressor and/or inotropic support",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "chronic low back pain (CLBP)",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Circadian rhythmicity and biopsychosocial characteristics influence opioid use in chronic low back pain.",
        "journal": "The Journal of clinical investigation",
        "publication_date": "2025-10-01",
        "pubmed_id": "41031896",
        "doi": "10.1172/JCI188620"
      },
      "supporting_quote": "This population had no opioid users, better biopsychosocial profiles",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:39:30"
    },
    {
      "id": 567,
      "intervention": {
        "name": "cognitive behavioral therapy",
        "canonical_name": "cognitive behavioral therapy",
        "category": "therapy",
        "details": "{}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "anxiety and substance use disorders",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 26,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Feasibility, Acceptability, and Preliminary Clinical Impact of a Computer-Assisted Transdiagnostic CBT Intervention for Veterans with Co-Occurring Anxiety and Substance Use Disorders.",
        "journal": "Journal of dual diagnosis",
        "publication_date": "2025-10-01",
        "pubmed_id": "41033342",
        "doi": "10.1080/15504263.2025.2559174"
      },
      "supporting_quote": "This study examined feasibility, acceptability, and preliminary clinical impact of Veterans Affairs Coordinated Anxiety Learning and Management- Substance (VA CALM-S), a computer-assisted, transdiagnostic cognitive behavioral intervention for co-occurring anxiety and substance use disorders",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:37:04"
    },
    {
      "id": 564,
      "intervention": {
        "name": "montelukast",
        "canonical_name": "budesonide-formoterol",
        "category": "medication",
        "details": "{\"dosage\": \"not specified\", \"frequency\": \"daily\", \"duration\": \"throughout the study period\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "doxorubicin-induced cardiotoxicity in breast cancer patients",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.644,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "prospective, randomized, controlled clinical study",
        "sample_size": 50,
        "duration": "up to four courses at 21-day intervals",
        "population": null,
        "adverse_effects": null,
        "cost_category": "medium"
      },
      "paper": {
        "title": "Evaluating the role of montelukast on doxorubicin-induced cardiotoxicity in breast cancer patients.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034674",
        "doi": "10.1007/s00520-025-09947-z"
      },
      "supporting_quote": "The incorporation of ML into AC led to a substantial decrease in cardiac biomarkers confirming the feasibility of incorporating ML in individuals with breast cancer as an auxiliary treatment to prevent DOX-induced cardiotoxicity.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:36:20"
    },
    {
      "id": 565,
      "intervention": {
        "name": "doxorubicin",
        "canonical_name": "cyclophosphamide",
        "category": "medication",
        "details": "{\"dosage\": \"60 mg/m2\", \"frequency\": \"every 21 days\", \"duration\": \"up to four courses\"}",
        "delivery_method": "intravenous"
      },
      "condition": {
        "name": "breast cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "prospective, randomized, controlled clinical study",
        "sample_size": 50,
        "duration": "up to four courses at 21-day intervals",
        "population": null,
        "adverse_effects": "cardiotoxicity",
        "cost_category": "high"
      },
      "paper": {
        "title": "Evaluating the role of montelukast on doxorubicin-induced cardiotoxicity in breast cancer patients.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034674",
        "doi": "10.1007/s00520-025-09947-z"
      },
      "supporting_quote": "This study examined the potential protective effects of montelukast (ML), an anti-asthmatic drug with anti-inflammatory characteristics, against doxorubicin-induced cardiotoxicity (DIC) in breast cancer (BC) patients.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:36:20"
    },
    {
      "id": 566,
      "intervention": {
        "name": "cyclophosphamide",
        "canonical_name": "cyclophosphamide",
        "category": "medication",
        "details": "{\"dosage\": \"600 mg/m2\", \"frequency\": \"every 21 days\", \"duration\": \"up to four courses\"}",
        "delivery_method": "intravenous"
      },
      "condition": {
        "name": "breast cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "prospective, randomized, controlled clinical study",
        "sample_size": 50,
        "duration": "up to four courses at 21-day intervals",
        "population": null,
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Evaluating the role of montelukast on doxorubicin-induced cardiotoxicity in breast cancer patients.",
        "journal": "Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034674",
        "doi": "10.1007/s00520-025-09947-z"
      },
      "supporting_quote": "This study examined the potential protective effects of montelukast (ML), an anti-asthmatic drug with anti-inflammatory characteristics, against doxorubicin-induced cardiotoxicity (DIC) in breast cancer (BC) patients.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:36:20"
    },
    {
      "id": 563,
      "intervention": {
        "name": "trastuzumab deruxtecan (T-DXd)",
        "canonical_name": null,
        "category": "medication",
        "details": "{\"dosage\": \"5.4\\u2005mg/kg and 6.4\\u202fmg/kg\"}",
        "delivery_method": "intravenous"
      },
      "condition": {
        "name": "HER2-mutant metastatic non-small cell lung cancer",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "interstitial lung disease (ILD)",
        "cost_category": null
      },
      "paper": {
        "title": "Trastuzumab deruxtecan: An antibody-drug conjugates for non-small cell lung cancer.",
        "journal": "Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners",
        "publication_date": "2025-10-01",
        "pubmed_id": "41032684",
        "doi": "10.1177/10781552251383762"
      },
      "supporting_quote": "T-DXd, a HER2-targeted ADC and second line treatment, has shown significant clinical benefit in HER2-mutant metastatic NSCLC",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:34:04"
    },
    {
      "id": 562,
      "intervention": {
        "name": "high-fat-high-glucose meal challenge",
        "canonical_name": "high-fat-high-glucose meal challenge",
        "category": "diet",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "increased liver fat",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "secondary analysis of a randomized clinical trial",
        "sample_size": 66,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Mixed-meal challenge differentially modulates metabolic pathways in adipose tissue in healthy abdominally obese subjects with high versus low liver fat: a secondary analysis of a randomized clinical trial.",
        "journal": "Nutrition & metabolism",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034990",
        "doi": "10.1186/s12986-025-01010-2"
      },
      "supporting_quote": "Participants received a high-fat-high-glucose mixed-meal challenge (3833 kJ).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:31:55"
    },
    {
      "id": 561,
      "intervention": {
        "name": "digital intervention",
        "canonical_name": "digital therapeutics (DTx)",
        "category": "emerging",
        "details": "{\"proposed_category\": \"digital therapeutics\", \"category_rationale\": \"The digital intervention is a novel approach aimed at preventing type 2 diabetes through technology.\"}",
        "delivery_method": "digital"
      },
      "condition": {
        "name": "type 2 diabetes (T2D)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "cluster-randomised controlled trial",
        "sample_size": 3240,
        "duration": "24 months",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Evaluating a digital intervention for prevention of type 2 diabetes: protocol for a cluster-randomised controlled trial in urban and rural India.",
        "journal": "BMC public health",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034772",
        "doi": "10.1186/s12889-025-24337-0"
      },
      "supporting_quote": "This study aims to evaluate the effectiveness of a digital intervention designed to prevent T2D in individuals with pre-diabetes in India.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:31:15"
    },
    {
      "id": 559,
      "intervention": {
        "name": "medication for opioid use disorder (MOUD)",
        "canonical_name": "medication for opioid use disorder (MOUD)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "opioid overdose fatalities",
        "canonical_name": null,
        "category": "toxicological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": "high"
      },
      "paper": {
        "title": "Cost of implementing evidence-based practices to reduce opioid overdose fatalities in New York State communities.",
        "journal": "Addiction science & clinical practice",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034965",
        "doi": "10.1186/s13722-025-00606-6"
      },
      "supporting_quote": "The trial was conducted in 67 highly impacted communities in 4 states, including 8 Rural and 8 urban communities in New York State (NYS). To inform future community-level decision making, we estimated the implementation costs of the EBPs selected by NYS communities.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:29:49"
    },
    {
      "id": 560,
      "intervention": {
        "name": "safer opioid prescribing",
        "canonical_name": "medication for opioid use disorder (MOUD)",
        "category": "lifestyle",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "opioid overdose fatalities",
        "canonical_name": null,
        "category": "toxicological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": "low"
      },
      "paper": {
        "title": "Cost of implementing evidence-based practices to reduce opioid overdose fatalities in New York State communities.",
        "journal": "Addiction science & clinical practice",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034965",
        "doi": "10.1186/s13722-025-00606-6"
      },
      "supporting_quote": "The trial was conducted in 67 highly impacted communities in 4 states, including 8 Rural and 8 urban communities in New York State (NYS). To inform future community-level decision making, we estimated the implementation costs of the EBPs selected by NYS communities.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:29:49"
    },
    {
      "id": 558,
      "intervention": {
        "name": "inulin/oligofructose mixture",
        "canonical_name": null,
        "category": "supplement",
        "details": "{\"duration\": \"8 weeks\", \"dosage\": \"4.6 grams twice daily (total 9.2 grams/day)\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "constipation-predominant irritable bowel syndrome",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized, single-blind, placebo-controlled clinical trial",
        "sample_size": 34,
        "duration": "8 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "A randomized trial of inulin for bowel symptoms, depression and quality of life in constipation predominant IBS.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034384",
        "doi": "10.1038/s41598-025-16321-w"
      },
      "supporting_quote": "This study was conducted to evaluate the effect of inulin on bowel symptoms, depression and quality of life in individuals with constipation-predominant IBS.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:27:56"
    },
    {
      "id": 557,
      "intervention": {
        "name": "adaptive Cognitive Training Kit (COGNI-TRAcK)",
        "canonical_name": "IKAP theory-based digital health management",
        "category": "therapy",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "multiple sclerosis",
        "canonical_name": null,
        "category": "neurological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.5,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomised controlled trial",
        "sample_size": 34,
        "duration": "8 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Home-based EXergames To impRovE cognitive function in MUltiple Sclerosis (EXTREMUS).",
        "journal": "Journal of neurology, neurosurgery, and psychiatry",
        "publication_date": "2025-10-01",
        "pubmed_id": "41033785",
        "doi": "10.1136/jnnp-2025-336609"
      },
      "supporting_quote": "People with MS and impaired processing speed were randomised in a 1:1:1 ratio to an 8-week home-based training with exergames (intervention of interest), adaptive Cognitive Training Kit (COGNI-TRAcK) (working memory training as comparator intervention)",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:27:04"
    },
    {
      "id": 556,
      "intervention": {
        "name": "levetiracetam",
        "canonical_name": null,
        "category": "medication",
        "details": "{\"dosage\": \"2/3 of the daily dose in the evening and 1/3 in the morning for Group A, single night-time dose for Group B, equal split doses twice daily for Group C\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "self-limited epilepsy with centrotemporal spikes (SeLECTS)",
        "canonical_name": null,
        "category": "neurological",
        "severity": "mild"
      },
      "correlation": {
        "type": "positive",
        "strength": 0.85,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized clinical trial",
        "sample_size": 192,
        "duration": "6- and 12-months",
        "population": null,
        "adverse_effects": null,
        "cost_category": "medium"
      },
      "paper": {
        "title": "Safety and efficacy of one-dose nocturnal levetiracetam for the treatment of self-limited epilepsy with centrotemporal spikes: a randomized clinical trial.",
        "journal": "Scientific reports",
        "publication_date": "2025-10-01",
        "pubmed_id": "41034293",
        "doi": "10.1038/s41598-025-11906-x"
      },
      "supporting_quote": "Group B required the lowest effective dose, while Group C had higher blood drug concentrations (P < 0.05).",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:25:45"
    },
    {
      "id": 551,
      "intervention": {
        "name": "inotropes",
        "canonical_name": "corticosteroids",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "congenital diaphragmatic hernia (CDH)",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": "Therapeutic interventions primarily involve pulmonary vasodilators, inotropes and vasopressors, prostaglandins, and corticosteroids",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:24:57"
    },
    {
      "id": 552,
      "intervention": {
        "name": "vasopressors",
        "canonical_name": "corticosteroids",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "congenital diaphragmatic hernia (CDH)",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": "Therapeutic interventions primarily involve pulmonary vasodilators, inotropes and vasopressors, prostaglandins, and corticosteroids",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:24:57"
    },
    {
      "id": 553,
      "intervention": {
        "name": "prostaglandins",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "congenital diaphragmatic hernia (CDH)",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": "Therapeutic interventions primarily involve pulmonary vasodilators, inotropes and vasopressors, prostaglandins, and corticosteroids",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:24:57"
    },
    {
      "id": 554,
      "intervention": {
        "name": "corticosteroids",
        "canonical_name": "corticosteroids",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "congenital diaphragmatic hernia (CDH)",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": "Therapeutic interventions primarily involve pulmonary vasodilators, inotropes and vasopressors, prostaglandins, and corticosteroids",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:24:57"
    },
    {
      "id": 555,
      "intervention": {
        "name": "precision medicine approach",
        "canonical_name": null,
        "category": "emerging",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "congenital diaphragmatic hernia (CDH)",
        "canonical_name": null,
        "category": "other",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.",
        "journal": "NeoReviews",
        "publication_date": "2025-10-01",
        "pubmed_id": "41027625",
        "doi": "10.1542/neo.26-10-060"
      },
      "supporting_quote": "Recent reports highlight the benefits of a precision medicine approach, focusing on individualized treatments based on evolving pathophysiology",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:24:57"
    },
    {
      "id": 549,
      "intervention": {
        "name": "drug-coated balloon (DCB)",
        "canonical_name": "drug-coated balloon (DCB)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "de novo lesions of large coronary arteries",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 9745,
        "duration": "17 ± 8 months (DCB), 16 ± 4 months (DES)",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Drug-Coated Balloon Versus Drug-Eluting Stent for De Novo Lesions of Large Coronary Arteries: A Systematic Review and Meta-Analysis of Angiographic and Clinical Outcomes.",
        "journal": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions",
        "publication_date": "2025-10-01",
        "pubmed_id": "41031479",
        "doi": "10.1002/ccd.70223"
      },
      "supporting_quote": "Compared with DES, treatment with DCB yields a less optimal immediate angiographic result but comparable clinical outcomes in patients with de novo lesions of large coronary arteries.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:23:02"
    },
    {
      "id": 550,
      "intervention": {
        "name": "drug-eluting stent (DES)",
        "canonical_name": "drug-coated balloon (DCB)",
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "de novo lesions of large coronary arteries",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 9745,
        "duration": "17 ± 8 months (DCB), 16 ± 4 months (DES)",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Drug-Coated Balloon Versus Drug-Eluting Stent for De Novo Lesions of Large Coronary Arteries: A Systematic Review and Meta-Analysis of Angiographic and Clinical Outcomes.",
        "journal": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions",
        "publication_date": "2025-10-01",
        "pubmed_id": "41031479",
        "doi": "10.1002/ccd.70223"
      },
      "supporting_quote": "Compared with DES, treatment with DCB yields a less optimal immediate angiographic result but comparable clinical outcomes in patients with de novo lesions of large coronary arteries.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:23:02"
    },
    {
      "id": 547,
      "intervention": {
        "name": "hypomethylating agents (HMA)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "acute myeloid leukemia (AML)",
        "canonical_name": null,
        "category": "hematological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.",
        "journal": "American journal of hematology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41036595",
        "doi": "10.1002/ajh.70091"
      },
      "supporting_quote": "Primary endpoint treatment-change-free survival (TCFS), defined as time from randomization to death or initiation of a new disease-modifying treatment in the phase 2 DELTA trial.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:21:44"
    },
    {
      "id": 548,
      "intervention": {
        "name": "eltrombopag (EPAG)",
        "canonical_name": null,
        "category": "medication",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "acute myeloid leukemia (AML)",
        "canonical_name": null,
        "category": "hematological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.",
        "journal": "American journal of hematology",
        "publication_date": "2025-10-02",
        "pubmed_id": "41036595",
        "doi": "10.1002/ajh.70091"
      },
      "supporting_quote": "Primary endpoint treatment-change-free survival (TCFS), defined as time from randomization to death or initiation of a new disease-modifying treatment in the phase 2 DELTA trial.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:21:44"
    },
    {
      "id": 546,
      "intervention": {
        "name": "Exercise Interventions",
        "canonical_name": "latissimus dorsi-thoracolumbar fascia (LD-TLF) complex stretching",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "Breast Cancer During Adjuvant Therapy",
        "canonical_name": null,
        "category": "oncological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "Systematic Review and Meta-Analysis",
        "sample_size": 2696,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Effects of Exercise Interventions on Breast Cancer Patients During Adjuvant Therapy: A Systematic Review and Meta-Analysis.",
        "journal": "Cancer research and treatment",
        "publication_date": "2025-10-02",
        "pubmed_id": "41035214",
        "doi": "10.4143/crt.2025.762"
      },
      "supporting_quote": "Exercise can enhance the therapeutic effects of adjuvant medications, improve both physiological and psychological functions, and increase physical fitness among breast cancer patients receiving adjuvant therapy.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:20:40"
    },
    {
      "id": 545,
      "intervention": {
        "name": "latissimus dorsi-thoracolumbar fascia (LD-TLF) complex stretching",
        "canonical_name": "latissimus dorsi-thoracolumbar fascia (LD-TLF) complex stretching",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "chronic low back pain (CLBP)",
        "canonical_name": null,
        "category": "musculoskeletal",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.67,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomised clinical trial",
        "sample_size": 30,
        "duration": "4 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Role of Latissimus Dorsi-Thoracolumbar Fascia Complex Stretching on Pain and Pain-Related Parameters in Patients With Chronic Low Back Pain: A Randomised Clinical Trial.",
        "journal": "European journal of pain (London, England)",
        "publication_date": "2025-11",
        "pubmed_id": "41035304",
        "doi": "10.1002/ejp.70143"
      },
      "supporting_quote": "The study group received 4 weeks of LD-TLF complex stretching in combination with conventional physiotherapy, while the control group received conventional physiotherapy only.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:20:00"
    },
    {
      "id": 544,
      "intervention": {
        "name": "gluten-free diet (GFD)",
        "canonical_name": "standard preoperative diet",
        "category": "diet",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "refractory irritable bowel syndrome and functional dyspepsia",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized double-blind placebo-controlled study",
        "sample_size": 252,
        "duration": "6 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Prevalence and predictors of nonceliac wheat sensitivity in refractory irritable bowel syndrome and functional dyspepsia: results from a randomized double-blind placebo-controlled study.",
        "journal": "European journal of gastroenterology & hepatology",
        "publication_date": "2025-11-01",
        "pubmed_id": "41025571",
        "doi": "10.1097/MEG.0000000000003046"
      },
      "supporting_quote": "Participants underwent a 6-week GFD; gluten responders subsequently underwent a double-blind placebo-controlled gluten challenge (DBPCGC) with crossover.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:18:42"
    },
    {
      "id": 542,
      "intervention": {
        "name": "metformin",
        "canonical_name": "metformin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "olanzapine-induced metabolic adverse effects",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": 0.7,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Does Adjuvant Metformin Reduce Olanzapine-Induced Metabolic Adverse Effects in Patients Diagnosed With Schizophrenia.",
        "journal": "Neuropsychopharmacology reports",
        "publication_date": "2025-12",
        "pubmed_id": "40998755",
        "doi": "10.1002/npr2.70061"
      },
      "supporting_quote": "adjunctive metformin was shown to play a role in reducing metabolic adverse effects associated with olanzapine",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:18:05"
    },
    {
      "id": 543,
      "intervention": {
        "name": "olanzapine",
        "canonical_name": "antipsychotic medications",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "schizophrenia, bipolar disorder, major depressive disorder",
        "canonical_name": null,
        "category": "psychiatric",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.8,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "body weight gain, increased adiposity, insulin resistance, dyslipidaemia",
        "cost_category": null
      },
      "paper": {
        "title": "Does Adjuvant Metformin Reduce Olanzapine-Induced Metabolic Adverse Effects in Patients Diagnosed With Schizophrenia.",
        "journal": "Neuropsychopharmacology reports",
        "publication_date": "2025-12",
        "pubmed_id": "40998755",
        "doi": "10.1002/npr2.70061"
      },
      "supporting_quote": "olanzapine carries other prominent adverse effects associated with its use. These relate to the endocrine system and include body weight gain, increased adiposity, insulin resistance, and dyslipidaemia",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 15:18:05"
    },
    {
      "id": 538,
      "intervention": {
        "name": "sofosbuvir/daclatasvir regimen",
        "canonical_name": "ribavirin",
        "category": "medication",
        "details": "{\"duration\": \"12 weeks\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "hepatitis C",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "clinical trial",
        "sample_size": 1021,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam.",
        "journal": "Journal of viral hepatitis",
        "publication_date": "2025-11",
        "pubmed_id": "41017776",
        "doi": "10.1111/jvh.70090"
      },
      "supporting_quote": "PWID with detectable HCV RNA were referred to three public hospitals for a 12-week regimen of generic sofosbuvir/daclatasvir, with ribavirin if cirrhosis, and with CBO support for referral and adherence.",
      "extraction_model": "gemma2:9b",
      "extraction_timestamp": "2025-10-02 14:26:02"
    },
    {
      "id": 539,
      "intervention": {
        "name": "ribavirin",
        "canonical_name": "ribavirin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "hepatitis C (cirrhosis)",
        "canonical_name": null,
        "category": "endocrine",
        "severity": "severe"
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "clinical trial",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam.",
        "journal": "Journal of viral hepatitis",
        "publication_date": "2025-11",
        "pubmed_id": "41017776",
        "doi": "10.1111/jvh.70090"
      },
      "supporting_quote": "with ribavirin if cirrhosis",
      "extraction_model": "gemma2:9b",
      "extraction_timestamp": "2025-10-02 14:26:02"
    },
    {
      "id": 540,
      "intervention": {
        "name": "sofosbuvir/daclatasvir",
        "canonical_name": "ribavirin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "hepatitis C (HCV)",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.98,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "observational study",
        "sample_size": 979,
        "duration": "12 weeks",
        "population": null,
        "adverse_effects": null,
        "cost_category": "medium"
      },
      "paper": {
        "title": "High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam.",
        "journal": "Journal of viral hepatitis",
        "publication_date": "2025-11",
        "pubmed_id": "41017776",
        "doi": "10.1111/jvh.70090"
      },
      "supporting_quote": "In total, 979 participants started HCV treatment, and 901 of the 924 participants tested at SVR12 (98%) were cured.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 14:26:02"
    },
    {
      "id": 541,
      "intervention": {
        "name": "ribavirin",
        "canonical_name": "ribavirin",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "hepatitis C (HCV) with cirrhosis",
        "canonical_name": null,
        "category": "endocrine",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": 0.85,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "observational study",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": "medium"
      },
      "paper": {
        "title": "High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam.",
        "journal": "Journal of viral hepatitis",
        "publication_date": "2025-11",
        "pubmed_id": "41017776",
        "doi": "10.1111/jvh.70090"
      },
      "supporting_quote": "with ribavirin if cirrhosis",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 14:26:02"
    },
    {
      "id": 531,
      "intervention": {
        "name": "Potassium-competitive acid blockers (PCABs)",
        "canonical_name": "Potassium-competitive acid blockers (PCABs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "peptic ulcer disease",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "profound acid suppression may contribute to hypergastrinemia and increased risk of gastrointestinal infections",
        "cost_category": null
      },
      "paper": {
        "title": "Potassium-competitive acid blockers.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-11-01",
        "pubmed_id": "40923937",
        "doi": "10.1097/MOG.0000000000001127"
      },
      "supporting_quote": "[gemma2:9b, conf=0.90]: Potassium-competitive acid blockers (PCABs) are a novel class of acid suppressants that are effective in the management of symptomatic and erosive GERD, peptic ulcer disease and H. pylori infection. | [qwen2.5:14b, conf=1.00]: Potassium-competitive acid blockers (PCABs) are a novel class of acid suppressants that are effective in the management of peptic ulcer disease",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 14:23:19"
    },
    {
      "id": 532,
      "intervention": {
        "name": "Proton pump inhibitors (PPIs)",
        "canonical_name": "Potassium-competitive acid blockers (PCABs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "gastroesophageal reflux disease (GERD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Potassium-competitive acid blockers.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-11-01",
        "pubmed_id": "40923937",
        "doi": "10.1097/MOG.0000000000001127"
      },
      "supporting_quote": "Drawbacks of standard management with proton pump inhibitors (PPIs) include acid lability requiring enteric coating, slow onset of effect, lack of suppression of nocturnal acid breakthrough, and need for administration before meals.",
      "extraction_model": "gemma2:9b",
      "extraction_timestamp": "2025-10-02 14:23:19"
    },
    {
      "id": 533,
      "intervention": {
        "name": "Potassium-competitive acid blockers (PCABs)",
        "canonical_name": "Potassium-competitive acid blockers (PCABs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "symptomatic and erosive GERD",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "profound acid suppression may contribute to hypergastrinemia and increased risk of gastrointestinal infections",
        "cost_category": null
      },
      "paper": {
        "title": "Potassium-competitive acid blockers.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-11-01",
        "pubmed_id": "40923937",
        "doi": "10.1097/MOG.0000000000001127"
      },
      "supporting_quote": "Potassium-competitive acid blockers (PCABs) are a novel class of acid suppressants that are effective in the management of symptomatic and erosive GERD, peptic ulcer disease and H. pylori infection.",
      "extraction_model": "gemma2:9b",
      "extraction_timestamp": "2025-10-02 14:23:19"
    },
    {
      "id": 534,
      "intervention": {
        "name": "Potassium-competitive acid blockers (PCABs)",
        "canonical_name": "Potassium-competitive acid blockers (PCABs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "H. pylori infection",
        "canonical_name": null,
        "category": "infectious",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "profound acid suppression may contribute to hypergastrinemia and increased risk of gastrointestinal infections",
        "cost_category": null
      },
      "paper": {
        "title": "Potassium-competitive acid blockers.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-11-01",
        "pubmed_id": "40923937",
        "doi": "10.1097/MOG.0000000000001127"
      },
      "supporting_quote": "Potassium-competitive acid blockers (PCABs) are a novel class of acid suppressants that are effective in the management of symptomatic and erosive GERD, peptic ulcer disease and H. pylori infection.",
      "extraction_model": "gemma2:9b",
      "extraction_timestamp": "2025-10-02 14:23:19"
    },
    {
      "id": 535,
      "intervention": {
        "name": "Potassium-competitive acid blockers (PCABs)",
        "canonical_name": "Potassium-competitive acid blockers (PCABs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "gastroesophageal reflux disease (GERD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "profound acid suppression may contribute to hypergastrinemia and increased risk of gastrointestinal infections",
        "cost_category": null
      },
      "paper": {
        "title": "Potassium-competitive acid blockers.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-11-01",
        "pubmed_id": "40923937",
        "doi": "10.1097/MOG.0000000000001127"
      },
      "supporting_quote": "Potassium-competitive acid blockers (PCABs) are a novel class of acid suppressants that are effective in the management of symptomatic and erosive GERD",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 14:23:19"
    },
    {
      "id": 536,
      "intervention": {
        "name": "Potassium-competitive acid blockers (PCABs)",
        "canonical_name": "Potassium-competitive acid blockers (PCABs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "profound acid suppression may contribute to hypergastrinemia and increased risk of gastrointestinal infections",
        "cost_category": null
      },
      "paper": {
        "title": "Potassium-competitive acid blockers.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-11-01",
        "pubmed_id": "40923937",
        "doi": "10.1097/MOG.0000000000001127"
      },
      "supporting_quote": "Potassium-competitive acid blockers (PCABs) are a novel class of acid suppressants that are effective in the management of Helicobacter pylori infection",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 14:23:19"
    },
    {
      "id": 537,
      "intervention": {
        "name": "proton pump inhibitors (PPIs)",
        "canonical_name": "Potassium-competitive acid blockers (PCABs)",
        "category": "medication",
        "details": "{}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "gastroesophageal reflux disease (GERD)",
        "canonical_name": null,
        "category": "digestive",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": "acid lability requiring enteric coating, slow onset of effect, lack of suppression of nocturnal acid breakthrough, and need for administration before meals",
        "cost_category": null
      },
      "paper": {
        "title": "Potassium-competitive acid blockers.",
        "journal": "Current opinion in gastroenterology",
        "publication_date": "2025-11-01",
        "pubmed_id": "40923937",
        "doi": "10.1097/MOG.0000000000001127"
      },
      "supporting_quote": "Drawbacks of standard management with proton pump inhibitors (PPIs) include acid lability requiring enteric coating, slow onset of effect, lack of suppression of nocturnal acid breakthrough, and need for administration before meals",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 14:23:19"
    },
    {
      "id": 525,
      "intervention": {
        "name": "walking",
        "canonical_name": "cycling",
        "category": "exercise",
        "details": "{\"exercise_type\": \"walking\", \"frequency\": \">4 times/week for women, 3-4 times/week for men\"}",
        "delivery_method": null
      },
      "condition": {
        "name": "hip or knee osteoarthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 94,
        "duration": "two years",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Walking is the form of physical activity people with osteoarthritis in the hip or knee choose and maintain after two years.",
        "journal": "Osteoarthritis and cartilage open",
        "publication_date": "2025-12",
        "pubmed_id": "41030622",
        "doi": "10.1016/j.ocarto.2025.100681"
      },
      "supporting_quote": "Walking is the form of physical activity patients with osteoarthritis most often choose, perform and maintain.",
      "extraction_model": "gemma2:9b",
      "extraction_timestamp": "2025-10-02 14:19:26"
    },
    {
      "id": 526,
      "intervention": {
        "name": "strength training",
        "canonical_name": "cycling",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "hip or knee osteoarthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "inconclusive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 94,
        "duration": "two years",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Walking is the form of physical activity people with osteoarthritis in the hip or knee choose and maintain after two years.",
        "journal": "Osteoarthritis and cartilage open",
        "publication_date": "2025-12",
        "pubmed_id": "41030622",
        "doi": "10.1016/j.ocarto.2025.100681"
      },
      "supporting_quote": "The proportions of individuals maintaining the same activity after one and two years were 50 % for walking and 2 % for strength training.",
      "extraction_model": "gemma2:9b",
      "extraction_timestamp": "2025-10-02 14:19:26"
    },
    {
      "id": 527,
      "intervention": {
        "name": "cycling",
        "canonical_name": "cycling",
        "category": "exercise",
        "details": "{}",
        "delivery_method": null
      },
      "condition": {
        "name": "hip or knee osteoarthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 94,
        "duration": "two years",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Walking is the form of physical activity people with osteoarthritis in the hip or knee choose and maintain after two years.",
        "journal": "Osteoarthritis and cartilage open",
        "publication_date": "2025-12",
        "pubmed_id": "41030622",
        "doi": "10.1016/j.ocarto.2025.100681"
      },
      "supporting_quote": "Everyday activities and cycling were performed 2-3 times/week by both women and men.",
      "extraction_model": "gemma2:9b",
      "extraction_timestamp": "2025-10-02 14:19:26"
    },
    {
      "id": 528,
      "intervention": {
        "name": "walking",
        "canonical_name": "cycling",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "osteoarthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Walking is the form of physical activity people with osteoarthritis in the hip or knee choose and maintain after two years.",
        "journal": "Osteoarthritis and cartilage open",
        "publication_date": "2025-12",
        "pubmed_id": "41030622",
        "doi": "10.1016/j.ocarto.2025.100681"
      },
      "supporting_quote": "Walking is the form of physical activity patients with osteoarthritis most often choose, perform and maintain.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 14:19:26"
    },
    {
      "id": 529,
      "intervention": {
        "name": "strength training",
        "canonical_name": "cycling",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "osteoarthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "negative",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Walking is the form of physical activity people with osteoarthritis in the hip or knee choose and maintain after two years.",
        "journal": "Osteoarthritis and cartilage open",
        "publication_date": "2025-12",
        "pubmed_id": "41030622",
        "doi": "10.1016/j.ocarto.2025.100681"
      },
      "supporting_quote": "The proportions of individuals maintaining the same activity after one and two years were 50% for walking and 2% for strength training.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 14:19:26"
    },
    {
      "id": 530,
      "intervention": {
        "name": "cycling",
        "canonical_name": "cycling",
        "category": "exercise",
        "details": "{}",
        "delivery_method": "behavioral"
      },
      "condition": {
        "name": "osteoarthritis",
        "canonical_name": null,
        "category": "rheumatological",
        "severity": null
      },
      "correlation": {
        "type": "neutral",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": null,
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Walking is the form of physical activity people with osteoarthritis in the hip or knee choose and maintain after two years.",
        "journal": "Osteoarthritis and cartilage open",
        "publication_date": "2025-12",
        "pubmed_id": "41030622",
        "doi": "10.1016/j.ocarto.2025.100681"
      },
      "supporting_quote": "Everyday activities and cycling were performed 2-3 times/week by both women and men.",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 14:19:26"
    },
    {
      "id": 523,
      "intervention": {
        "name": "atorvastatin",
        "canonical_name": "atorvastatin",
        "category": "medication",
        "details": "{\"dosage\": \"['20 mg', '40 mg', '60 mg', '80 mg']\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "ST-segment elevation myocardial infarction (STEMI)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "observational study",
        "sample_size": 2426,
        "duration": "2 years",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Atorvastatin pretreatment, ST-segment resolution and long-term prognosis for ST-segment elevation myocardial infarction with primary percutaneous coronary intervention.",
        "journal": "International journal of cardiology. Heart & vasculature",
        "publication_date": "2025-12",
        "pubmed_id": "41036325",
        "doi": "10.1016/j.ijcha.2025.101808"
      },
      "supporting_quote": "A single dose of atorvastatin pretreatment before primary PCI significantly improves myocardial reperfusion parameters and may be associated with long-term clinical benefits",
      "extraction_model": "gemma2:9b",
      "extraction_timestamp": "2025-10-02 14:13:02"
    },
    {
      "id": 524,
      "intervention": {
        "name": "atorvastatin pretreatment",
        "canonical_name": "atorvastatin",
        "category": "medication",
        "details": "{\"dosage\": \"20 mg, 40 mg, 60 mg or 80 mg\"}",
        "delivery_method": "oral"
      },
      "condition": {
        "name": "ST-segment elevation myocardial infarction (STEMI)",
        "canonical_name": null,
        "category": "cardiac",
        "severity": null
      },
      "correlation": {
        "type": "positive",
        "strength": null,
        "extraction_confidence": null,
        "study_confidence": null
      },
      "study": {
        "type": "propensity score matching study",
        "sample_size": 2426,
        "duration": "2 years",
        "population": null,
        "adverse_effects": null,
        "cost_category": null
      },
      "paper": {
        "title": "Atorvastatin pretreatment, ST-segment resolution and long-term prognosis for ST-segment elevation myocardial infarction with primary percutaneous coronary intervention.",
        "journal": "International journal of cardiology. Heart & vasculature",
        "publication_date": "2025-12",
        "pubmed_id": "41036325",
        "doi": "10.1016/j.ijcha.2025.101808"
      },
      "supporting_quote": "A single dose of atorvastatin pretreatment before primary PCI significantly improves myocardial reperfusion parameters and may be associated with long-term clinical benefits",
      "extraction_model": "qwen2.5:14b",
      "extraction_timestamp": "2025-10-02 14:13:02"
    }
  ]
}